data_2kvx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kvx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.5 m -151.89 168.32 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.23 140.04 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.604 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 t -74.13 -39.75 63.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.835 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.97 -38.2 2.67 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 45.0 p-10 -90.16 -174.89 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.602 . . . . 0.0 111.089 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.416 ' HB ' ' CD2' ' A' ' 9' ' ' PHE . 17.1 p -133.96 142.46 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.549 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 37.7 t -97.14 -8.78 29.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.6 p90 -69.67 -26.99 64.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.056 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 11' ' ' LEU . 1.1 m -80.26 -61.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.634 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.601 ' H ' HG22 ' A' ' 10' ' ' VAL . 3.0 mm? -133.77 -58.5 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.403 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 168.57 161.51 18.77 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.635 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 25.7 m -67.63 137.37 55.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.678 0.275 . . . . 0.0 111.039 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -74.9 -52.12 12.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.748 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 12.2 t0 -75.21 135.58 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.061 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -66.42 -21.3 66.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -89.06 -7.21 56.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 111.005 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.748 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 78.7 m -89.38 118.13 28.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.734 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 p -83.92 144.49 29.15 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -74.8 68.43 1.73 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.32 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -88.0 67.21 8.9 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -29.8 135.52 0.19 Allowed Pre-proline 0 N--CA 1.469 0.499 0 O-C-N 124.673 1.233 . . . . 0.0 113.437 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.37 -30.66 4.32 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.126 -1.614 . . . . 0.0 114.933 0.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.765 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.47 152.51 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 74.8 m -89.34 149.14 23.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.935 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.0 m -133.79 146.59 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.986 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -139.33 144.83 38.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.759 -0.201 . . . . 0.0 110.764 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.409 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 5.3 m-20 . . . . . 0 N--CA 1.47 0.553 0 O-C-N 124.252 0.97 . . . . 0.0 111.236 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.459 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 m -89.06 154.99 19.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.986 0.393 . . . . 0.0 111.181 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.22 148.08 49.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.464 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.3 t -144.92 131.4 19.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.434 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.53 -122.04 19.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.274 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.0 -148.32 0.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.061 0.458 . . . . 0.0 110.36 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 9' ' ' PHE . 38.7 p -75.36 152.81 38.05 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.129 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 m -84.69 39.6 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.703 0.763 . . . . 0.0 109.269 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HE1' ' HB2' ' A' ' 23' ' ' PRO . 32.1 m-85 -107.25 -45.23 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.718 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.59 -50.65 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tm? -150.15 -47.38 0.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.17 -71.31 2.55 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.894 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 p -167.54 126.53 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.366 0.603 . . . . 0.0 112.0 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -80.76 -30.9 36.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.52 125.54 25.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.9 m -72.26 -9.11 58.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.343 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -87.39 -17.71 31.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.23 0.538 . . . . 0.0 109.896 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.1 m -89.97 134.75 34.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.923 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -106.44 142.6 35.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.9 t -81.73 96.23 7.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.23 0.538 . . . . 0.0 111.319 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.24 82.76 6.5 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 3.4 p90 -27.24 123.12 0.24 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.578 ' HB2' ' HE1' ' A' ' 9' ' ' PHE . 16.4 Cg_endo -104.61 36.31 5.03 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.193 -1.17 . . . . 0.0 114.133 0.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.72 153.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.397 0.544 . . . . 0.0 111.178 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 m -87.64 140.47 29.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.292 0.568 . . . . 0.0 111.682 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 m -136.3 155.79 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.569 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -150.23 122.66 8.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 121.728 0.775 . . . . 0.0 110.369 -179.45 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.285 0 N-CA-C 112.944 -0.063 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -136.29 155.53 49.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 110.273 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.91 126.6 31.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.9 m -72.07 -22.54 61.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.949 0.404 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.77 19.58 72.88 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -123.99 150.79 44.43 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.755 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.3 p -109.64 137.08 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.222 0.534 . . . . 0.0 112.203 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.601 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 53.0 t -101.51 -17.03 16.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.853 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -62.26 -27.56 69.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.658 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.25 -58.56 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.417 ' C ' HD13 ' A' ' 11' ' ' LEU . 1.8 tm? -153.15 -54.07 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.95 142.13 4.27 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.923 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -71.88 147.64 46.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 111.356 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.98 -53.09 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.699 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.479 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 32.6 t70 -70.94 123.87 23.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.438 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 m -71.44 -16.44 62.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.511 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -89.74 -4.84 57.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.416 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.836 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 59.1 m -87.52 124.59 33.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -78.14 139.67 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.884 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -74.05 72.19 1.65 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.135 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.19 73.29 8.97 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -35.46 137.25 0.43 Allowed Pre-proline 0 N--CA 1.466 0.332 0 O-C-N 124.54 1.15 . . . . 0.0 112.732 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.6 -28.12 7.81 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.282 -1.549 . . . . 0.0 114.797 1.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.803 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.36 -162.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.836 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 30.4 m -128.52 145.95 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.741 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.87 143.45 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HZ2' ' CG ' ' A' ' 15' ' ' ASP . 79.2 tttt -150.7 136.37 18.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.736 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.681 0.613 . . . . 0.0 111.124 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.726 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 p -150.01 -163.6 1.82 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.59 HD22 HG13 ' A' ' 24' ' ' ILE . 72.8 mt -77.15 160.3 29.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.612 0.244 . . . . 0.0 110.455 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 3.4 t -145.83 132.15 19.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.688 0.28 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.13 -123.37 32.84 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.823 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -131.55 -137.59 0.2 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 20.1 p -87.78 143.24 27.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.281 0.562 . . . . 0.0 111.351 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 42.9 t -87.9 -17.66 30.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.202 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -69.73 -18.16 63.5 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.805 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.43 -47.27 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.06 0.457 . . . . 0.0 110.562 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -151.68 -62.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.858 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.02 130.87 2.56 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.605 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -83.72 68.95 10.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.19 50.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.944 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.908 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.1 t70 -80.75 157.07 25.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -69.88 -18.81 63.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.697 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 32.3 p -134.87 37.76 3.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.873 0.368 . . . . 0.0 111.187 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.908 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . 40.4 t -140.12 151.35 45.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -119.67 140.72 50.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 110.015 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 134.62 38.41 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 49.0 t30 -147.89 158.08 43.86 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -115.56 135.07 22.58 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 120.996 0.427 . . . . 0.0 110.799 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.61 -43.32 0.66 Allowed 'Cis proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.28 -1.55 . . . . 0.0 113.175 0.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.682 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.67 156.74 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 57.8 m -85.8 174.04 9.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.23 151.78 32.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.993 0.425 . . . . 0.0 111.458 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HG3' ' O ' ' A' ' 17' ' ' SER . 48.9 tttm -148.72 133.23 17.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 . . . . . 0 N--CA 1.472 0.666 0 O-C-N 124.463 1.102 . . . . 0.0 111.621 178.663 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.765 -0.134 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 t -150.87 -162.12 1.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -80.52 133.03 35.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 110.9 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.1 t -75.53 -40.08 57.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.877 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.85 -56.35 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.94 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -89.67 170.47 10.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.167 0.508 . . . . 0.0 110.528 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 p -110.04 145.78 36.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.852 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 35.4 t -88.9 32.79 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -37.65 12.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.707 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.65 -56.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.396 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 11' ' ' LEU . 2.0 tm? -152.77 -52.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 109.712 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.562 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -179.84 163.09 30.07 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 43.7 m -62.38 132.65 53.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.82 0.343 . . . . 0.0 110.734 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -50.41 64.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.759 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.6 t0 -77.73 131.24 37.58 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.5 m -64.69 -17.85 64.46 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.503 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.58 -8.07 55.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.019 0.438 . . . . 0.0 110.795 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 85.7 m -89.18 122.61 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.798 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -84.86 143.78 28.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.232 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 m -80.27 66.78 5.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.109 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -88.25 70.16 9.17 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -30.78 135.28 0.21 Allowed Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 124.647 1.217 . . . . 0.0 113.551 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.17 -27.25 6.03 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.94 -1.692 . . . . 0.0 114.808 0.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.803 ' H ' HD11 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.4 153.66 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 85.8 m -88.61 140.4 29.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.925 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.15 139.76 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.645 0.259 . . . . 0.0 110.735 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 17' ' ' SER . 79.2 tttt -151.55 146.38 25.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.418 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.829 0.706 . . . . 0.0 111.458 179.212 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 N-CA-C 112.911 -0.076 . . . . 0.0 112.911 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -110.14 158.99 17.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.45 126.66 30.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.983 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.773 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 47.7 t -83.11 140.87 32.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.07 47.36 1.93 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.318 -0.468 . . . . 0.0 113.525 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.434 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 39.9 t0 -151.53 165.2 34.97 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.73 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 41.2 p -129.29 139.38 51.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.566 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 77.8 m -98.1 -2.9 39.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.36 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.441 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.8 p90 -66.58 -26.31 67.05 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.115 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -70.05 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.109 0.48 . . . . 0.0 110.493 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.8 tm? -153.38 -53.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.486 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.15 153.41 16.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.566 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 0.6 OUTLIER -64.99 137.53 57.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.698 0.249 . . . . 0.0 110.763 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -70.36 -41.64 72.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -80.78 122.3 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.049 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.7 t -69.67 -11.18 60.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.201 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -24.6 23.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.981 0.42 . . . . 0.0 110.52 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 68.9 m -87.5 128.64 35.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -85.25 148.8 25.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.225 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.8 m -76.97 127.31 32.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.176 0.513 . . . . 0.0 111.596 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -146.07 73.74 1.35 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.462 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 5.0 m-85 -36.18 134.49 0.57 Allowed Pre-proline 0 N--CA 1.462 0.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.756 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.43 -27.97 7.6 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.169 -1.596 . . . . 0.0 115.216 1.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -89.24 -164.77 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 61.4 m -116.88 159.76 21.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.522 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.45 135.51 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.8 ttpt -152.46 141.7 21.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 . . . . . 0 N--CA 1.464 0.266 0 O-C-N 123.635 0.584 . . . . 0.0 110.707 179.401 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.913 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -149.46 156.05 41.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.499 HD23 HG13 ' A' ' 24' ' ' ILE . 53.5 mt -71.67 133.75 45.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 26.4 m -71.13 -32.22 68.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 109.922 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.25 -39.17 2.9 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.553 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -88.36 143.93 26.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.206 0.527 . . . . 0.0 111.087 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 36.2 p -92.3 139.9 30.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.715 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.9 p -89.47 -18.6 26.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -66.95 -22.78 65.92 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.105 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.463 ' O ' HD21 ' A' ' 11' ' ' LEU . 61.5 t -81.12 -53.26 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.755 0.312 . . . . 0.0 111.089 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD21 ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -138.48 -54.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 8' ' ' CYS . . . 171.62 -148.51 11.06 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 78.7 m -117.43 134.28 55.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.688 0.244 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.08 -47.15 72.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.545 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.883 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m-20 -80.0 140.56 36.53 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 m -67.09 -24.1 65.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.249 0.547 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -93.92 6.13 49.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.082 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.883 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 51.6 m -89.65 123.26 33.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.664 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -87.59 146.72 25.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.39 71.4 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.238 0.542 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -88.78 74.5 8.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -27.27 130.87 0.18 Allowed Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 124.646 1.216 . . . . 0.0 113.839 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.441 ' HD2' HD13 ' A' ' 24' ' ' ILE . 29.3 Cg_endo -90.45 -23.04 7.85 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.366 -1.514 . . . . 0.0 114.491 0.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.806 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -91.27 160.1 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.31 0.576 . . . . 0.0 112.518 -178.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.3 m -88.66 140.47 29.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.344 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.39 140.3 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.4 ttpt -131.5 120.95 23.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.882 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 N--CA 1.47 0.566 0 O-C-N 124.38 1.05 . . . . 0.0 110.903 -179.532 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 t -155.2 -141.73 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.603 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 3' ' ' LEU . 97.9 mt -80.2 143.88 33.41 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.03 -39.69 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.952 0.406 . . . . 0.0 110.761 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.92 -29.86 10.2 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.807 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 150.21 23.98 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 69.0 p -95.1 137.21 34.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.264 0.554 . . . . 0.0 112.468 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 53.2 t -109.41 -12.3 14.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.177 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 9.6 p90 -63.18 -27.25 69.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.465 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.73 -56.22 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.482 . . . . 0.0 110.653 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.435 ' C ' HD13 ' A' ' 11' ' ' LEU . 1.8 tm? -153.17 -53.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.359 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.444 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 177.84 145.51 5.94 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.751 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 63.0 m -68.57 140.56 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.107 0.48 . . . . 0.0 111.494 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -68.93 -44.47 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.32 116.56 6.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.399 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.8 m -75.29 -12.32 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.7 m -89.15 -15.61 33.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.181 0.515 . . . . 0.0 110.142 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.17 137.41 32.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.604 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.17 128.56 34.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -62.2 130.38 45.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.51 0.672 . . . . 0.0 112.023 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 46.6 t30 -150.83 152.68 34.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.914 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.41 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 2.4 m-85 -104.72 134.18 19.79 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 78.0 Cg_endo -81.23 -33.61 3.1 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.329 -1.53 . . . . 0.0 113.209 0.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.741 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.02 152.46 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.946 -179.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p -86.71 173.06 9.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.408 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.82 152.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.337 . . . . 0.0 111.243 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -131.3 142.74 50.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 N--CA 1.465 0.323 0 O-C-N 124.29 0.994 . . . . 0.0 111.853 -178.557 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 m -149.36 154.08 38.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.024 0.44 . . . . 0.0 111.161 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.6 mt -69.28 138.02 53.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.373 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.641 ' SG ' ' HG2' ' A' ' 27' ' ' LYS . 73.4 m -82.82 -39.07 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.774 0.321 . . . . 0.0 111.094 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.92 -31.81 3.8 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.406 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -87.95 153.06 21.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.12 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 10' ' ' VAL . 17.6 p -122.8 156.04 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.688 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 m -87.81 -13.99 40.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -74.53 -25.19 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.595 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -83.13 -58.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 111.209 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.595 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.0 tm? -151.6 -54.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.51 -160.49 34.09 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.746 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 m -87.13 131.66 34.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.555 0.217 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -80.31 -44.46 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.433 0.635 . . . . 0.0 109.37 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.38 129.31 35.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.724 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.6 t -71.17 -23.35 62.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.128 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.429 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 2.9 m -89.69 37.31 0.87 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.814 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.673 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 34.9 t -139.88 154.18 47.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -119.34 145.36 46.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -83.39 120.24 25.64 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.242 0.544 . . . . 0.0 111.349 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -122.53 82.54 1.99 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 27.2 m-85 -31.59 123.73 0.36 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.305 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HD2' HD11 ' A' ' 24' ' ' ILE . 63.6 Cg_endo -102.33 25.4 14.1 Favored 'Cis proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.062 -1.224 . . . . 0.0 114.713 0.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.52 HD11 ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -131.14 151.66 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.411 0.551 . . . . 0.0 112.294 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.673 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 74.2 m -89.79 132.92 34.99 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.838 0.351 . . . . 0.0 110.376 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.49 153.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.641 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 5.9 pttm -139.76 137.07 34.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.644 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 N--CA 1.468 0.439 0 O-C-N 124.322 1.014 . . . . 0.0 110.566 -179.132 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.411 0 N-CA-C 113.541 0.177 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.9 m -100.66 -172.92 2.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.005 0.402 . . . . 0.0 111.02 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.15 129.12 38.11 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.439 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 54.0 t -76.97 -34.46 57.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.21 18.33 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.02 156.48 19.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.332 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 10' ' ' VAL . 8.2 p -127.47 144.67 51.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 111.112 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.5 m -87.32 -23.81 24.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.8 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -70.56 -22.88 62.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.412 HG21 ' OG1' ' A' ' 7' ' ' THR . 93.9 t -82.25 -57.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.289 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 11' ' ' LEU . 1.7 tm? -152.78 -55.13 0.12 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.573 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.9 -165.12 38.31 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.471 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.414 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 9.5 m -91.46 126.72 36.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.752 0.31 . . . . 0.0 110.541 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -81.68 -43.47 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.037 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.861 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 9.2 t0 -62.22 137.03 58.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.06 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -70.21 -33.57 71.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.381 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -96.28 40.01 1.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.861 ' HB2' ' HB3' ' A' ' 15' ' ' ASP . 37.9 t -124.07 147.19 48.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.504 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -123.33 146.65 47.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.11 131.47 35.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.12 0.486 . . . . 0.0 111.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -139.11 78.06 1.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.4 m-85 -27.31 125.87 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.85 -1.068 . . . . 0.0 113.651 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 64.1 Cg_endo -99.28 14.69 26.83 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.828 -1.322 . . . . 0.0 114.403 0.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.594 ' H ' HD11 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -124.62 155.51 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.2 0.524 . . . . 0.0 112.313 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.758 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 72.1 m -90.03 144.19 26.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.141 0.496 . . . . 0.0 110.95 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 25.9 m -113.35 151.21 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.133 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 4' ' ' CYS . 31.6 ttpt -150.5 123.12 8.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.872 0.844 . . . . 0.0 110.236 -179.035 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.466 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -140.15 154.95 47.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.268 0.534 . . . . 0.0 110.844 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.528 HD22 HG12 ' A' ' 26' ' ' VAL . 89.0 mt -67.16 128.49 36.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.84 24.96 7.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.06 30.5 75.76 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.647 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.754 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 4.7 t0 -126.31 156.48 40.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.417 ' HB ' ' CD1' ' A' ' 9' ' ' PHE . 6.7 p -145.11 141.38 28.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.196 0.522 . . . . 0.0 112.126 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.1 m -89.23 42.89 1.11 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 23' ' ' PRO . 3.3 m-85 -74.44 -50.12 19.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.434 ' H ' HG21 ' A' ' 10' ' ' VAL . 1.2 m -71.13 -59.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.766 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.436 ' C ' HD11 ' A' ' 11' ' ' LEU . 2.3 tm? -151.77 -50.95 0.12 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 -176.22 36.55 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.404 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.6 m -67.94 141.84 56.2 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.877 0.398 . . . . 0.0 111.751 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -67.94 -47.74 67.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.7 128.47 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.015 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 m -71.44 -9.49 58.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.413 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -88.21 -15.3 36.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 110.639 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 88.1 m -90.01 137.4 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 31.2 t -89.51 147.92 23.71 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.485 0.659 . . . . 0.0 109.778 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 77.46 9.88 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.476 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -88.33 65.27 7.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 7.2 m-85 -26.91 124.78 0.22 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 114.269 -1.332 . . . . 0.0 114.074 -176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 42.6 Cg_endo -99.42 13.58 26.48 Favored 'Cis proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.608 -1.414 . . . . 0.0 113.583 0.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.23 143.94 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.754 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 72.1 m -91.99 128.97 38.03 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.61 0.719 . . . . 0.0 111.745 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.528 HG12 HD22 ' A' ' 3' ' ' LEU . 28.2 m -115.54 143.13 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.808 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -150.11 132.01 15.15 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 121.985 0.898 . . . . 0.0 109.865 -178.527 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 N-CA-C 112.962 -0.055 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -90.96 152.0 20.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 111.176 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.417 HD23 HG11 ' A' ' 26' ' ' VAL . 21.4 mt -76.83 130.58 37.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.86 -63.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.262 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.44 -47.68 0.25 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 119.303 -1.427 . . . . 0.0 114.3 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.62 153.21 21.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 69.1 p -84.78 155.57 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.149 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 10.0 t -131.2 29.8 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 0.0 110.506 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -92.07 -22.88 19.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.704 0.288 . . . . 0.0 110.98 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -71.74 -61.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.068 0.461 . . . . 0.0 111.067 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -152.75 -50.86 0.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.468 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -167.24 141.3 6.8 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 p -78.56 144.55 35.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.334 0.588 . . . . 0.0 111.795 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -65.29 -23.9 67.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.537 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 68.6 m-20 -68.04 82.95 0.22 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -60.36 -31.61 70.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.21 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 m -89.92 29.28 1.21 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 76.3 m -142.81 156.99 45.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.17 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -89.98 154.66 19.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.522 0.677 . . . . 0.0 110.583 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.71 73.31 9.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.07 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.78 87.95 7.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -41.7 135.37 2.11 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.029 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -97.72 29.37 14.88 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.402 -1.499 . . . . 0.0 114.288 1.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 20.0 pt -140.36 -169.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.941 -0.474 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -112.05 134.16 53.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG11 HD23 ' A' ' 3' ' ' LEU . 22.1 m -135.11 155.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.087 0.47 . . . . 0.0 112.055 -178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -147.36 134.01 19.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.14 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.467 0.376 0 O-C-N 123.558 0.536 . . . . 0.0 110.395 -179.56 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -130.15 152.04 50.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.704 0.288 . . . . 0.0 110.351 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.564 HD23 HG13 ' A' ' 24' ' ' ILE . 50.4 mt -73.06 139.27 46.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 20.7 p -161.83 154.33 19.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.7 0.286 . . . . 0.0 111.089 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.16 -125.4 7.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.161 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 7' ' ' THR . 56.8 t0 -139.21 -128.97 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 20.5 p -126.21 142.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.227 0.537 . . . . 0.0 111.222 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 87.7 m -93.29 3.28 55.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.965 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -75.02 -24.13 58.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.878 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.13 -54.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -152.71 -61.99 0.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.331 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.41 150.47 5.52 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.652 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.0 m -70.59 128.63 36.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.942 0.371 . . . . 0.0 110.677 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.01 -33.24 75.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.447 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.74 126.94 31.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.664 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t -81.72 1.38 34.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.092 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -87.94 -39.71 14.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.264 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 82.9 m -88.11 124.24 33.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.176 0.512 . . . . 0.0 109.723 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -79.57 147.38 32.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 m -79.15 63.75 3.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -88.05 78.57 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -33.4 138.84 0.26 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 124.504 1.127 . . . . 0.0 113.266 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.61 -33.93 2.73 Favored 'Cis proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.003 -1.665 . . . . 0.0 115.012 0.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.564 HG13 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -89.54 166.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 41.3 m -89.68 141.81 28.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 m -135.4 147.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.323 0.583 . . . . 0.0 112.263 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 21.7 ttpp -150.08 134.73 17.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.598 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 110.234 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.439 0 CA-C-O 120.457 -0.079 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 p -98.16 170.96 8.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.876 0.338 . . . . 0.0 111.105 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 3' ' ' LEU . 95.8 mt -72.82 128.81 36.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.2 t -66.66 -47.9 71.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.45 -43.88 1.25 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.712 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.486 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 30.8 m-20 -87.51 148.66 24.82 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.115 0.483 . . . . 0.0 110.484 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 14.5 p -91.7 140.58 29.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.417 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 7.7 t -105.29 32.89 3.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.014 0.435 . . . . 0.0 111.617 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -95.04 -16.5 22.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 t -85.26 -64.5 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.426 HD12 ' C ' ' A' ' 11' ' ' LEU . 1.5 tm? -152.55 -48.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.009 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.07 -150.81 7.44 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.641 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 6' ' ' ASP . 84.9 m -141.59 168.02 20.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.74 0.27 . . . . 0.0 110.541 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -68.15 -55.11 13.56 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.721 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.9 t0 -72.67 130.19 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -76.2 -13.93 60.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.185 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.528 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -88.36 -4.29 58.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.199 0.523 . . . . 0.0 110.331 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 72.9 m -88.43 120.61 29.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.547 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.4 m -76.15 142.3 41.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -80.61 74.8 7.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -88.8 78.22 7.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 63.7 m-85 -33.5 128.55 0.41 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.999 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 24' ' ' ILE . 65.2 Cg_endo -100.75 25.63 16.42 Favored 'Cis proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.175 -1.177 . . . . 0.0 114.343 0.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.546 HD12 ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -136.52 152.57 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.814 -0.554 . . . . 0.0 111.636 -179.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 66.1 m -88.32 140.86 29.04 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.999 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -117.56 147.01 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.686 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 50.9 tttm -148.3 129.69 14.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.604 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 C--N 1.329 -0.295 0 O-C-N 123.752 0.658 . . . . 0.0 110.573 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 CA-C-O 120.155 -0.247 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 m -94.02 149.56 21.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.377 0.588 . . . . 0.0 111.067 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 74.1 mt -59.39 128.91 39.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.678 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 28.2 p -84.48 -36.48 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.62 -30.28 1.55 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.748 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.67 165.2 16.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.0 111.06 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 p -138.81 143.32 38.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.936 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.52 -14.4 43.12 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.579 ' HB3' ' HB2' ' A' ' 23' ' ' PRO . 16.0 p90 -77.03 -17.71 58.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.739 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -89.0 -58.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.948 0.404 . . . . 0.0 110.418 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.443 ' C ' HD11 ' A' ' 11' ' ' LEU . 1.9 tm? -152.62 -54.48 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.935 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.94 -150.1 12.73 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.436 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 m -116.76 123.75 47.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.939 0.369 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -76.37 -39.15 54.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 10.5 t0 -62.39 117.89 6.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.199 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 m -63.7 -28.14 69.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.1 p -95.63 1.55 53.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 111.705 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.683 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 8.7 t -89.64 140.75 29.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -95.03 140.71 29.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.07 78.01 9.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -87.93 70.45 9.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -32.59 131.56 0.32 Allowed Pre-proline 0 N--CA 1.454 -0.238 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.73 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.579 ' HB2' ' HB3' ' A' ' 9' ' ' PHE . 63.9 Cg_endo -96.24 23.58 25.04 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.355 -1.519 . . . . 0.0 114.404 1.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.06 144.97 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.89 -0.506 . . . . 0.0 112.161 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.639 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 61.6 m -89.36 132.76 34.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.992 0.425 . . . . 0.0 110.227 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.4 151.51 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.683 ' HG2' ' HA ' ' A' ' 18' ' ' CYS . 13.6 mtmm -128.94 126.23 39.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.332 0.586 . . . . 0.0 110.53 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t -150.69 -161.08 1.26 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 pp -73.3 134.15 44.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.991 0.424 . . . . 0.0 110.6 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.9 t -85.79 -49.94 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.27 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.04 -47.3 0.81 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.361 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.95 172.46 9.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.34 0.59 . . . . 0.0 111.322 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 2.7 p -120.61 154.28 35.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.245 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.6 m -88.42 37.41 0.82 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.808 0.337 . . . . 0.0 110.557 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.443 ' HE2' ' HB3' ' A' ' 23' ' ' PRO . 37.2 m-85 -144.5 38.03 1.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.43 -60.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.662 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -151.54 -55.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.51 -140.64 5.83 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -116.01 139.45 50.25 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -67.92 -55.52 12.5 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.705 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 14.4 t0 -66.72 138.03 57.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.081 0.467 . . . . 0.0 111.34 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -66.69 -32.95 74.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.604 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.4 m -93.67 17.1 12.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.126 0.489 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.711 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 46.5 t -89.77 150.28 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -120.9 150.61 40.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.645 0.26 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -93.08 130.63 38.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.012 0.434 . . . . 0.0 110.947 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -140.41 85.4 2.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.7 m-85 -32.31 128.88 0.33 Allowed Pre-proline 0 N--CA 1.465 0.275 0 O-C-N 124.197 0.936 . . . . 0.0 113.196 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.443 ' HB3' ' HE2' ' A' ' 9' ' ' PHE . 44.4 Cg_endo -99.11 22.01 22.74 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.699 -1.376 . . . . 0.0 114.711 1.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -135.76 164.73 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.352 0.596 . . . . 0.0 112.401 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.711 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 91.7 m -88.86 144.88 25.91 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.42 143.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 110.771 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 17.7 tptm -151.14 141.05 21.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.494 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 1.4 m-20 . . . . . 0 N--CA 1.47 0.547 0 O-C-N 123.814 0.696 . . . . 0.0 111.491 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -135.84 147.38 48.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.9 mt -77.44 132.58 38.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.001 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 59.9 m -98.57 148.95 23.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.905 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.33 1.72 55.41 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -87.97 137.93 31.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.01 -0.595 . . . . 0.0 109.96 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.759 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 21.3 p -110.86 137.01 49.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.869 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 43.6 t -102.5 -12.14 18.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.909 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.414 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 8.1 p90 -67.27 -25.89 66.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -73.67 -61.33 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 110.805 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.422 ' C ' HD13 ' A' ' 11' ' ' LEU . 1.7 tm? -152.95 -54.76 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.702 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.91 144.35 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.499 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.61 140.85 41.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.727 0.299 . . . . 0.0 111.033 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.62 -48.57 66.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.491 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -65.17 121.6 15.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -74.38 -9.21 58.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.002 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.503 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 1.5 m -87.08 -25.06 24.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.159 0.504 . . . . 0.0 109.951 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 95.4 m -89.45 116.86 27.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.4 t -85.09 155.68 21.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.314 0.578 . . . . 0.0 110.238 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -70.63 123.95 23.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.868 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -147.63 70.99 1.18 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.478 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 3.6 m-85 -33.86 135.63 0.34 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 114.321 -1.308 . . . . 0.0 112.908 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.6 -31.67 5.01 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.312 -1.537 . . . . 0.0 115.126 0.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.792 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.53 -161.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.484 0.659 . . . . 0.0 112.77 -178.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 12.0 m -125.49 153.66 43.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.066 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.2 m -122.52 133.87 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 111.226 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 20.8 ttpt -112.76 109.02 18.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.997 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 124.524 1.14 . . . . 0.0 110.474 -179.161 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.3 0 N-CA-C 112.802 -0.119 . . . . 0.0 112.802 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -150.91 -157.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.4 mt -80.36 129.43 34.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.681 0.277 . . . . 0.0 110.507 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.05 -54.31 7.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.986 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.37 -39.57 1.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.515 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.708 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 58.7 m-20 -86.62 148.37 25.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.054 0.454 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.567 HG21 HG22 ' A' ' 24' ' ' ILE . 17.7 p -97.32 138.76 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.553 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 48.6 t -92.32 -19.77 21.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -68.25 -25.58 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.894 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.96 -56.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.485 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -152.46 -62.8 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.128 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.96 148.48 5.29 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.092 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.708 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -72.33 138.17 47.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.276 0.23 . . . . 0.0 110.984 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -78.78 -30.8 45.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.577 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 13.2 t0 -66.93 126.8 30.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 t -68.64 -15.42 63.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.088 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.511 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.44 -14.11 38.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.498 . . . . 0.0 110.121 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 27' ' ' LYS . 72.2 m -88.98 124.18 34.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.783 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.93 133.28 33.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 124.75 24.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.293 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' CYS . 7.4 t-20 -151.47 153.53 34.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -97.94 133.46 23.24 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.349 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.05 -25.67 6.54 Favored 'Cis proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.198 -1.584 . . . . 0.0 113.887 0.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.603 ' H ' HD11 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -107.76 159.34 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.178 0.514 . . . . 0.0 112.365 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.5 m -85.94 152.33 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -109.06 140.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 82.9 tttt -151.51 144.88 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.467 0.383 0 O-C-N 123.848 0.718 . . . . 0.0 111.342 179.18 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.341 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -146.5 -162.04 1.45 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.5 130.18 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.97 0.414 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.0 t -83.31 -45.41 13.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.05 -38.84 2.71 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.701 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.427 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.8 t0 -87.86 157.38 19.0 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 54.1 p -111.48 142.35 43.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.867 0.365 . . . . 0.0 111.603 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.696 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 11.0 t -125.89 30.85 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.077 0.465 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.569 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 23.3 p90 -93.66 7.12 45.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.7 -57.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.118 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.436 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.5 mm? -97.79 -108.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.032 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 179.74 133.73 2.05 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.535 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 6' ' ' ASP . 80.5 m -69.09 117.81 11.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -79.31 -23.56 43.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.657 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -58.73 124.69 20.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -68.83 -29.35 67.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.0 p -92.01 38.1 0.99 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.752 0.787 . . . . 0.0 109.126 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 45.0 t -150.47 146.36 26.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.775 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.25 136.58 53.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.774 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -65.87 131.27 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.5 0.666 . . . . 0.0 111.766 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -151.25 160.31 43.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.17 132.92 21.84 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-O 120.629 0.252 . . . . 0.0 110.699 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 97.0 Cg_endo -83.27 -32.48 3.26 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.105 -1.623 . . . . 0.0 112.906 -0.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.524 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -97.01 157.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.858 -179.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.774 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 65.2 m -86.88 163.86 16.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.12 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -109.11 148.68 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.14 0.495 . . . . 0.0 111.645 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 21.7 ttmm -145.67 125.51 13.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.524 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.718 0.77 . . . . 0.0 111.042 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 t -89.94 174.66 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 110.52 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.95 128.18 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.446 ' HB3' ' C ' ' A' ' 25' ' ' CYS . 47.2 t -90.07 136.15 33.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.65 44.54 2.02 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.242 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.522 ' OD2' ' HA ' ' A' ' 13' ' ' CYS . 41.8 t0 -151.67 164.63 36.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.414 ' HB ' ' CD2' ' A' ' 9' ' ' PHE . 36.6 p -124.55 139.0 54.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.0 110.777 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 5.8 t -97.93 -8.76 27.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.999 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.453 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 7.4 p90 -68.63 -24.68 64.58 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.641 0.258 . . . . 0.0 110.637 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.05 -58.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.995 0.426 . . . . 0.0 110.617 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -152.97 -56.47 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.927 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 175.67 149.25 7.29 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.634 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -64.99 131.62 47.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.723 0.296 . . . . 0.0 110.652 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.1 -38.34 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 18' ' ' CYS . 55.8 t0 -66.88 130.44 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -72.36 -21.29 61.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.17 -14.44 38.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.862 0.839 . . . . 0.0 109.223 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . 47.2 t -89.53 141.77 28.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.408 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 31.0 t -108.53 149.95 28.14 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.409 0.624 . . . . 0.0 110.594 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.634 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 47.6 t -69.25 128.23 35.88 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.716 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 44.1 t30 -152.18 148.21 27.33 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 4.9 m-85 -111.34 134.29 21.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.4 -36.01 1.96 Allowed 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.941 -1.691 . . . . 0.0 112.706 -0.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.704 ' H ' HD11 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.1 152.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.491 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.7 m -85.98 172.65 10.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.056 0.455 . . . . 0.0 111.32 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.14 149.84 31.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.29 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.7 tmmt? -146.53 125.02 12.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 124.254 1.022 . . . . 0.0 112.061 -177.603 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.5 m -151.89 168.32 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.5 pp -66.23 140.04 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.604 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 t -74.13 -39.75 63.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.835 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.97 -38.2 2.67 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 45.0 p-10 -90.16 -174.89 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.602 . . . . 0.0 111.089 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.416 ' HB ' ' CD2' ' A' ' 9' ' ' PHE . 17.1 p -133.96 142.46 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.549 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 37.7 t -97.14 -8.78 29.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.416 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.6 p90 -69.67 -26.99 64.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.056 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 11' ' ' LEU . 1.1 m -80.26 -61.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.634 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.601 ' H ' HG22 ' A' ' 10' ' ' VAL . 3.0 mm? -133.77 -58.5 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.403 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 168.57 161.51 18.77 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.635 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 25.7 m -67.63 137.37 55.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.678 0.275 . . . . 0.0 111.039 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -74.9 -52.12 12.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.748 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 12.2 t0 -75.21 135.58 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.061 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -66.42 -21.3 66.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -89.06 -7.21 56.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 111.005 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.748 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 78.7 m -89.38 118.13 28.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.734 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 p -83.92 144.49 29.15 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -74.8 68.43 1.73 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.32 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -88.0 67.21 8.9 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -29.8 135.52 0.19 Allowed Pre-proline 0 N--CA 1.469 0.499 0 O-C-N 124.673 1.233 . . . . 0.0 113.437 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.37 -30.66 4.32 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.126 -1.614 . . . . 0.0 114.933 0.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.765 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.47 152.51 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 74.8 m -89.34 149.14 23.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.935 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.0 m -133.79 146.59 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.986 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -139.33 144.83 38.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.759 -0.201 . . . . 0.0 110.764 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 5.3 m-20 . . . . . 0 N--CA 1.47 0.553 0 O-C-N 124.252 0.97 . . . . 0.0 111.236 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.459 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 m -89.06 154.99 19.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.986 0.393 . . . . 0.0 111.181 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.22 148.08 49.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.464 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.3 t -144.92 131.4 19.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.434 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.53 -122.04 19.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.274 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.0 -148.32 0.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.061 0.458 . . . . 0.0 110.36 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 9' ' ' PHE . 38.7 p -75.36 152.81 38.05 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.129 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 m -84.69 39.6 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.703 0.763 . . . . 0.0 109.269 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.578 ' HE1' ' HB2' ' A' ' 23' ' ' PRO . 32.1 m-85 -107.25 -45.23 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.718 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.59 -50.65 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tm? -150.15 -47.38 0.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.17 -71.31 2.55 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.894 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 p -167.54 126.53 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.366 0.603 . . . . 0.0 112.0 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -80.76 -30.9 36.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.52 125.54 25.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.9 m -72.26 -9.11 58.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.343 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -87.39 -17.71 31.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.23 0.538 . . . . 0.0 109.896 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.1 m -89.97 134.75 34.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.923 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -106.44 142.6 35.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.9 t -81.73 96.23 7.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.23 0.538 . . . . 0.0 111.319 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.24 82.76 6.5 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 3.4 p90 -27.24 123.12 0.24 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.578 ' HB2' ' HE1' ' A' ' 9' ' ' PHE . 16.4 Cg_endo -104.61 36.31 5.03 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.193 -1.17 . . . . 0.0 114.133 0.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.72 153.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.397 0.544 . . . . 0.0 111.178 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 m -87.64 140.47 29.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.292 0.568 . . . . 0.0 111.682 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 m -136.3 155.79 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.569 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -150.23 122.66 8.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 121.728 0.775 . . . . 0.0 110.369 -179.45 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.285 0 N-CA-C 112.944 -0.063 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -136.29 155.53 49.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 110.273 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.9 mt -75.91 126.6 31.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.9 m -72.07 -22.54 61.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.949 0.404 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.77 19.58 72.88 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -123.99 150.79 44.43 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.755 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.3 p -109.64 137.08 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.222 0.534 . . . . 0.0 112.203 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.601 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 53.0 t -101.51 -17.03 16.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.853 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -62.26 -27.56 69.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.658 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.25 -58.56 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.417 ' C ' HD13 ' A' ' 11' ' ' LEU . 1.8 tm? -153.15 -54.07 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.95 142.13 4.27 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.923 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -71.88 147.64 46.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 111.356 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.98 -53.09 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.699 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.479 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 32.6 t70 -70.94 123.87 23.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.438 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 m -71.44 -16.44 62.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.511 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -89.74 -4.84 57.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.416 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.836 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 59.1 m -87.52 124.59 33.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -78.14 139.67 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.884 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -74.05 72.19 1.65 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.135 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.19 73.29 8.97 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -35.46 137.25 0.43 Allowed Pre-proline 0 N--CA 1.466 0.332 0 O-C-N 124.54 1.15 . . . . 0.0 112.732 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.6 -28.12 7.81 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.282 -1.549 . . . . 0.0 114.797 1.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.803 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.36 -162.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.836 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 30.4 m -128.52 145.95 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.741 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.0 m -119.87 143.45 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.479 ' HZ2' ' CG ' ' A' ' 15' ' ' ASP . 79.2 tttt -150.7 136.37 18.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.736 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.681 0.613 . . . . 0.0 111.124 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.726 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 p -150.01 -163.6 1.82 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.59 HD22 HG13 ' A' ' 24' ' ' ILE . 72.8 mt -77.15 160.3 29.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.612 0.244 . . . . 0.0 110.455 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 3.4 t -145.83 132.15 19.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.688 0.28 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.13 -123.37 32.84 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.823 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -131.55 -137.59 0.2 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 20.1 p -87.78 143.24 27.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.281 0.562 . . . . 0.0 111.351 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.55 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 42.9 t -87.9 -17.66 30.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.202 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -69.73 -18.16 63.5 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.805 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.43 -47.27 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.06 0.457 . . . . 0.0 110.562 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -151.68 -62.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.858 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.02 130.87 2.56 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.605 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -83.72 68.95 10.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.19 50.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.944 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.908 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.1 t70 -80.75 157.07 25.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -69.88 -18.81 63.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.697 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 32.3 p -134.87 37.76 3.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.873 0.368 . . . . 0.0 111.187 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.908 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . 40.4 t -140.12 151.35 45.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -119.67 140.72 50.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 110.015 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 134.62 38.41 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.437 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 49.0 t30 -147.89 158.08 43.86 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -115.56 135.07 22.58 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 120.996 0.427 . . . . 0.0 110.799 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -76.61 -43.32 0.66 Allowed 'Cis proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.28 -1.55 . . . . 0.0 113.175 0.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.682 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.67 156.74 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 57.8 m -85.8 174.04 9.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.23 151.78 32.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.993 0.425 . . . . 0.0 111.458 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.697 ' HG3' ' O ' ' A' ' 17' ' ' SER . 48.9 tttm -148.72 133.23 17.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 . . . . . 0 N--CA 1.472 0.666 0 O-C-N 124.463 1.102 . . . . 0.0 111.621 178.663 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.765 -0.134 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 t -150.87 -162.12 1.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -80.52 133.03 35.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 110.9 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.1 t -75.53 -40.08 57.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.877 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.85 -56.35 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.94 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -89.67 170.47 10.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.167 0.508 . . . . 0.0 110.528 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.5 p -110.04 145.78 36.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.852 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.562 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 35.4 t -88.9 32.79 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -37.65 12.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.707 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.65 -56.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.396 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 11' ' ' LEU . 2.0 tm? -152.77 -52.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 109.712 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.562 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -179.84 163.09 30.07 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 43.7 m -62.38 132.65 53.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.82 0.343 . . . . 0.0 110.734 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -50.41 64.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.759 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.6 t0 -77.73 131.24 37.58 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.5 m -64.69 -17.85 64.46 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.503 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.58 -8.07 55.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.019 0.438 . . . . 0.0 110.795 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 85.7 m -89.18 122.61 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.798 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -84.86 143.78 28.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.232 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 m -80.27 66.78 5.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.109 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -88.25 70.16 9.17 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -30.78 135.28 0.21 Allowed Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 124.647 1.217 . . . . 0.0 113.551 -178.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.17 -27.25 6.03 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.94 -1.692 . . . . 0.0 114.808 0.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.803 ' H ' HD11 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.4 153.66 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 85.8 m -88.61 140.4 29.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.925 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.15 139.76 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.645 0.259 . . . . 0.0 110.735 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 17' ' ' SER . 79.2 tttt -151.55 146.38 25.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.418 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.829 0.706 . . . . 0.0 111.458 179.212 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 N-CA-C 112.911 -0.076 . . . . 0.0 112.911 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -110.14 158.99 17.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.45 126.66 30.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.983 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.773 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 47.7 t -83.11 140.87 32.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.07 47.36 1.93 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.318 -0.468 . . . . 0.0 113.525 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.434 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 39.9 t0 -151.53 165.2 34.97 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.73 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 41.2 p -129.29 139.38 51.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.566 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 77.8 m -98.1 -2.9 39.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.36 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.441 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.8 p90 -66.58 -26.31 67.05 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.115 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -70.05 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.109 0.48 . . . . 0.0 110.493 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 11' ' ' LEU . 1.8 tm? -153.38 -53.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.486 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.15 153.41 16.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.566 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 0.6 OUTLIER -64.99 137.53 57.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.698 0.249 . . . . 0.0 110.763 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -70.36 -41.64 72.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -80.78 122.3 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.049 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.7 t -69.67 -11.18 60.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.201 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -24.6 23.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.981 0.42 . . . . 0.0 110.52 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 68.9 m -87.5 128.64 35.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -85.25 148.8 25.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.225 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.8 m -76.97 127.31 32.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.176 0.513 . . . . 0.0 111.596 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -146.07 73.74 1.35 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.462 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 5.0 m-85 -36.18 134.49 0.57 Allowed Pre-proline 0 N--CA 1.462 0.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.756 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.43 -27.97 7.6 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.169 -1.596 . . . . 0.0 115.216 1.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -89.24 -164.77 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.773 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 61.4 m -116.88 159.76 21.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.522 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.45 135.51 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.8 ttpt -152.46 141.7 21.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 . . . . . 0 N--CA 1.464 0.266 0 O-C-N 123.635 0.584 . . . . 0.0 110.707 179.401 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.913 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -149.46 156.05 41.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.499 HD23 HG13 ' A' ' 24' ' ' ILE . 53.5 mt -71.67 133.75 45.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 26.4 m -71.13 -32.22 68.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 109.922 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.25 -39.17 2.9 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.553 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -88.36 143.93 26.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.206 0.527 . . . . 0.0 111.087 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 36.2 p -92.3 139.9 30.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.715 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.9 p -89.47 -18.6 26.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -66.95 -22.78 65.92 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.105 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.463 ' O ' HD21 ' A' ' 11' ' ' LEU . 61.5 t -81.12 -53.26 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.755 0.312 . . . . 0.0 111.089 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD21 ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -138.48 -54.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 8' ' ' CYS . . . 171.62 -148.51 11.06 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 78.7 m -117.43 134.28 55.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.688 0.244 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.08 -47.15 72.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.545 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.883 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m-20 -80.0 140.56 36.53 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 m -67.09 -24.1 65.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.249 0.547 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -93.92 6.13 49.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.082 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.883 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 51.6 m -89.65 123.26 33.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.664 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -87.59 146.72 25.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.39 71.4 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.238 0.542 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -88.78 74.5 8.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -27.27 130.87 0.18 Allowed Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 124.646 1.216 . . . . 0.0 113.839 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.441 ' HD2' HD13 ' A' ' 24' ' ' ILE . 29.3 Cg_endo -90.45 -23.04 7.85 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.366 -1.514 . . . . 0.0 114.491 0.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.806 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -91.27 160.1 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.31 0.576 . . . . 0.0 112.518 -178.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.3 m -88.66 140.47 29.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.344 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.39 140.3 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.4 ttpt -131.5 120.95 23.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.882 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 N--CA 1.47 0.566 0 O-C-N 124.38 1.05 . . . . 0.0 110.903 -179.532 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 t -155.2 -141.73 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.603 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 3' ' ' LEU . 97.9 mt -80.2 143.88 33.41 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.03 -39.69 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.952 0.406 . . . . 0.0 110.761 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.92 -29.86 10.2 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.807 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 150.21 23.98 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 69.0 p -95.1 137.21 34.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.264 0.554 . . . . 0.0 112.468 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.53 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 53.2 t -109.41 -12.3 14.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.177 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.519 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 9.6 p90 -63.18 -27.25 69.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.465 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.73 -56.22 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.482 . . . . 0.0 110.653 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.435 ' C ' HD13 ' A' ' 11' ' ' LEU . 1.8 tm? -153.17 -53.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.359 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.444 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 177.84 145.51 5.94 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.751 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.53 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 63.0 m -68.57 140.56 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.107 0.48 . . . . 0.0 111.494 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -68.93 -44.47 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.32 116.56 6.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.399 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.8 m -75.29 -12.32 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.7 m -89.15 -15.61 33.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.181 0.515 . . . . 0.0 110.142 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.17 137.41 32.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.604 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.17 128.56 34.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -62.2 130.38 45.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.51 0.672 . . . . 0.0 112.023 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 46.6 t30 -150.83 152.68 34.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.914 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.41 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 2.4 m-85 -104.72 134.18 19.79 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.519 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 78.0 Cg_endo -81.23 -33.61 3.1 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.329 -1.53 . . . . 0.0 113.209 0.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.741 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.02 152.46 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.946 -179.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p -86.71 173.06 9.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.408 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.82 152.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.337 . . . . 0.0 111.243 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -131.3 142.74 50.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 N--CA 1.465 0.323 0 O-C-N 124.29 0.994 . . . . 0.0 111.853 -178.557 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 m -149.36 154.08 38.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.024 0.44 . . . . 0.0 111.161 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 72.6 mt -69.28 138.02 53.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.373 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.641 ' SG ' ' HG2' ' A' ' 27' ' ' LYS . 73.4 m -82.82 -39.07 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.774 0.321 . . . . 0.0 111.094 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.92 -31.81 3.8 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.406 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -87.95 153.06 21.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.12 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 10' ' ' VAL . 17.6 p -122.8 156.04 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.688 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 m -87.81 -13.99 40.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -74.53 -25.19 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.595 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -83.13 -58.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 111.209 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.595 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.0 tm? -151.6 -54.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.51 -160.49 34.09 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.746 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 m -87.13 131.66 34.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.555 0.217 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -80.31 -44.46 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.433 0.635 . . . . 0.0 109.37 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.38 129.31 35.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.724 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.6 t -71.17 -23.35 62.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.128 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.429 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 2.9 m -89.69 37.31 0.87 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.814 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.673 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 34.9 t -139.88 154.18 47.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -119.34 145.36 46.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -83.39 120.24 25.64 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.242 0.544 . . . . 0.0 111.349 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -122.53 82.54 1.99 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 27.2 m-85 -31.59 123.73 0.36 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.305 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HD2' HD11 ' A' ' 24' ' ' ILE . 63.6 Cg_endo -102.33 25.4 14.1 Favored 'Cis proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.062 -1.224 . . . . 0.0 114.713 0.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.52 HD11 ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -131.14 151.66 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.411 0.551 . . . . 0.0 112.294 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.673 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 74.2 m -89.79 132.92 34.99 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.838 0.351 . . . . 0.0 110.376 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -137.49 153.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.641 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 5.9 pttm -139.76 137.07 34.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.644 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 N--CA 1.468 0.439 0 O-C-N 124.322 1.014 . . . . 0.0 110.566 -179.132 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.411 0 N-CA-C 113.541 0.177 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.9 m -100.66 -172.92 2.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.005 0.402 . . . . 0.0 111.02 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.15 129.12 38.11 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.439 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 54.0 t -76.97 -34.46 57.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.21 18.33 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.02 156.48 19.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.332 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 10' ' ' VAL . 8.2 p -127.47 144.67 51.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 111.112 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.5 m -87.32 -23.81 24.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.8 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -70.56 -22.88 62.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.412 HG21 ' OG1' ' A' ' 7' ' ' THR . 93.9 t -82.25 -57.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.289 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 11' ' ' LEU . 1.7 tm? -152.78 -55.13 0.12 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.573 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.9 -165.12 38.31 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.471 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.414 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 9.5 m -91.46 126.72 36.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.752 0.31 . . . . 0.0 110.541 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -81.68 -43.47 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.037 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.861 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 9.2 t0 -62.22 137.03 58.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.06 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -70.21 -33.57 71.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.381 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -96.28 40.01 1.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.861 ' HB2' ' HB3' ' A' ' 15' ' ' ASP . 37.9 t -124.07 147.19 48.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.504 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -123.33 146.65 47.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.11 131.47 35.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.12 0.486 . . . . 0.0 111.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -139.11 78.06 1.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.4 m-85 -27.31 125.87 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.85 -1.068 . . . . 0.0 113.651 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 64.1 Cg_endo -99.28 14.69 26.83 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.828 -1.322 . . . . 0.0 114.403 0.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.594 ' H ' HD11 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -124.62 155.51 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.2 0.524 . . . . 0.0 112.313 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.758 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 72.1 m -90.03 144.19 26.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.141 0.496 . . . . 0.0 110.95 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 25.9 m -113.35 151.21 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.133 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 4' ' ' CYS . 31.6 ttpt -150.5 123.12 8.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.872 0.844 . . . . 0.0 110.236 -179.035 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.466 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -140.15 154.95 47.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.268 0.534 . . . . 0.0 110.844 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.528 HD22 HG12 ' A' ' 26' ' ' VAL . 89.0 mt -67.16 128.49 36.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.84 24.96 7.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.06 30.5 75.76 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.647 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.754 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 4.7 t0 -126.31 156.48 40.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.417 ' HB ' ' CD1' ' A' ' 9' ' ' PHE . 6.7 p -145.11 141.38 28.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.196 0.522 . . . . 0.0 112.126 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.1 m -89.23 42.89 1.11 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CE1' ' HB2' ' A' ' 23' ' ' PRO . 3.3 m-85 -74.44 -50.12 19.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.434 ' H ' HG21 ' A' ' 10' ' ' VAL . 1.2 m -71.13 -59.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.766 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.436 ' C ' HD11 ' A' ' 11' ' ' LEU . 2.3 tm? -151.77 -50.95 0.12 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 -176.22 36.55 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.404 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.6 m -67.94 141.84 56.2 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.877 0.398 . . . . 0.0 111.751 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -67.94 -47.74 67.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.7 128.47 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.015 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 m -71.44 -9.49 58.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.413 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -88.21 -15.3 36.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 110.639 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 88.1 m -90.01 137.4 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 31.2 t -89.51 147.92 23.71 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.485 0.659 . . . . 0.0 109.778 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 77.46 9.88 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.476 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -88.33 65.27 7.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 7.2 m-85 -26.91 124.78 0.22 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 114.269 -1.332 . . . . 0.0 114.074 -176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.512 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 42.6 Cg_endo -99.42 13.58 26.48 Favored 'Cis proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.608 -1.414 . . . . 0.0 113.583 0.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 10.1 pt -109.23 143.94 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.754 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 72.1 m -91.99 128.97 38.03 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.61 0.719 . . . . 0.0 111.745 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.528 HG12 HD22 ' A' ' 3' ' ' LEU . 28.2 m -115.54 143.13 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.808 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -150.11 132.01 15.15 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 121.985 0.898 . . . . 0.0 109.865 -178.527 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 N-CA-C 112.962 -0.055 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -90.96 152.0 20.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 111.176 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.417 HD23 HG11 ' A' ' 26' ' ' VAL . 21.4 mt -76.83 130.58 37.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.86 -63.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.262 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.44 -47.68 0.25 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 119.303 -1.427 . . . . 0.0 114.3 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.62 153.21 21.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.693 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 69.1 p -84.78 155.57 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.149 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 10.0 t -131.2 29.8 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 0.0 110.506 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -92.07 -22.88 19.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.704 0.288 . . . . 0.0 110.98 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -71.74 -61.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.068 0.461 . . . . 0.0 111.067 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -152.75 -50.86 0.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -167.24 141.3 6.8 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 p -78.56 144.55 35.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.334 0.588 . . . . 0.0 111.795 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -65.29 -23.9 67.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.537 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 68.6 m-20 -68.04 82.95 0.22 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -60.36 -31.61 70.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.21 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 m -89.92 29.28 1.21 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 76.3 m -142.81 156.99 45.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.17 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -89.98 154.66 19.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.522 0.677 . . . . 0.0 110.583 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.71 73.31 9.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.07 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.78 87.95 7.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -41.7 135.37 2.11 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.029 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -97.72 29.37 14.88 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.402 -1.499 . . . . 0.0 114.288 1.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 20.0 pt -140.36 -169.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.941 -0.474 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -112.05 134.16 53.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG11 HD23 ' A' ' 3' ' ' LEU . 22.1 m -135.11 155.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.087 0.47 . . . . 0.0 112.055 -178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -147.36 134.01 19.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.14 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.467 0.376 0 O-C-N 123.558 0.536 . . . . 0.0 110.395 -179.56 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -130.15 152.04 50.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.704 0.288 . . . . 0.0 110.351 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.564 HD23 HG13 ' A' ' 24' ' ' ILE . 50.4 mt -73.06 139.27 46.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 20.7 p -161.83 154.33 19.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.7 0.286 . . . . 0.0 111.089 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.16 -125.4 7.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.161 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' CG ' ' H ' ' A' ' 7' ' ' THR . 56.8 t0 -139.21 -128.97 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 20.5 p -126.21 142.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.227 0.537 . . . . 0.0 111.222 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 87.7 m -93.29 3.28 55.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.965 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -75.02 -24.13 58.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.878 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.13 -54.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -152.71 -61.99 0.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.331 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.41 150.47 5.52 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.652 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.0 m -70.59 128.63 36.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.942 0.371 . . . . 0.0 110.677 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.01 -33.24 75.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.447 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.74 126.94 31.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.664 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t -81.72 1.38 34.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.092 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -87.94 -39.71 14.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.264 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 82.9 m -88.11 124.24 33.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.176 0.512 . . . . 0.0 109.723 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -79.57 147.38 32.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 m -79.15 63.75 3.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -88.05 78.57 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -33.4 138.84 0.26 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 124.504 1.127 . . . . 0.0 113.266 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.61 -33.93 2.73 Favored 'Cis proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.003 -1.665 . . . . 0.0 115.012 0.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.564 HG13 HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -89.54 166.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 41.3 m -89.68 141.81 28.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 m -135.4 147.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.323 0.583 . . . . 0.0 112.263 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.598 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 21.7 ttpp -150.08 134.73 17.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.598 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 110.234 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.439 0 CA-C-O 120.457 -0.079 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 p -98.16 170.96 8.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.876 0.338 . . . . 0.0 111.105 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 3' ' ' LEU . 95.8 mt -72.82 128.81 36.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.2 t -66.66 -47.9 71.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.45 -43.88 1.25 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.712 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.486 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 30.8 m-20 -87.51 148.66 24.82 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.115 0.483 . . . . 0.0 110.484 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 14.5 p -91.7 140.58 29.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.417 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 7.7 t -105.29 32.89 3.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.014 0.435 . . . . 0.0 111.617 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -95.04 -16.5 22.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 t -85.26 -64.5 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.426 HD12 ' C ' ' A' ' 11' ' ' LEU . 1.5 tm? -152.55 -48.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.009 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.07 -150.81 7.44 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.641 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 6' ' ' ASP . 84.9 m -141.59 168.02 20.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.74 0.27 . . . . 0.0 110.541 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -68.15 -55.11 13.56 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.721 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.9 t0 -72.67 130.19 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -76.2 -13.93 60.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.185 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.528 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -88.36 -4.29 58.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.199 0.523 . . . . 0.0 110.331 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 72.9 m -88.43 120.61 29.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.547 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.4 m -76.15 142.3 41.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -80.61 74.8 7.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -88.8 78.22 7.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 63.7 m-85 -33.5 128.55 0.41 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.999 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 24' ' ' ILE . 65.2 Cg_endo -100.75 25.63 16.42 Favored 'Cis proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.175 -1.177 . . . . 0.0 114.343 0.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.546 HD12 ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -136.52 152.57 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.814 -0.554 . . . . 0.0 111.636 -179.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.746 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 66.1 m -88.32 140.86 29.04 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.999 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -117.56 147.01 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.686 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 50.9 tttm -148.3 129.69 14.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.604 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 C--N 1.329 -0.295 0 O-C-N 123.752 0.658 . . . . 0.0 110.573 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 CA-C-O 120.155 -0.247 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 m -94.02 149.56 21.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.377 0.588 . . . . 0.0 111.067 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 74.1 mt -59.39 128.91 39.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.678 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 28.2 p -84.48 -36.48 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.62 -30.28 1.55 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.748 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.67 165.2 16.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.0 111.06 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 p -138.81 143.32 38.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.936 179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.52 -14.4 43.12 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.579 ' HB3' ' HB2' ' A' ' 23' ' ' PRO . 16.0 p90 -77.03 -17.71 58.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.739 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -89.0 -58.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.948 0.404 . . . . 0.0 110.418 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.443 ' C ' HD11 ' A' ' 11' ' ' LEU . 1.9 tm? -152.62 -54.48 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.935 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.94 -150.1 12.73 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.436 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 m -116.76 123.75 47.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.939 0.369 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -76.37 -39.15 54.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.575 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 10.5 t0 -62.39 117.89 6.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.199 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 m -63.7 -28.14 69.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.1 p -95.63 1.55 53.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 111.705 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.683 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 8.7 t -89.64 140.75 29.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -95.03 140.71 29.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.07 78.01 9.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -87.93 70.45 9.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -32.59 131.56 0.32 Allowed Pre-proline 0 N--CA 1.454 -0.238 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.73 -177.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.579 ' HB2' ' HB3' ' A' ' 9' ' ' PHE . 63.9 Cg_endo -96.24 23.58 25.04 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.355 -1.519 . . . . 0.0 114.404 1.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.06 144.97 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.89 -0.506 . . . . 0.0 112.161 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.639 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 61.6 m -89.36 132.76 34.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.992 0.425 . . . . 0.0 110.227 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 m -131.4 151.51 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.683 ' HG2' ' HA ' ' A' ' 18' ' ' CYS . 13.6 mtmm -128.94 126.23 39.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.332 0.586 . . . . 0.0 110.53 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t -150.69 -161.08 1.26 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 pp -73.3 134.15 44.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.991 0.424 . . . . 0.0 110.6 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.9 t -85.79 -49.94 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.27 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.04 -47.3 0.81 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.361 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.95 172.46 9.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.34 0.59 . . . . 0.0 111.322 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 2.7 p -120.61 154.28 35.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.245 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.6 m -88.42 37.41 0.82 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.808 0.337 . . . . 0.0 110.557 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.443 ' HE2' ' HB3' ' A' ' 23' ' ' PRO . 37.2 m-85 -144.5 38.03 1.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -146.43 -60.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.662 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -151.54 -55.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.51 -140.64 5.83 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -116.01 139.45 50.25 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -67.92 -55.52 12.5 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.705 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 14.4 t0 -66.72 138.03 57.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.081 0.467 . . . . 0.0 111.34 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -66.69 -32.95 74.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.604 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.4 m -93.67 17.1 12.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.126 0.489 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.711 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 46.5 t -89.77 150.28 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -120.9 150.61 40.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.645 0.26 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -93.08 130.63 38.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.012 0.434 . . . . 0.0 110.947 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -140.41 85.4 2.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.7 m-85 -32.31 128.88 0.33 Allowed Pre-proline 0 N--CA 1.465 0.275 0 O-C-N 124.197 0.936 . . . . 0.0 113.196 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.443 ' HB3' ' HE2' ' A' ' 9' ' ' PHE . 44.4 Cg_endo -99.11 22.01 22.74 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.699 -1.376 . . . . 0.0 114.711 1.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.2 OUTLIER -135.76 164.73 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.352 0.596 . . . . 0.0 112.401 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.711 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 91.7 m -88.86 144.88 25.91 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.42 143.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 110.771 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.494 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 17.7 tptm -151.14 141.05 21.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.494 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 1.4 m-20 . . . . . 0 N--CA 1.47 0.547 0 O-C-N 123.814 0.696 . . . . 0.0 111.491 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -135.84 147.38 48.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.9 mt -77.44 132.58 38.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.001 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 59.9 m -98.57 148.95 23.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.905 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.33 1.72 55.41 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -87.97 137.93 31.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.01 -0.595 . . . . 0.0 109.96 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.759 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 21.3 p -110.86 137.01 49.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.869 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 43.6 t -102.5 -12.14 18.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.909 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.414 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 8.1 p90 -67.27 -25.89 66.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -73.67 -61.33 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 110.805 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.422 ' C ' HD13 ' A' ' 11' ' ' LEU . 1.7 tm? -152.95 -54.76 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.702 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.91 144.35 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.499 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.61 140.85 41.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.727 0.299 . . . . 0.0 111.033 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.62 -48.57 66.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.491 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -65.17 121.6 15.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -74.38 -9.21 58.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.002 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.503 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 1.5 m -87.08 -25.06 24.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.159 0.504 . . . . 0.0 109.951 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 95.4 m -89.45 116.86 27.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.4 t -85.09 155.68 21.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.314 0.578 . . . . 0.0 110.238 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -70.63 123.95 23.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.868 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -147.63 70.99 1.18 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.478 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 3.6 m-85 -33.86 135.63 0.34 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 114.321 -1.308 . . . . 0.0 112.908 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.6 -31.67 5.01 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.312 -1.537 . . . . 0.0 115.126 0.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.792 HD12 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.53 -161.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.484 0.659 . . . . 0.0 112.77 -178.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.653 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 12.0 m -125.49 153.66 43.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.066 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.2 m -122.52 133.87 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 111.226 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 20.8 ttpt -112.76 109.02 18.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.997 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 124.524 1.14 . . . . 0.0 110.474 -179.161 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.3 0 N-CA-C 112.802 -0.119 . . . . 0.0 112.802 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -150.91 -157.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 86.4 mt -80.36 129.43 34.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.681 0.277 . . . . 0.0 110.507 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.05 -54.31 7.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.986 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.37 -39.57 1.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.515 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.708 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 58.7 m-20 -86.62 148.37 25.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.054 0.454 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.567 HG21 HG22 ' A' ' 24' ' ' ILE . 17.7 p -97.32 138.76 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.553 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 48.6 t -92.32 -19.77 21.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -68.25 -25.58 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.894 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.96 -56.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.485 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -152.46 -62.8 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.128 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.96 148.48 5.29 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.092 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.708 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -72.33 138.17 47.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.276 0.23 . . . . 0.0 110.984 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -78.78 -30.8 45.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.577 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 13.2 t0 -66.93 126.8 30.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 t -68.64 -15.42 63.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.088 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.511 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.44 -14.11 38.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.498 . . . . 0.0 110.121 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.583 ' SG ' ' HD2' ' A' ' 27' ' ' LYS . 72.2 m -88.98 124.18 34.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.783 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.93 133.28 33.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 124.75 24.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.293 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' CYS . 7.4 t-20 -151.47 153.53 34.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -97.94 133.46 23.24 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.349 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.05 -25.67 6.54 Favored 'Cis proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.198 -1.584 . . . . 0.0 113.887 0.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.603 ' H ' HD11 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -107.76 159.34 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.178 0.514 . . . . 0.0 112.365 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.5 m -85.94 152.33 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -109.06 140.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 82.9 tttt -151.51 144.88 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.467 0.383 0 O-C-N 123.848 0.718 . . . . 0.0 111.342 179.18 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.341 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -146.5 -162.04 1.45 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.5 130.18 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.97 0.414 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.0 t -83.31 -45.41 13.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.05 -38.84 2.71 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.701 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.427 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.8 t0 -87.86 157.38 19.0 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 54.1 p -111.48 142.35 43.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.867 0.365 . . . . 0.0 111.603 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.696 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 11.0 t -125.89 30.85 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.077 0.465 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.569 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 23.3 p90 -93.66 7.12 45.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.7 -57.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.118 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.436 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.5 mm? -97.79 -108.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.032 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.543 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 179.74 133.73 2.05 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.535 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 6' ' ' ASP . 80.5 m -69.09 117.81 11.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -79.31 -23.56 43.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.657 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -58.73 124.69 20.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -68.83 -29.35 67.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.0 p -92.01 38.1 0.99 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.752 0.787 . . . . 0.0 109.126 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 45.0 t -150.47 146.36 26.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.775 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.25 136.58 53.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.774 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -65.87 131.27 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.5 0.666 . . . . 0.0 111.766 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -151.25 160.31 43.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.17 132.92 21.84 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-O 120.629 0.252 . . . . 0.0 110.699 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 97.0 Cg_endo -83.27 -32.48 3.26 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.105 -1.623 . . . . 0.0 112.906 -0.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.524 ' O ' ' HB3' ' A' ' 21' ' ' ASN . 0.2 OUTLIER -97.01 157.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.858 -179.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.774 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 65.2 m -86.88 163.86 16.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.12 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -109.11 148.68 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.14 0.495 . . . . 0.0 111.645 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.496 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 21.7 ttmm -145.67 125.51 13.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.524 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.718 0.77 . . . . 0.0 111.042 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 t -89.94 174.66 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 110.52 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.95 128.18 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.446 ' HB3' ' C ' ' A' ' 25' ' ' CYS . 47.2 t -90.07 136.15 33.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.65 44.54 2.02 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.242 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.522 ' OD2' ' HA ' ' A' ' 13' ' ' CYS . 41.8 t0 -151.67 164.63 36.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.414 ' HB ' ' CD2' ' A' ' 9' ' ' PHE . 36.6 p -124.55 139.0 54.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.0 110.777 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 5.8 t -97.93 -8.76 27.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.999 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.453 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 7.4 p90 -68.63 -24.68 64.58 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.641 0.258 . . . . 0.0 110.637 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.05 -58.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.995 0.426 . . . . 0.0 110.617 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -152.97 -56.47 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.927 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 175.67 149.25 7.29 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.634 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -64.99 131.62 47.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.723 0.296 . . . . 0.0 110.652 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.1 -38.34 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 18' ' ' CYS . 55.8 t0 -66.88 130.44 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -72.36 -21.29 61.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.17 -14.44 38.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.862 0.839 . . . . 0.0 109.223 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . 47.2 t -89.53 141.77 28.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.408 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 31.0 t -108.53 149.95 28.14 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.409 0.624 . . . . 0.0 110.594 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.634 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 47.6 t -69.25 128.23 35.88 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.716 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 44.1 t30 -152.18 148.21 27.33 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TYR . . . . . 0.453 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 4.9 m-85 -111.34 134.29 21.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.4 -36.01 1.96 Allowed 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.941 -1.691 . . . . 0.0 112.706 -0.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.704 ' H ' HD11 ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.1 152.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.491 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.7 m -85.98 172.65 10.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.056 0.455 . . . . 0.0 111.32 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.14 149.84 31.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.29 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.7 tmmt? -146.53 125.02 12.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 124.254 1.022 . . . . 0.0 112.061 -177.603 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.5 m -151.89 168.32 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.451 ' HA ' HG12 ' A' ' 26' ' ' VAL . 3.5 pp -66.23 140.04 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.604 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 t -74.13 -39.75 63.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.835 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.97 -38.2 2.67 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 45.0 p-10 -90.16 -174.89 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.602 . . . . 0.0 111.089 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 24' ' ' ILE . 17.1 p -133.96 142.46 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.549 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 37.7 t -97.14 -8.78 29.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.417 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.6 p90 -69.67 -26.99 64.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.056 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.558 HG23 ' H ' ' A' ' 11' ' ' LEU . 1.1 m -80.26 -61.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.634 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.558 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.0 mm? -133.77 -58.5 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.412 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 168.57 161.51 18.77 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.635 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 25.7 m -67.63 137.37 55.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.678 0.275 . . . . 0.0 111.039 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -74.9 -52.12 12.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.759 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 12.2 t0 -75.21 135.58 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.061 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -66.42 -21.3 66.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -89.06 -7.21 56.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 111.005 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 78.7 m -89.38 118.13 28.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.734 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 p -83.92 144.49 29.15 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -74.8 68.43 1.73 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.32 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -88.0 67.21 8.9 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.402 ' H ' ' HD1' ' A' ' 22' ' ' TYR . 5.2 m-85 -29.8 135.52 0.19 Allowed Pre-proline 0 N--CA 1.469 0.499 0 O-C-N 124.673 1.233 . . . . 0.0 113.437 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.37 -30.66 4.32 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.126 -1.614 . . . . 0.0 114.933 0.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.699 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.47 152.51 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 74.8 m -89.34 149.14 23.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.935 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 3' ' ' LEU . 28.0 m -133.79 146.59 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.986 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -139.33 144.83 38.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.759 -0.201 . . . . 0.0 110.764 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.47 0.553 0 O-C-N 124.252 0.97 . . . . 0.0 111.236 178.555 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.459 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 m -89.06 154.99 19.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.986 0.393 . . . . 0.0 111.181 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.22 148.08 49.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.464 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.3 t -144.92 131.4 19.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.434 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.53 -122.04 19.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.274 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.0 -148.32 0.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.061 0.458 . . . . 0.0 110.36 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.454 HG22 HG22 ' A' ' 24' ' ' ILE . 38.7 p -75.36 152.81 38.05 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.129 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 m -84.69 39.6 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.703 0.763 . . . . 0.0 109.269 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HE1' ' HB2' ' A' ' 23' ' ' PRO . 32.1 m-85 -107.25 -45.23 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.718 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.59 -50.65 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tm? -150.15 -47.38 0.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.17 -71.31 2.55 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.894 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 p -167.54 126.53 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.366 0.603 . . . . 0.0 112.0 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -80.76 -30.9 36.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.52 125.54 25.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.9 m -72.26 -9.11 58.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.343 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -87.39 -17.71 31.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.23 0.538 . . . . 0.0 109.896 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.1 m -89.97 134.75 34.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.923 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -106.44 142.6 35.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.9 t -81.73 96.23 7.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.23 0.538 . . . . 0.0 111.319 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.24 82.76 6.5 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 3.4 p90 -27.24 123.12 0.24 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.612 ' HB2' ' HE1' ' A' ' 9' ' ' PHE . 16.4 Cg_endo -104.61 36.31 5.03 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.193 -1.17 . . . . 0.0 114.133 0.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -139.72 153.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.397 0.544 . . . . 0.0 111.178 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 m -87.64 140.47 29.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.292 0.568 . . . . 0.0 111.682 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 m -136.3 155.79 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.569 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -150.23 122.66 8.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 121.728 0.775 . . . . 0.0 110.369 -179.45 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.285 0 N-CA-C 112.944 -0.063 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -136.29 155.53 49.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 110.273 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 26' ' ' VAL . 97.9 mt -75.91 126.6 31.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.9 m -72.07 -22.54 61.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.949 0.404 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.77 19.58 72.88 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -123.99 150.79 44.43 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.3 p -109.64 137.08 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.222 0.534 . . . . 0.0 112.203 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.619 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 53.0 t -101.51 -17.03 16.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.853 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -62.26 -27.56 69.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.658 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.25 -58.56 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.8 tm? -153.15 -54.07 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.95 142.13 4.27 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.923 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -71.88 147.64 46.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 111.356 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.98 -53.09 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.699 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 32.6 t70 -70.94 123.87 23.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.438 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 m -71.44 -16.44 62.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.511 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -89.74 -4.84 57.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.416 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 59.1 m -87.52 124.59 33.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -78.14 139.67 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.884 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -74.05 72.19 1.65 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.135 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -88.19 73.29 8.97 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -35.46 137.25 0.43 Allowed Pre-proline 0 N--CA 1.466 0.332 0 O-C-N 124.54 1.15 . . . . 0.0 112.732 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.6 -28.12 7.81 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.282 -1.549 . . . . 0.0 114.797 1.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.795 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.36 -162.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 30.4 m -128.52 145.95 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.741 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 3' ' ' LEU . 30.0 m -119.87 143.45 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 79.2 tttt -150.7 136.37 18.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.736 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.681 0.613 . . . . 0.0 111.124 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.726 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 p -150.01 -163.6 1.82 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.515 HD22 HG13 ' A' ' 24' ' ' ILE . 72.8 mt -77.15 160.3 29.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.612 0.244 . . . . 0.0 110.455 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 3.4 t -145.83 132.15 19.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.688 0.28 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.13 -123.37 32.84 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.823 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -131.55 -137.59 0.2 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 20.1 p -87.78 143.24 27.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.281 0.562 . . . . 0.0 111.351 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 42.9 t -87.9 -17.66 30.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.202 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.412 ' HE2' ' HB3' ' A' ' 23' ' ' PRO . 2.7 p90 -69.73 -18.16 63.5 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.805 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.43 -47.27 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.06 0.457 . . . . 0.0 110.562 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.6 tm? -151.68 -62.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.858 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.02 130.87 2.56 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.605 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -83.72 68.95 10.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -74.19 50.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.944 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.94 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.1 t70 -80.75 157.07 25.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -69.88 -18.81 63.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.707 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 32.3 p -134.87 37.76 3.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.873 0.368 . . . . 0.0 111.187 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . 40.4 t -140.12 151.35 45.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -119.67 140.72 50.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 110.015 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 134.62 38.41 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 49.0 t30 -147.89 158.08 43.86 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -115.56 135.07 22.58 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 120.996 0.427 . . . . 0.0 110.799 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.416 ' HD2' HD13 ' A' ' 24' ' ' ILE . 6.1 Cg_exo -76.61 -43.32 0.66 Allowed 'Cis proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.28 -1.55 . . . . 0.0 113.175 0.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.784 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.67 156.74 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 57.8 m -85.8 174.04 9.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.23 151.78 32.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.993 0.425 . . . . 0.0 111.458 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.707 ' HG3' ' O ' ' A' ' 17' ' ' SER . 48.9 tttm -148.72 133.23 17.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 . . . . . 0 N--CA 1.472 0.666 0 O-C-N 124.463 1.102 . . . . 0.0 111.621 178.663 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.765 -0.134 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 t -150.87 -162.12 1.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.676 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.4 pt? -80.52 133.03 35.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 110.9 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.1 t -75.53 -40.08 57.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.877 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.85 -56.35 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.94 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -89.67 170.47 10.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.167 0.508 . . . . 0.0 110.528 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.472 HG22 HG22 ' A' ' 24' ' ' ILE . 33.5 p -110.04 145.78 36.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.852 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.571 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 35.4 t -88.9 32.79 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -37.65 12.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.707 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.65 -56.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.396 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -152.77 -52.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 109.712 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.571 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -179.84 163.09 30.07 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 43.7 m -62.38 132.65 53.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.82 0.343 . . . . 0.0 110.734 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -50.41 64.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.772 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.6 t0 -77.73 131.24 37.58 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.5 m -64.69 -17.85 64.46 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.514 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.58 -8.07 55.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.019 0.438 . . . . 0.0 110.795 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 85.7 m -89.18 122.61 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.798 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -84.86 143.78 28.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.232 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 m -80.27 66.78 5.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.109 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -88.25 70.16 9.17 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.427 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 7.0 m-85 -30.78 135.28 0.21 Allowed Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 124.647 1.217 . . . . 0.0 113.551 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.17 -27.25 6.03 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.94 -1.692 . . . . 0.0 114.808 0.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.4 153.66 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 85.8 m -88.61 140.4 29.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.925 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.15 139.76 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.645 0.259 . . . . 0.0 110.735 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HE3' ' HB2' ' A' ' 17' ' ' SER . 79.2 tttt -151.55 146.38 25.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.418 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.829 0.706 . . . . 0.0 111.458 179.212 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 N-CA-C 112.911 -0.076 . . . . 0.0 112.911 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -110.14 158.99 17.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.45 126.66 30.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.983 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.796 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 47.7 t -83.11 140.87 32.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.07 47.36 1.93 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.318 -0.468 . . . . 0.0 113.525 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.439 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 39.9 t0 -151.53 165.2 34.97 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.733 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 41.2 p -129.29 139.38 51.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 77.8 m -98.1 -2.9 39.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.36 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.442 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.8 p90 -66.58 -26.31 67.05 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.115 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -70.05 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.109 0.48 . . . . 0.0 110.493 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -153.38 -53.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.486 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.15 153.41 16.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 0.6 OUTLIER -64.99 137.53 57.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.698 0.249 . . . . 0.0 110.763 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -70.36 -41.64 72.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -80.78 122.3 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.049 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.7 t -69.67 -11.18 60.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.201 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -24.6 23.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.981 0.42 . . . . 0.0 110.52 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 68.9 m -87.5 128.64 35.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -85.25 148.8 25.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.225 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.8 m -76.97 127.31 32.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.176 0.513 . . . . 0.0 111.596 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -146.07 73.74 1.35 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.517 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 5.0 m-85 -36.18 134.49 0.57 Allowed Pre-proline 0 N--CA 1.462 0.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.756 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.43 -27.97 7.6 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.169 -1.596 . . . . 0.0 115.216 1.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.761 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.24 -164.77 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.796 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 61.4 m -116.88 159.76 21.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.522 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.45 135.51 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.8 ttpt -152.46 141.7 21.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 . . . . . 0 N--CA 1.464 0.266 0 O-C-N 123.635 0.584 . . . . 0.0 110.707 179.401 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.913 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -149.46 156.05 41.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.499 HD22 HG13 ' A' ' 24' ' ' ILE . 53.5 mt -71.67 133.75 45.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 26.4 m -71.13 -32.22 68.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 109.922 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.25 -39.17 2.9 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.553 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -88.36 143.93 26.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.206 0.527 . . . . 0.0 111.087 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 36.2 p -92.3 139.9 30.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.718 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.9 p -89.47 -18.6 26.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -66.95 -22.78 65.92 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.105 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.473 ' O ' HD22 ' A' ' 11' ' ' LEU . 61.5 t -81.12 -53.26 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.755 0.312 . . . . 0.0 111.089 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -138.48 -54.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 8' ' ' CYS . . . 171.62 -148.51 11.06 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 78.7 m -117.43 134.28 55.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.688 0.244 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.08 -47.15 72.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.545 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.891 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m-20 -80.0 140.56 36.53 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 m -67.09 -24.1 65.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.249 0.547 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -93.92 6.13 49.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.082 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.891 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 51.6 m -89.65 123.26 33.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.664 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -87.59 146.72 25.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.39 71.4 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.238 0.542 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -88.78 74.5 8.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 74.7 m-85 -27.27 130.87 0.18 Allowed Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 124.646 1.216 . . . . 0.0 113.839 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 29.3 Cg_endo -90.45 -23.04 7.85 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.366 -1.514 . . . . 0.0 114.491 0.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.707 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -91.27 160.1 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.31 0.576 . . . . 0.0 112.518 -178.326 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.3 m -88.66 140.47 29.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.344 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.39 140.3 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.637 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.4 ttpt -131.5 120.95 23.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.882 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 N--CA 1.47 0.566 0 O-C-N 124.38 1.05 . . . . 0.0 110.903 -179.532 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 t -155.2 -141.73 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.603 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.9 mt -80.2 143.88 33.41 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.03 -39.69 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.952 0.406 . . . . 0.0 110.761 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.92 -29.86 10.2 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.807 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 150.21 23.98 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.52 HG22 HG22 ' A' ' 24' ' ' ILE . 69.0 p -95.1 137.21 34.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.264 0.554 . . . . 0.0 112.468 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 53.2 t -109.41 -12.3 14.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.177 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.523 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 9.6 p90 -63.18 -27.25 69.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.465 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.73 -56.22 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.482 . . . . 0.0 110.653 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.8 tm? -153.17 -53.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.359 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 177.84 145.51 5.94 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.751 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 63.0 m -68.57 140.56 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.107 0.48 . . . . 0.0 111.494 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -68.93 -44.47 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.32 116.56 6.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.399 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.8 m -75.29 -12.32 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.7 m -89.15 -15.61 33.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.181 0.515 . . . . 0.0 110.142 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.17 137.41 32.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.604 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.17 128.56 34.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -62.2 130.38 45.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.51 0.672 . . . . 0.0 112.023 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 46.6 t30 -150.83 152.68 34.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.914 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 2.4 m-85 -104.72 134.18 19.79 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 78.0 Cg_endo -81.23 -33.61 3.1 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.329 -1.53 . . . . 0.0 113.209 0.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.73 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.02 152.46 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.946 -179.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p -86.71 173.06 9.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.408 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.82 152.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.337 . . . . 0.0 111.243 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -131.3 142.74 50.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 N--CA 1.465 0.323 0 O-C-N 124.29 0.994 . . . . 0.0 111.853 -178.557 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 m -149.36 154.08 38.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.024 0.44 . . . . 0.0 111.161 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.619 HD23 HG12 ' A' ' 26' ' ' VAL . 72.6 mt -69.28 138.02 53.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.373 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.64 ' SG ' ' HG2' ' A' ' 27' ' ' LYS . 73.4 m -82.82 -39.07 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.774 0.321 . . . . 0.0 111.094 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.92 -31.81 3.8 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -87.95 153.06 21.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.12 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.726 HG22 HG22 ' A' ' 24' ' ' ILE . 17.6 p -122.8 156.04 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.688 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 m -87.81 -13.99 40.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CE1' HG13 ' A' ' 10' ' ' VAL . 4.8 p90 -74.53 -25.19 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -83.13 -58.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 111.209 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.0 tm? -151.6 -54.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.51 -160.49 34.09 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.746 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 m -87.13 131.66 34.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.555 0.217 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -80.31 -44.46 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.433 0.635 . . . . 0.0 109.37 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.38 129.31 35.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.724 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.6 t -71.17 -23.35 62.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.128 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.434 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 2.9 m -89.69 37.31 0.87 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.814 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 34.9 t -139.88 154.18 47.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -119.34 145.36 46.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -83.39 120.24 25.64 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.242 0.544 . . . . 0.0 111.349 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -122.53 82.54 1.99 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 27.2 m-85 -31.59 123.73 0.36 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.305 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 63.6 Cg_endo -102.33 25.4 14.1 Favored 'Cis proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.062 -1.224 . . . . 0.0 114.713 0.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.726 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -131.14 151.66 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.411 0.551 . . . . 0.0 112.294 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.692 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 74.2 m -89.79 132.92 34.99 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.838 0.351 . . . . 0.0 110.376 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.619 HG12 HD23 ' A' ' 3' ' ' LEU . 27.2 m -137.49 153.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.64 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 5.9 pttm -139.76 137.07 34.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.644 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 N--CA 1.468 0.439 0 O-C-N 124.322 1.014 . . . . 0.0 110.566 -179.132 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.411 0 N-CA-C 113.541 0.177 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.9 m -100.66 -172.92 2.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.005 0.402 . . . . 0.0 111.02 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.15 129.12 38.11 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 54.0 t -76.97 -34.46 57.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.21 18.33 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.02 156.48 19.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.332 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -127.47 144.67 51.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 111.112 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.5 m -87.32 -23.81 24.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.8 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -70.56 -22.88 62.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -82.25 -57.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.289 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.7 tm? -152.78 -55.13 0.12 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.573 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.9 -165.12 38.31 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.471 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 9.5 m -91.46 126.72 36.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.752 0.31 . . . . 0.0 110.541 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -81.68 -43.47 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.037 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.902 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 9.2 t0 -62.22 137.03 58.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.06 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -70.21 -33.57 71.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.381 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -96.28 40.01 1.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.902 ' HB2' ' HB3' ' A' ' 15' ' ' ASP . 37.9 t -124.07 147.19 48.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.504 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -123.33 146.65 47.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.11 131.47 35.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.12 0.486 . . . . 0.0 111.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -139.11 78.06 1.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.4 m-85 -27.31 125.87 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.85 -1.068 . . . . 0.0 113.651 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 64.1 Cg_endo -99.28 14.69 26.83 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.828 -1.322 . . . . 0.0 114.403 0.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -124.62 155.51 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.2 0.524 . . . . 0.0 112.313 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.768 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 72.1 m -90.03 144.19 26.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.141 0.496 . . . . 0.0 110.95 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.437 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 25.9 m -113.35 151.21 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.133 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 4' ' ' CYS . 31.6 ttpt -150.5 123.12 8.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.872 0.844 . . . . 0.0 110.236 -179.035 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.466 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -140.15 154.95 47.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.268 0.534 . . . . 0.0 110.844 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.588 HD21 HD12 ' A' ' 24' ' ' ILE . 89.0 mt -67.16 128.49 36.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.84 24.96 7.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.06 30.5 75.76 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.647 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.763 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 4.7 t0 -126.31 156.48 40.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.422 ' HB ' ' CD1' ' A' ' 9' ' ' PHE . 6.7 p -145.11 141.38 28.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.196 0.522 . . . . 0.0 112.126 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.1 m -89.23 42.89 1.11 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 23' ' ' PRO . 3.3 m-85 -74.44 -50.12 19.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.564 HG23 ' H ' ' A' ' 11' ' ' LEU . 1.2 m -71.13 -59.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.766 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.564 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.3 tm? -151.77 -50.95 0.12 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 -176.22 36.55 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.404 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.6 m -67.94 141.84 56.2 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.877 0.398 . . . . 0.0 111.751 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -67.94 -47.74 67.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.7 128.47 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.015 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 m -71.44 -9.49 58.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.413 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -88.21 -15.3 36.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 110.639 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 88.1 m -90.01 137.4 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 31.2 t -89.51 147.92 23.71 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.485 0.659 . . . . 0.0 109.778 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 77.46 9.88 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.476 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -88.33 65.27 7.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 7.2 m-85 -26.91 124.78 0.22 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 114.269 -1.332 . . . . 0.0 114.074 -176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 42.6 Cg_endo -99.42 13.58 26.48 Favored 'Cis proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.608 -1.414 . . . . 0.0 113.583 0.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.588 HD12 HD21 ' A' ' 3' ' ' LEU . 10.1 pt -109.23 143.94 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.763 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 72.1 m -91.99 128.97 38.03 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.61 0.719 . . . . 0.0 111.745 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.532 HG12 HD23 ' A' ' 3' ' ' LEU . 28.2 m -115.54 143.13 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.808 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -150.11 132.01 15.15 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 121.985 0.898 . . . . 0.0 109.865 -178.527 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 N-CA-C 112.962 -0.055 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -90.96 152.0 20.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 111.176 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 24' ' ' ILE . 21.4 mt -76.83 130.58 37.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.86 -63.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.262 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.44 -47.68 0.25 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 119.303 -1.427 . . . . 0.0 114.3 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.62 153.21 21.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 69.1 p -84.78 155.57 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.149 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 10.0 t -131.2 29.8 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 0.0 110.506 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -92.07 -22.88 19.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.704 0.288 . . . . 0.0 110.98 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -71.74 -61.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.068 0.461 . . . . 0.0 111.067 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.4 tm? -152.75 -50.86 0.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.468 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -167.24 141.3 6.8 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 p -78.56 144.55 35.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.334 0.588 . . . . 0.0 111.795 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -65.29 -23.9 67.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.553 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 68.6 m-20 -68.04 82.95 0.22 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -60.36 -31.61 70.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.21 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 m -89.92 29.28 1.21 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 76.3 m -142.81 156.99 45.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.17 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -89.98 154.66 19.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.522 0.677 . . . . 0.0 110.583 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.71 73.31 9.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.07 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -88.78 87.95 7.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -41.7 135.37 2.11 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.029 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -97.72 29.37 14.88 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.402 -1.499 . . . . 0.0 114.288 1.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 20.0 pt -140.36 -169.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.941 -0.474 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -112.05 134.16 53.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.11 155.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.087 0.47 . . . . 0.0 112.055 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -147.36 134.01 19.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.14 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.467 0.376 0 O-C-N 123.558 0.536 . . . . 0.0 110.395 -179.56 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -130.15 152.04 50.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.704 0.288 . . . . 0.0 110.351 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.674 HD22 HG13 ' A' ' 24' ' ' ILE . 50.4 mt -73.06 139.27 46.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.603 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 20.7 p -161.83 154.33 19.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.7 0.286 . . . . 0.0 111.089 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.16 -125.4 7.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.161 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -139.21 -128.97 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.476 HG22 HG22 ' A' ' 24' ' ' ILE . 20.5 p -126.21 142.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.227 0.537 . . . . 0.0 111.222 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 87.7 m -93.29 3.28 55.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.965 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -75.02 -24.13 58.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.878 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.13 -54.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -152.71 -61.99 0.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.331 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.41 150.47 5.52 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.652 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.0 m -70.59 128.63 36.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.942 0.371 . . . . 0.0 110.677 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.01 -33.24 75.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.447 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.74 126.94 31.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.664 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t -81.72 1.38 34.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.092 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -87.94 -39.71 14.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.264 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 82.9 m -88.11 124.24 33.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.176 0.512 . . . . 0.0 109.723 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -79.57 147.38 32.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 m -79.15 63.75 3.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -88.05 78.57 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.439 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 5.9 m-85 -33.4 138.84 0.26 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 124.504 1.127 . . . . 0.0 113.266 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.61 -33.93 2.73 Favored 'Cis proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.003 -1.665 . . . . 0.0 115.012 0.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.69 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.54 166.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 41.3 m -89.68 141.81 28.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.443 HG12 HD23 ' A' ' 3' ' ' LEU . 32.6 m -135.4 147.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.323 0.583 . . . . 0.0 112.263 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 21.7 ttpp -150.08 134.73 17.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.604 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 110.234 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.439 0 CA-C-O 120.457 -0.079 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 p -98.16 170.96 8.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.876 0.338 . . . . 0.0 111.105 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.82 128.81 36.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.2 t -66.66 -47.9 71.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.45 -43.88 1.25 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.712 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.509 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 30.8 m-20 -87.51 148.66 24.82 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.115 0.483 . . . . 0.0 110.484 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.744 HG22 HG22 ' A' ' 24' ' ' ILE . 14.5 p -91.7 140.58 29.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.417 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 7.7 t -105.29 32.89 3.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.014 0.435 . . . . 0.0 111.617 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -95.04 -16.5 22.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 t -85.26 -64.5 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.5 tm? -152.55 -48.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.009 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.07 -150.81 7.44 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.641 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 6' ' ' ASP . 84.9 m -141.59 168.02 20.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.74 0.27 . . . . 0.0 110.541 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -68.15 -55.11 13.56 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.729 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.9 t0 -72.67 130.19 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -76.2 -13.93 60.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.185 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.536 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -88.36 -4.29 58.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.199 0.523 . . . . 0.0 110.331 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 72.9 m -88.43 120.61 29.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.547 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.4 m -76.15 142.3 41.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -80.61 74.8 7.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -88.8 78.22 7.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 63.7 m-85 -33.5 128.55 0.41 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.999 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 65.2 Cg_endo -100.75 25.63 16.42 Favored 'Cis proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.175 -1.177 . . . . 0.0 114.343 0.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.744 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -136.52 152.57 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.814 -0.554 . . . . 0.0 111.636 -179.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 66.1 m -88.32 140.86 29.04 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.999 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -117.56 147.01 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.686 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.616 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 50.9 tttm -148.3 129.69 14.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 C--N 1.329 -0.295 0 O-C-N 123.752 0.658 . . . . 0.0 110.573 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 CA-C-O 120.155 -0.247 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 m -94.02 149.56 21.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.377 0.588 . . . . 0.0 111.067 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.598 HD23 HG12 ' A' ' 26' ' ' VAL . 74.1 mt -59.39 128.91 39.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.704 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 28.2 p -84.48 -36.48 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.62 -30.28 1.55 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.748 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.67 165.2 16.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.0 111.06 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.466 HG22 HG22 ' A' ' 24' ' ' ILE . 7.0 p -138.81 143.32 38.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.936 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.52 -14.4 43.12 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.607 ' HB3' ' HB2' ' A' ' 23' ' ' PRO . 16.0 p90 -77.03 -17.71 58.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.739 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -89.0 -58.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.948 0.404 . . . . 0.0 110.418 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.9 tm? -152.62 -54.48 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.935 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.94 -150.1 12.73 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.436 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 m -116.76 123.75 47.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.939 0.369 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -76.37 -39.15 54.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 10.5 t0 -62.39 117.89 6.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.199 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 m -63.7 -28.14 69.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.1 p -95.63 1.55 53.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 111.705 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.711 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 8.7 t -89.64 140.75 29.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -95.03 140.71 29.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.07 78.01 9.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -87.93 70.45 9.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 6.6 p90 -32.59 131.56 0.32 Allowed Pre-proline 0 N--CA 1.454 -0.238 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.73 -177.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.607 ' HB2' ' HB3' ' A' ' 9' ' ' PHE . 63.9 Cg_endo -96.24 23.58 25.04 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.355 -1.519 . . . . 0.0 114.404 1.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.466 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -130.06 144.97 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.89 -0.506 . . . . 0.0 112.161 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 61.6 m -89.36 132.76 34.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.992 0.425 . . . . 0.0 110.227 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.598 HG12 HD23 ' A' ' 3' ' ' LEU . 27.2 m -131.4 151.51 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 18' ' ' CYS . 13.6 mtmm -128.94 126.23 39.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.332 0.586 . . . . 0.0 110.53 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t -150.69 -161.08 1.26 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 pp -73.3 134.15 44.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.991 0.424 . . . . 0.0 110.6 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.9 t -85.79 -49.94 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.27 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.04 -47.3 0.81 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.361 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.95 172.46 9.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.34 0.59 . . . . 0.0 111.322 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.811 HG22 HG22 ' A' ' 24' ' ' ILE . 2.7 p -120.61 154.28 35.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.245 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.6 m -88.42 37.41 0.82 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.808 0.337 . . . . 0.0 110.557 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' A' ' 23' ' ' PRO . 37.2 m-85 -144.5 38.03 1.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.545 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -146.43 -60.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.662 179.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.545 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.2 tm? -151.54 -55.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.51 -140.64 5.83 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -116.01 139.45 50.25 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -67.92 -55.52 12.5 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 14.4 t0 -66.72 138.03 57.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.081 0.467 . . . . 0.0 111.34 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -66.69 -32.95 74.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.604 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.4 m -93.67 17.1 12.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.126 0.489 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 46.5 t -89.77 150.28 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -120.9 150.61 40.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.645 0.26 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -93.08 130.63 38.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.012 0.434 . . . . 0.0 110.947 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -140.41 85.4 2.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.7 m-85 -32.31 128.88 0.33 Allowed Pre-proline 0 N--CA 1.465 0.275 0 O-C-N 124.197 0.936 . . . . 0.0 113.196 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 44.4 Cg_endo -99.11 22.01 22.74 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.699 -1.376 . . . . 0.0 114.711 1.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.811 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -135.76 164.73 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.352 0.596 . . . . 0.0 112.401 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.725 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 91.7 m -88.86 144.88 25.91 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.42 143.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 110.771 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 17.7 tptm -151.14 141.05 21.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 1.4 m-20 . . . . . 0 N--CA 1.47 0.547 0 O-C-N 123.814 0.696 . . . . 0.0 111.491 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -135.84 147.38 48.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.506 HD23 HG12 ' A' ' 26' ' ' VAL . 92.9 mt -77.44 132.58 38.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.001 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 59.9 m -98.57 148.95 23.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.905 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.33 1.72 55.41 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -87.97 137.93 31.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.01 -0.595 . . . . 0.0 109.96 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.777 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 21.3 p -110.86 137.01 49.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.869 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 43.6 t -102.5 -12.14 18.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.909 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.421 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 8.1 p90 -67.27 -25.89 66.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -73.67 -61.33 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 110.805 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -152.95 -54.76 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.702 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.91 144.35 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.499 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.61 140.85 41.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.727 0.299 . . . . 0.0 111.033 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.62 -48.57 66.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.491 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -65.17 121.6 15.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -74.38 -9.21 58.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.002 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.549 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 1.5 m -87.08 -25.06 24.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.159 0.504 . . . . 0.0 109.951 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 95.4 m -89.45 116.86 27.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.4 t -85.09 155.68 21.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.314 0.578 . . . . 0.0 110.238 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -70.63 123.95 23.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.868 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -147.63 70.99 1.18 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.531 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 3.6 m-85 -33.86 135.63 0.34 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 114.321 -1.308 . . . . 0.0 112.908 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.6 -31.67 5.01 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.312 -1.537 . . . . 0.0 115.126 0.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.786 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.53 -161.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.484 0.659 . . . . 0.0 112.77 -178.166 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 12.0 m -125.49 153.66 43.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.066 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.506 HG12 HD23 ' A' ' 3' ' ' LEU . 18.2 m -122.52 133.87 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 111.226 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.58 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 20.8 ttpt -112.76 109.02 18.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.997 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 124.524 1.14 . . . . 0.0 110.474 -179.161 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.3 0 N-CA-C 112.802 -0.119 . . . . 0.0 112.802 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -150.91 -157.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.419 HD22 HG13 ' A' ' 24' ' ' ILE . 86.4 mt -80.36 129.43 34.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.681 0.277 . . . . 0.0 110.507 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.05 -54.31 7.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.986 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.37 -39.57 1.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.515 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 58.7 m-20 -86.62 148.37 25.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.054 0.454 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.673 HG22 HG22 ' A' ' 24' ' ' ILE . 17.7 p -97.32 138.76 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.553 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 48.6 t -92.32 -19.77 21.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -68.25 -25.58 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.894 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.96 -56.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.485 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.5 tm? -152.46 -62.8 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.128 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.96 148.48 5.29 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.092 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.73 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -72.33 138.17 47.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.276 0.23 . . . . 0.0 110.984 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -78.78 -30.8 45.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.584 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 13.2 t0 -66.93 126.8 30.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 t -68.64 -15.42 63.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.088 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.524 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.44 -14.11 38.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.498 . . . . 0.0 110.121 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.594 ' SG ' ' HD2' ' A' ' 27' ' ' LYS . 72.2 m -88.98 124.18 34.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.783 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.93 133.28 33.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 124.75 24.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.293 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' CYS . 7.4 t-20 -151.47 153.53 34.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -97.94 133.46 23.24 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.349 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.05 -25.67 6.54 Favored 'Cis proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.198 -1.584 . . . . 0.0 113.887 0.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -107.76 159.34 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.178 0.514 . . . . 0.0 112.365 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.5 m -85.94 152.33 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -109.06 140.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 82.9 tttt -151.51 144.88 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.467 0.383 0 O-C-N 123.848 0.718 . . . . 0.0 111.342 179.18 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.341 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -146.5 -162.04 1.45 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.5 130.18 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.97 0.414 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.0 t -83.31 -45.41 13.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.05 -38.84 2.71 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.701 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.8 t0 -87.86 157.38 19.0 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.612 HG22 HG22 ' A' ' 24' ' ' ILE . 54.1 p -111.48 142.35 43.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.867 0.365 . . . . 0.0 111.603 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.714 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 11.0 t -125.89 30.85 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.077 0.465 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.598 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 23.3 p90 -93.66 7.12 45.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.7 -57.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.118 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.419 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.5 mm? -97.79 -108.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.032 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.555 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 179.74 133.73 2.05 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.535 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 6' ' ' ASP . 80.5 m -69.09 117.81 11.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -79.31 -23.56 43.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.657 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -58.73 124.69 20.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -68.83 -29.35 67.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.0 p -92.01 38.1 0.99 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.752 0.787 . . . . 0.0 109.126 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 45.0 t -150.47 146.36 26.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.775 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.25 136.58 53.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.786 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -65.87 131.27 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.5 0.666 . . . . 0.0 111.766 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 51.9 t30 -151.25 160.31 43.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.17 132.92 21.84 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-O 120.629 0.252 . . . . 0.0 110.699 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 97.0 Cg_endo -83.27 -32.48 3.26 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.105 -1.623 . . . . 0.0 112.906 -0.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.72 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -97.01 157.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.858 -179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.786 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 65.2 m -86.88 163.86 16.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.12 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -109.11 148.68 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.14 0.495 . . . . 0.0 111.645 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 21.7 ttmm -145.67 125.51 13.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.524 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.718 0.77 . . . . 0.0 111.042 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 t -89.94 174.66 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 110.52 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.95 128.18 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB3' ' C ' ' A' ' 25' ' ' CYS . 47.2 t -90.07 136.15 33.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.65 44.54 2.02 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.242 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 13' ' ' CYS . 41.8 t0 -151.67 164.63 36.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.419 ' HB ' ' CD2' ' A' ' 9' ' ' PHE . 36.6 p -124.55 139.0 54.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.0 110.777 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 5.8 t -97.93 -8.76 27.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.999 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.461 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 7.4 p90 -68.63 -24.68 64.58 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.641 0.258 . . . . 0.0 110.637 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.05 -58.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.995 0.426 . . . . 0.0 110.617 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -152.97 -56.47 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.927 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.409 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 175.67 149.25 7.29 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -64.99 131.62 47.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.723 0.296 . . . . 0.0 110.652 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.1 -38.34 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 18' ' ' CYS . 55.8 t0 -66.88 130.44 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -72.36 -21.29 61.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.17 -14.44 38.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.862 0.839 . . . . 0.0 109.223 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . 47.2 t -89.53 141.77 28.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.408 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 31.0 t -108.53 149.95 28.14 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.409 0.624 . . . . 0.0 110.594 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.643 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 47.6 t -69.25 128.23 35.88 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.716 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 44.1 t30 -152.18 148.21 27.33 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 4.9 m-85 -111.34 134.29 21.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.4 -36.01 1.96 Allowed 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.941 -1.691 . . . . 0.0 112.706 -0.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.1 152.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.491 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.7 m -85.98 172.65 10.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.056 0.455 . . . . 0.0 111.32 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.14 149.84 31.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.29 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.7 tmmt? -146.53 125.02 12.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 124.254 1.022 . . . . 0.0 112.061 -177.603 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.5 m -151.89 168.32 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.451 ' HA ' HG12 ' A' ' 26' ' ' VAL . 3.5 pp -66.23 140.04 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.604 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 t -74.13 -39.75 63.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.835 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.97 -38.2 2.67 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 45.0 p-10 -90.16 -174.89 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.602 . . . . 0.0 111.089 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 24' ' ' ILE . 17.1 p -133.96 142.46 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.549 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 37.7 t -97.14 -8.78 29.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.417 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.6 p90 -69.67 -26.99 64.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.056 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.558 HG23 ' H ' ' A' ' 11' ' ' LEU . 1.1 m -80.26 -61.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.634 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.558 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.0 mm? -133.77 -58.5 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 168.57 161.51 18.77 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.635 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 25.7 m -67.63 137.37 55.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.678 0.275 . . . . 0.0 111.039 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -74.9 -52.12 12.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.759 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 12.2 t0 -75.21 135.58 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.061 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -66.42 -21.3 66.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -89.06 -7.21 56.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 111.005 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 78.7 m -89.38 118.13 28.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.734 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 p -83.92 144.49 29.15 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -74.8 68.43 1.73 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.32 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -88.0 67.21 8.9 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.402 ' H ' ' HD1' ' A' ' 22' ' ' TYR . 5.2 m-85 -29.8 135.52 0.19 Allowed Pre-proline 0 N--CA 1.469 0.499 0 O-C-N 124.673 1.233 . . . . 0.0 113.437 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.37 -30.66 4.32 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.126 -1.614 . . . . 0.0 114.933 0.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.699 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.47 152.51 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 74.8 m -89.34 149.14 23.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.935 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 3' ' ' LEU . 28.0 m -133.79 146.59 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.986 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -139.33 144.83 38.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.759 -0.201 . . . . 0.0 110.764 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.47 0.553 0 O-C-N 124.252 0.97 . . . . 0.0 111.236 178.555 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.459 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 m -89.06 154.99 19.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.986 0.393 . . . . 0.0 111.181 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.22 148.08 49.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.464 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.3 t -144.92 131.4 19.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.434 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.53 -122.04 19.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.274 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.0 -148.32 0.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.061 0.458 . . . . 0.0 110.36 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.454 HG22 HG22 ' A' ' 24' ' ' ILE . 38.7 p -75.36 152.81 38.05 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.129 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 m -84.69 39.6 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.703 0.763 . . . . 0.0 109.269 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HE1' ' HB2' ' A' ' 23' ' ' PRO . 32.1 m-85 -107.25 -45.23 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.718 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.59 -50.65 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tm? -150.15 -47.38 0.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.17 -71.31 2.55 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.894 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 p -167.54 126.53 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.366 0.603 . . . . 0.0 112.0 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -80.76 -30.9 36.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.52 125.54 25.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.9 m -72.26 -9.11 58.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.343 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -87.39 -17.71 31.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.23 0.538 . . . . 0.0 109.896 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.1 m -89.97 134.75 34.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.923 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -106.44 142.6 35.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.9 t -81.73 96.23 7.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.23 0.538 . . . . 0.0 111.319 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.24 82.76 6.5 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 3.4 p90 -27.24 123.12 0.24 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.612 ' HB2' ' HE1' ' A' ' 9' ' ' PHE . 16.4 Cg_endo -104.61 36.31 5.03 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.193 -1.17 . . . . 0.0 114.133 0.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -139.72 153.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.397 0.544 . . . . 0.0 111.178 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 m -87.64 140.47 29.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.292 0.568 . . . . 0.0 111.682 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 m -136.3 155.79 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.569 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -150.23 122.66 8.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 121.728 0.775 . . . . 0.0 110.369 -179.45 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.285 0 N-CA-C 112.944 -0.063 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -136.29 155.53 49.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 110.273 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 26' ' ' VAL . 97.9 mt -75.91 126.6 31.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.9 m -72.07 -22.54 61.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.949 0.404 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.77 19.58 72.88 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -123.99 150.79 44.43 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.3 p -109.64 137.08 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.222 0.534 . . . . 0.0 112.203 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.619 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 53.0 t -101.51 -17.03 16.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.853 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -62.26 -27.56 69.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.658 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.25 -58.56 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.8 tm? -153.15 -54.07 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.95 142.13 4.27 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.923 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -71.88 147.64 46.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 111.356 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.98 -53.09 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.699 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 32.6 t70 -70.94 123.87 23.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.438 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 m -71.44 -16.44 62.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.511 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -89.74 -4.84 57.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.416 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 59.1 m -87.52 124.59 33.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -78.14 139.67 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.884 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -74.05 72.19 1.65 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.135 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -88.19 73.29 8.97 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -35.46 137.25 0.43 Allowed Pre-proline 0 N--CA 1.466 0.332 0 O-C-N 124.54 1.15 . . . . 0.0 112.732 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.6 -28.12 7.81 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.282 -1.549 . . . . 0.0 114.797 1.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.795 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.36 -162.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 30.4 m -128.52 145.95 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.741 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 3' ' ' LEU . 30.0 m -119.87 143.45 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 79.2 tttt -150.7 136.37 18.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.736 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.681 0.613 . . . . 0.0 111.124 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.726 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 p -150.01 -163.6 1.82 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.515 HD22 HG13 ' A' ' 24' ' ' ILE . 72.8 mt -77.15 160.3 29.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.612 0.244 . . . . 0.0 110.455 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 3.4 t -145.83 132.15 19.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.688 0.28 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.13 -123.37 32.84 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.823 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -131.55 -137.59 0.2 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 20.1 p -87.78 143.24 27.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.281 0.562 . . . . 0.0 111.351 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 42.9 t -87.9 -17.66 30.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.202 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.412 ' HE2' ' HB3' ' A' ' 23' ' ' PRO . 2.7 p90 -69.73 -18.16 63.5 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.805 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.43 -47.27 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.06 0.457 . . . . 0.0 110.562 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.6 tm? -151.68 -62.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.858 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.02 130.87 2.56 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.605 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -83.72 68.95 10.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 t-20 -74.19 50.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.944 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.94 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.1 t70 -80.75 157.07 25.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -69.88 -18.81 63.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.707 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 32.3 p -134.87 37.76 3.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.873 0.368 . . . . 0.0 111.187 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . 40.4 t -140.12 151.35 45.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -119.67 140.72 50.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 110.015 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 134.62 38.41 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 49.0 t30 -147.89 158.08 43.86 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -115.56 135.07 22.58 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 120.996 0.427 . . . . 0.0 110.799 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.416 ' HD2' HD13 ' A' ' 24' ' ' ILE . 6.1 Cg_exo -76.61 -43.32 0.66 Allowed 'Cis proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.28 -1.55 . . . . 0.0 113.175 0.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.784 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.67 156.74 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 57.8 m -85.8 174.04 9.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.23 151.78 32.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.993 0.425 . . . . 0.0 111.458 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.707 ' HG3' ' O ' ' A' ' 17' ' ' SER . 48.9 tttm -148.72 133.23 17.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 . . . . . 0 N--CA 1.472 0.666 0 O-C-N 124.463 1.102 . . . . 0.0 111.621 178.663 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.765 -0.134 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 t -150.87 -162.12 1.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.676 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.4 pt? -80.52 133.03 35.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 110.9 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.1 t -75.53 -40.08 57.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.877 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.85 -56.35 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.94 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -89.67 170.47 10.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.167 0.508 . . . . 0.0 110.528 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.472 HG22 HG22 ' A' ' 24' ' ' ILE . 33.5 p -110.04 145.78 36.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.852 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.571 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 35.4 t -88.9 32.79 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -37.65 12.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.707 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.65 -56.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.396 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -152.77 -52.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 109.712 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.571 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -179.84 163.09 30.07 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 43.7 m -62.38 132.65 53.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.82 0.343 . . . . 0.0 110.734 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -50.41 64.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.772 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.6 t0 -77.73 131.24 37.58 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.5 m -64.69 -17.85 64.46 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.514 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.58 -8.07 55.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.019 0.438 . . . . 0.0 110.795 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 85.7 m -89.18 122.61 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.798 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -84.86 143.78 28.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.232 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 m -80.27 66.78 5.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.109 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -88.25 70.16 9.17 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 7.0 m-85 -30.78 135.28 0.21 Allowed Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 124.647 1.217 . . . . 0.0 113.551 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.17 -27.25 6.03 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.94 -1.692 . . . . 0.0 114.808 0.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.4 153.66 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 85.8 m -88.61 140.4 29.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.925 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.15 139.76 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.645 0.259 . . . . 0.0 110.735 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HE3' ' HB2' ' A' ' 17' ' ' SER . 79.2 tttt -151.55 146.38 25.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.418 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.829 0.706 . . . . 0.0 111.458 179.212 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 N-CA-C 112.911 -0.076 . . . . 0.0 112.911 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -110.14 158.99 17.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.45 126.66 30.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.983 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.796 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 47.7 t -83.11 140.87 32.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.07 47.36 1.93 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.318 -0.468 . . . . 0.0 113.525 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.439 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 39.9 t0 -151.53 165.2 34.97 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.733 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 41.2 p -129.29 139.38 51.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 77.8 m -98.1 -2.9 39.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.36 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.442 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.8 p90 -66.58 -26.31 67.05 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.115 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -70.05 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.109 0.48 . . . . 0.0 110.493 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -153.38 -53.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.486 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.15 153.41 16.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 0.6 OUTLIER -64.99 137.53 57.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.698 0.249 . . . . 0.0 110.763 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -70.36 -41.64 72.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -80.78 122.3 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.049 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.7 t -69.67 -11.18 60.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.201 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -24.6 23.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.981 0.42 . . . . 0.0 110.52 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 68.9 m -87.5 128.64 35.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -85.25 148.8 25.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.225 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.8 m -76.97 127.31 32.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.176 0.513 . . . . 0.0 111.596 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -146.07 73.74 1.35 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.517 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 5.0 m-85 -36.18 134.49 0.57 Allowed Pre-proline 0 N--CA 1.462 0.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.756 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.43 -27.97 7.6 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.169 -1.596 . . . . 0.0 115.216 1.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.761 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.24 -164.77 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.796 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 61.4 m -116.88 159.76 21.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.522 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.45 135.51 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.8 ttpt -152.46 141.7 21.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 . . . . . 0 N--CA 1.464 0.266 0 O-C-N 123.635 0.584 . . . . 0.0 110.707 179.401 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.913 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -149.46 156.05 41.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.499 HD22 HG13 ' A' ' 24' ' ' ILE . 53.5 mt -71.67 133.75 45.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 26.4 m -71.13 -32.22 68.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 109.922 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.25 -39.17 2.9 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.553 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -88.36 143.93 26.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.206 0.527 . . . . 0.0 111.087 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 36.2 p -92.3 139.9 30.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.718 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.9 p -89.47 -18.6 26.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -66.95 -22.78 65.92 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.105 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.473 ' O ' HD22 ' A' ' 11' ' ' LEU . 61.5 t -81.12 -53.26 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.755 0.312 . . . . 0.0 111.089 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -138.48 -54.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 8' ' ' CYS . . . 171.62 -148.51 11.06 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 78.7 m -117.43 134.28 55.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.688 0.244 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.08 -47.15 72.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.545 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.891 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m-20 -80.0 140.56 36.53 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 m -67.09 -24.1 65.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.249 0.547 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -93.92 6.13 49.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.082 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.891 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 51.6 m -89.65 123.26 33.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.664 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -87.59 146.72 25.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.39 71.4 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.238 0.542 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -88.78 74.5 8.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 74.7 m-85 -27.27 130.87 0.18 Allowed Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 124.646 1.216 . . . . 0.0 113.839 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 29.3 Cg_endo -90.45 -23.04 7.85 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.366 -1.514 . . . . 0.0 114.491 0.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.707 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -91.27 160.1 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.31 0.576 . . . . 0.0 112.518 -178.326 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.3 m -88.66 140.47 29.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.344 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.39 140.3 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.637 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.4 ttpt -131.5 120.95 23.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.882 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 N--CA 1.47 0.566 0 O-C-N 124.38 1.05 . . . . 0.0 110.903 -179.532 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 t -155.2 -141.73 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.603 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.9 mt -80.2 143.88 33.41 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.03 -39.69 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.952 0.406 . . . . 0.0 110.761 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.92 -29.86 10.2 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.807 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 150.21 23.98 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.52 HG22 HG22 ' A' ' 24' ' ' ILE . 69.0 p -95.1 137.21 34.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.264 0.554 . . . . 0.0 112.468 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 53.2 t -109.41 -12.3 14.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.177 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.523 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 9.6 p90 -63.18 -27.25 69.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.465 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.73 -56.22 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.482 . . . . 0.0 110.653 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.8 tm? -153.17 -53.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.359 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 177.84 145.51 5.94 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.751 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 63.0 m -68.57 140.56 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.107 0.48 . . . . 0.0 111.494 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -68.93 -44.47 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.32 116.56 6.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.399 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.8 m -75.29 -12.32 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.7 m -89.15 -15.61 33.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.181 0.515 . . . . 0.0 110.142 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.17 137.41 32.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.604 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.17 128.56 34.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -62.2 130.38 45.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.51 0.672 . . . . 0.0 112.023 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 46.6 t30 -150.83 152.68 34.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.914 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 2.4 m-85 -104.72 134.18 19.79 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 78.0 Cg_endo -81.23 -33.61 3.1 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.329 -1.53 . . . . 0.0 113.209 0.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.73 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.02 152.46 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.946 -179.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p -86.71 173.06 9.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.408 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.82 152.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.337 . . . . 0.0 111.243 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -131.3 142.74 50.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 N--CA 1.465 0.323 0 O-C-N 124.29 0.994 . . . . 0.0 111.853 -178.557 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 m -149.36 154.08 38.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.024 0.44 . . . . 0.0 111.161 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.619 HD23 HG12 ' A' ' 26' ' ' VAL . 72.6 mt -69.28 138.02 53.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.373 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.64 ' SG ' ' HG2' ' A' ' 27' ' ' LYS . 73.4 m -82.82 -39.07 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.774 0.321 . . . . 0.0 111.094 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.92 -31.81 3.8 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -87.95 153.06 21.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.12 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.726 HG22 HG22 ' A' ' 24' ' ' ILE . 17.6 p -122.8 156.04 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.688 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 m -87.81 -13.99 40.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CE1' HG13 ' A' ' 10' ' ' VAL . 4.8 p90 -74.53 -25.19 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -83.13 -58.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 111.209 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.0 tm? -151.6 -54.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.51 -160.49 34.09 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.746 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 m -87.13 131.66 34.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.555 0.217 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -80.31 -44.46 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.433 0.635 . . . . 0.0 109.37 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.38 129.31 35.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.724 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.6 t -71.17 -23.35 62.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.128 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.434 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 2.9 m -89.69 37.31 0.87 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.814 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 34.9 t -139.88 154.18 47.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -119.34 145.36 46.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -83.39 120.24 25.64 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.242 0.544 . . . . 0.0 111.349 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -122.53 82.54 1.99 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 27.2 m-85 -31.59 123.73 0.36 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.305 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 63.6 Cg_endo -102.33 25.4 14.1 Favored 'Cis proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.062 -1.224 . . . . 0.0 114.713 0.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.726 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -131.14 151.66 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.411 0.551 . . . . 0.0 112.294 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.692 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 74.2 m -89.79 132.92 34.99 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.838 0.351 . . . . 0.0 110.376 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.619 HG12 HD23 ' A' ' 3' ' ' LEU . 27.2 m -137.49 153.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.64 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 5.9 pttm -139.76 137.07 34.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.644 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 N--CA 1.468 0.439 0 O-C-N 124.322 1.014 . . . . 0.0 110.566 -179.132 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.411 0 N-CA-C 113.541 0.177 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.9 m -100.66 -172.92 2.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.005 0.402 . . . . 0.0 111.02 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.15 129.12 38.11 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 54.0 t -76.97 -34.46 57.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.21 18.33 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.02 156.48 19.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.332 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -127.47 144.67 51.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 111.112 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.5 m -87.32 -23.81 24.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.8 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -70.56 -22.88 62.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -82.25 -57.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.289 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.7 tm? -152.78 -55.13 0.12 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.573 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.9 -165.12 38.31 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.471 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 9.5 m -91.46 126.72 36.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.752 0.31 . . . . 0.0 110.541 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -81.68 -43.47 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.037 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.902 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 9.2 t0 -62.22 137.03 58.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.06 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -70.21 -33.57 71.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.381 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -96.28 40.01 1.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.902 ' HB2' ' HB3' ' A' ' 15' ' ' ASP . 37.9 t -124.07 147.19 48.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.504 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -123.33 146.65 47.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.11 131.47 35.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.12 0.486 . . . . 0.0 111.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -139.11 78.06 1.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.4 m-85 -27.31 125.87 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.85 -1.068 . . . . 0.0 113.651 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 64.1 Cg_endo -99.28 14.69 26.83 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.828 -1.322 . . . . 0.0 114.403 0.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -124.62 155.51 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.2 0.524 . . . . 0.0 112.313 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.768 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 72.1 m -90.03 144.19 26.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.141 0.496 . . . . 0.0 110.95 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.437 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 25.9 m -113.35 151.21 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.133 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 4' ' ' CYS . 31.6 ttpt -150.5 123.12 8.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.872 0.844 . . . . 0.0 110.236 -179.035 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.466 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -140.15 154.95 47.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.268 0.534 . . . . 0.0 110.844 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.588 HD21 HD12 ' A' ' 24' ' ' ILE . 89.0 mt -67.16 128.49 36.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.84 24.96 7.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.06 30.5 75.76 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.647 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.763 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 4.7 t0 -126.31 156.48 40.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.422 ' HB ' ' CD1' ' A' ' 9' ' ' PHE . 6.7 p -145.11 141.38 28.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.196 0.522 . . . . 0.0 112.126 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.1 m -89.23 42.89 1.11 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 23' ' ' PRO . 3.3 m-85 -74.44 -50.12 19.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.564 HG23 ' H ' ' A' ' 11' ' ' LEU . 1.2 m -71.13 -59.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.766 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.564 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.3 tm? -151.77 -50.95 0.12 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 -176.22 36.55 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.404 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.6 m -67.94 141.84 56.2 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.877 0.398 . . . . 0.0 111.751 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -67.94 -47.74 67.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.7 128.47 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.015 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 m -71.44 -9.49 58.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.413 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -88.21 -15.3 36.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 110.639 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 88.1 m -90.01 137.4 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 31.2 t -89.51 147.92 23.71 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.485 0.659 . . . . 0.0 109.778 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 77.46 9.88 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.476 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -88.33 65.27 7.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 7.2 m-85 -26.91 124.78 0.22 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 114.269 -1.332 . . . . 0.0 114.074 -176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 42.6 Cg_endo -99.42 13.58 26.48 Favored 'Cis proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.608 -1.414 . . . . 0.0 113.583 0.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.588 HD12 HD21 ' A' ' 3' ' ' LEU . 10.1 pt -109.23 143.94 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.763 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 72.1 m -91.99 128.97 38.03 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.61 0.719 . . . . 0.0 111.745 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.532 HG12 HD23 ' A' ' 3' ' ' LEU . 28.2 m -115.54 143.13 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.808 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -150.11 132.01 15.15 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 121.985 0.898 . . . . 0.0 109.865 -178.527 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 N-CA-C 112.962 -0.055 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -90.96 152.0 20.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 111.176 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 24' ' ' ILE . 21.4 mt -76.83 130.58 37.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.86 -63.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.262 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.44 -47.68 0.25 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 119.303 -1.427 . . . . 0.0 114.3 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.62 153.21 21.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 69.1 p -84.78 155.57 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.149 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 10.0 t -131.2 29.8 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 0.0 110.506 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -92.07 -22.88 19.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.704 0.288 . . . . 0.0 110.98 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -71.74 -61.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.068 0.461 . . . . 0.0 111.067 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.4 tm? -152.75 -50.86 0.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -167.24 141.3 6.8 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 p -78.56 144.55 35.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.334 0.588 . . . . 0.0 111.795 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -65.29 -23.9 67.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.553 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 68.6 m-20 -68.04 82.95 0.22 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -60.36 -31.61 70.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.21 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 m -89.92 29.28 1.21 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 76.3 m -142.81 156.99 45.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.17 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -89.98 154.66 19.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.522 0.677 . . . . 0.0 110.583 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.71 73.31 9.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.07 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -88.78 87.95 7.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -41.7 135.37 2.11 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.029 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -97.72 29.37 14.88 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.402 -1.499 . . . . 0.0 114.288 1.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 20.0 pt -140.36 -169.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.941 -0.474 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -112.05 134.16 53.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.11 155.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.087 0.47 . . . . 0.0 112.055 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -147.36 134.01 19.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.14 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.467 0.376 0 O-C-N 123.558 0.536 . . . . 0.0 110.395 -179.56 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -130.15 152.04 50.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.704 0.288 . . . . 0.0 110.351 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.674 HD22 HG13 ' A' ' 24' ' ' ILE . 50.4 mt -73.06 139.27 46.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.603 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 20.7 p -161.83 154.33 19.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.7 0.286 . . . . 0.0 111.089 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.16 -125.4 7.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.161 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -139.21 -128.97 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.476 HG22 HG22 ' A' ' 24' ' ' ILE . 20.5 p -126.21 142.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.227 0.537 . . . . 0.0 111.222 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 87.7 m -93.29 3.28 55.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.965 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -75.02 -24.13 58.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.878 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.13 -54.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -152.71 -61.99 0.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.331 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.41 150.47 5.52 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.652 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.0 m -70.59 128.63 36.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.942 0.371 . . . . 0.0 110.677 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.01 -33.24 75.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.447 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.74 126.94 31.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.664 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t -81.72 1.38 34.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.092 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -87.94 -39.71 14.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.264 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 82.9 m -88.11 124.24 33.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.176 0.512 . . . . 0.0 109.723 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -79.57 147.38 32.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 m -79.15 63.75 3.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -88.05 78.57 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.439 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 5.9 m-85 -33.4 138.84 0.26 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 124.504 1.127 . . . . 0.0 113.266 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.61 -33.93 2.73 Favored 'Cis proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.003 -1.665 . . . . 0.0 115.012 0.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.69 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.54 166.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 41.3 m -89.68 141.81 28.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.443 HG12 HD23 ' A' ' 3' ' ' LEU . 32.6 m -135.4 147.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.323 0.583 . . . . 0.0 112.263 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 21.7 ttpp -150.08 134.73 17.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.604 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 110.234 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.439 0 CA-C-O 120.457 -0.079 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 p -98.16 170.96 8.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.876 0.338 . . . . 0.0 111.105 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.82 128.81 36.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.2 t -66.66 -47.9 71.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.45 -43.88 1.25 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.712 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.509 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 30.8 m-20 -87.51 148.66 24.82 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.115 0.483 . . . . 0.0 110.484 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.744 HG22 HG22 ' A' ' 24' ' ' ILE . 14.5 p -91.7 140.58 29.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.417 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 7.7 t -105.29 32.89 3.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.014 0.435 . . . . 0.0 111.617 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -95.04 -16.5 22.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 t -85.26 -64.5 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.5 tm? -152.55 -48.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.009 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.07 -150.81 7.44 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.641 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 6' ' ' ASP . 84.9 m -141.59 168.02 20.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.74 0.27 . . . . 0.0 110.541 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -68.15 -55.11 13.56 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.729 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.9 t0 -72.67 130.19 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -76.2 -13.93 60.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.185 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.536 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -88.36 -4.29 58.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.199 0.523 . . . . 0.0 110.331 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 72.9 m -88.43 120.61 29.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.547 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.4 m -76.15 142.3 41.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -80.61 74.8 7.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -88.8 78.22 7.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 63.7 m-85 -33.5 128.55 0.41 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.999 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 65.2 Cg_endo -100.75 25.63 16.42 Favored 'Cis proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.175 -1.177 . . . . 0.0 114.343 0.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.744 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -136.52 152.57 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.814 -0.554 . . . . 0.0 111.636 -179.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 66.1 m -88.32 140.86 29.04 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.999 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -117.56 147.01 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.686 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.616 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 50.9 tttm -148.3 129.69 14.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 C--N 1.329 -0.295 0 O-C-N 123.752 0.658 . . . . 0.0 110.573 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 CA-C-O 120.155 -0.247 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 m -94.02 149.56 21.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.377 0.588 . . . . 0.0 111.067 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.598 HD23 HG12 ' A' ' 26' ' ' VAL . 74.1 mt -59.39 128.91 39.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.704 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 28.2 p -84.48 -36.48 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.62 -30.28 1.55 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.748 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.67 165.2 16.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.0 111.06 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.466 HG22 HG22 ' A' ' 24' ' ' ILE . 7.0 p -138.81 143.32 38.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.936 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.52 -14.4 43.12 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.607 ' HB3' ' HB2' ' A' ' 23' ' ' PRO . 16.0 p90 -77.03 -17.71 58.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.739 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -89.0 -58.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.948 0.404 . . . . 0.0 110.418 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.9 tm? -152.62 -54.48 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.935 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.94 -150.1 12.73 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.436 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 m -116.76 123.75 47.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.939 0.369 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -76.37 -39.15 54.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 10.5 t0 -62.39 117.89 6.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.199 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 m -63.7 -28.14 69.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.1 p -95.63 1.55 53.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 111.705 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.711 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 8.7 t -89.64 140.75 29.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -95.03 140.71 29.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.07 78.01 9.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -87.93 70.45 9.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 6.6 p90 -32.59 131.56 0.32 Allowed Pre-proline 0 N--CA 1.454 -0.238 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.73 -177.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.607 ' HB2' ' HB3' ' A' ' 9' ' ' PHE . 63.9 Cg_endo -96.24 23.58 25.04 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.355 -1.519 . . . . 0.0 114.404 1.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.466 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -130.06 144.97 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.89 -0.506 . . . . 0.0 112.161 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 61.6 m -89.36 132.76 34.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.992 0.425 . . . . 0.0 110.227 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.598 HG12 HD23 ' A' ' 3' ' ' LEU . 27.2 m -131.4 151.51 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 18' ' ' CYS . 13.6 mtmm -128.94 126.23 39.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.332 0.586 . . . . 0.0 110.53 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t -150.69 -161.08 1.26 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 pp -73.3 134.15 44.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.991 0.424 . . . . 0.0 110.6 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.9 t -85.79 -49.94 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.27 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.04 -47.3 0.81 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.361 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.95 172.46 9.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.34 0.59 . . . . 0.0 111.322 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.811 HG22 HG22 ' A' ' 24' ' ' ILE . 2.7 p -120.61 154.28 35.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.245 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.6 m -88.42 37.41 0.82 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.808 0.337 . . . . 0.0 110.557 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' A' ' 23' ' ' PRO . 37.2 m-85 -144.5 38.03 1.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.545 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -146.43 -60.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.662 179.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.545 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.2 tm? -151.54 -55.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.51 -140.64 5.83 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -116.01 139.45 50.25 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -67.92 -55.52 12.5 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 14.4 t0 -66.72 138.03 57.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.081 0.467 . . . . 0.0 111.34 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -66.69 -32.95 74.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.604 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.4 m -93.67 17.1 12.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.126 0.489 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 46.5 t -89.77 150.28 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -120.9 150.61 40.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.645 0.26 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -93.08 130.63 38.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.012 0.434 . . . . 0.0 110.947 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -140.41 85.4 2.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.7 m-85 -32.31 128.88 0.33 Allowed Pre-proline 0 N--CA 1.465 0.275 0 O-C-N 124.197 0.936 . . . . 0.0 113.196 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 44.4 Cg_endo -99.11 22.01 22.74 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.699 -1.376 . . . . 0.0 114.711 1.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.811 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -135.76 164.73 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.352 0.596 . . . . 0.0 112.401 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.725 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 91.7 m -88.86 144.88 25.91 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.42 143.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 110.771 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 17.7 tptm -151.14 141.05 21.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 1.4 m-20 . . . . . 0 N--CA 1.47 0.547 0 O-C-N 123.814 0.696 . . . . 0.0 111.491 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -135.84 147.38 48.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.506 HD23 HG12 ' A' ' 26' ' ' VAL . 92.9 mt -77.44 132.58 38.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.001 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 59.9 m -98.57 148.95 23.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.905 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.33 1.72 55.41 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -87.97 137.93 31.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.01 -0.595 . . . . 0.0 109.96 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.777 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 21.3 p -110.86 137.01 49.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.869 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 43.6 t -102.5 -12.14 18.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.909 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.421 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 8.1 p90 -67.27 -25.89 66.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -73.67 -61.33 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 110.805 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -152.95 -54.76 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.702 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.91 144.35 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.499 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.61 140.85 41.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.727 0.299 . . . . 0.0 111.033 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.62 -48.57 66.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.491 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -65.17 121.6 15.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -74.38 -9.21 58.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.002 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.549 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 1.5 m -87.08 -25.06 24.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.159 0.504 . . . . 0.0 109.951 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 95.4 m -89.45 116.86 27.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.4 t -85.09 155.68 21.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.314 0.578 . . . . 0.0 110.238 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -70.63 123.95 23.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.868 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -147.63 70.99 1.18 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.531 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 3.6 m-85 -33.86 135.63 0.34 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 114.321 -1.308 . . . . 0.0 112.908 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.6 -31.67 5.01 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.312 -1.537 . . . . 0.0 115.126 0.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.786 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.53 -161.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.484 0.659 . . . . 0.0 112.77 -178.166 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 12.0 m -125.49 153.66 43.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.066 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.506 HG12 HD23 ' A' ' 3' ' ' LEU . 18.2 m -122.52 133.87 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 111.226 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.58 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 20.8 ttpt -112.76 109.02 18.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.997 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 124.524 1.14 . . . . 0.0 110.474 -179.161 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.3 0 N-CA-C 112.802 -0.119 . . . . 0.0 112.802 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -150.91 -157.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.419 HD22 HG13 ' A' ' 24' ' ' ILE . 86.4 mt -80.36 129.43 34.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.681 0.277 . . . . 0.0 110.507 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.05 -54.31 7.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.986 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.37 -39.57 1.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.515 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 58.7 m-20 -86.62 148.37 25.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.054 0.454 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.673 HG22 HG22 ' A' ' 24' ' ' ILE . 17.7 p -97.32 138.76 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.553 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 48.6 t -92.32 -19.77 21.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -68.25 -25.58 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.894 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.96 -56.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.485 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.5 tm? -152.46 -62.8 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.128 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.96 148.48 5.29 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.092 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.73 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -72.33 138.17 47.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.276 0.23 . . . . 0.0 110.984 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -78.78 -30.8 45.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.584 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 13.2 t0 -66.93 126.8 30.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 t -68.64 -15.42 63.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.088 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.524 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.44 -14.11 38.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.498 . . . . 0.0 110.121 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.594 ' SG ' ' HD2' ' A' ' 27' ' ' LYS . 72.2 m -88.98 124.18 34.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.783 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.93 133.28 33.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 124.75 24.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.293 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' CYS . 7.4 t-20 -151.47 153.53 34.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -97.94 133.46 23.24 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.349 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.05 -25.67 6.54 Favored 'Cis proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.198 -1.584 . . . . 0.0 113.887 0.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -107.76 159.34 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.178 0.514 . . . . 0.0 112.365 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.5 m -85.94 152.33 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -109.06 140.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 82.9 tttt -151.51 144.88 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.467 0.383 0 O-C-N 123.848 0.718 . . . . 0.0 111.342 179.18 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.341 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -146.5 -162.04 1.45 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.5 130.18 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.97 0.414 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.0 t -83.31 -45.41 13.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.05 -38.84 2.71 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.701 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.8 t0 -87.86 157.38 19.0 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.612 HG22 HG22 ' A' ' 24' ' ' ILE . 54.1 p -111.48 142.35 43.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.867 0.365 . . . . 0.0 111.603 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.714 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 11.0 t -125.89 30.85 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.077 0.465 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.598 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 23.3 p90 -93.66 7.12 45.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.7 -57.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.118 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.419 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.5 mm? -97.79 -108.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.032 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.555 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 179.74 133.73 2.05 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.535 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 6' ' ' ASP . 80.5 m -69.09 117.81 11.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -79.31 -23.56 43.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.657 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -58.73 124.69 20.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -68.83 -29.35 67.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.0 p -92.01 38.1 0.99 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.752 0.787 . . . . 0.0 109.126 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 45.0 t -150.47 146.36 26.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.775 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.25 136.58 53.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.786 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -65.87 131.27 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.5 0.666 . . . . 0.0 111.766 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 51.9 t30 -151.25 160.31 43.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.17 132.92 21.84 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-O 120.629 0.252 . . . . 0.0 110.699 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 97.0 Cg_endo -83.27 -32.48 3.26 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.105 -1.623 . . . . 0.0 112.906 -0.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.72 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -97.01 157.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.858 -179.673 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.786 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 65.2 m -86.88 163.86 16.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.12 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -109.11 148.68 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.14 0.495 . . . . 0.0 111.645 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 21.7 ttmm -145.67 125.51 13.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.524 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.718 0.77 . . . . 0.0 111.042 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 t -89.94 174.66 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 110.52 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.95 128.18 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB3' ' C ' ' A' ' 25' ' ' CYS . 47.2 t -90.07 136.15 33.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.65 44.54 2.02 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.242 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 13' ' ' CYS . 41.8 t0 -151.67 164.63 36.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.419 ' HB ' ' CD2' ' A' ' 9' ' ' PHE . 36.6 p -124.55 139.0 54.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.0 110.777 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 5.8 t -97.93 -8.76 27.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.999 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.461 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 7.4 p90 -68.63 -24.68 64.58 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.641 0.258 . . . . 0.0 110.637 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.05 -58.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.995 0.426 . . . . 0.0 110.617 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -152.97 -56.47 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.927 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 175.67 149.25 7.29 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -64.99 131.62 47.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.723 0.296 . . . . 0.0 110.652 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.1 -38.34 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 18' ' ' CYS . 55.8 t0 -66.88 130.44 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -72.36 -21.29 61.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.17 -14.44 38.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.862 0.839 . . . . 0.0 109.223 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . 47.2 t -89.53 141.77 28.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.408 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 31.0 t -108.53 149.95 28.14 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.409 0.624 . . . . 0.0 110.594 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.643 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 47.6 t -69.25 128.23 35.88 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.716 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 44.1 t30 -152.18 148.21 27.33 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 4.9 m-85 -111.34 134.29 21.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.4 -36.01 1.96 Allowed 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.941 -1.691 . . . . 0.0 112.706 -0.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.1 152.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.491 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.7 m -85.98 172.65 10.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.056 0.455 . . . . 0.0 111.32 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.14 149.84 31.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.29 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.7 tmmt? -146.53 125.02 12.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 124.254 1.022 . . . . 0.0 112.061 -177.603 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.5 m -151.89 168.32 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.451 ' HA ' HG12 ' A' ' 26' ' ' VAL . 3.5 pp -66.23 140.04 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.604 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 t -74.13 -39.75 63.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.835 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.97 -38.2 2.67 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 45.0 p-10 -90.16 -174.89 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.602 . . . . 0.0 111.089 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 24' ' ' ILE . 17.1 p -133.96 142.46 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.549 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 37.7 t -97.14 -8.78 29.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.417 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.6 p90 -69.67 -26.99 64.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.056 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.558 HG23 ' H ' ' A' ' 11' ' ' LEU . 1.1 m -80.26 -61.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.634 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.558 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.0 mm? -133.77 -58.5 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.412 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 168.57 161.51 18.77 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.635 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 25.7 m -67.63 137.37 55.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.678 0.275 . . . . 0.0 111.039 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -74.9 -52.12 12.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.759 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 12.2 t0 -75.21 135.58 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.061 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -66.42 -21.3 66.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -89.06 -7.21 56.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 111.005 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 78.7 m -89.38 118.13 28.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.734 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 p -83.92 144.49 29.15 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -74.8 68.43 1.73 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.32 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -88.0 67.21 8.9 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.402 ' H ' ' HD1' ' A' ' 22' ' ' TYR . 5.2 m-85 -29.8 135.52 0.19 Allowed Pre-proline 0 N--CA 1.469 0.499 0 O-C-N 124.673 1.233 . . . . 0.0 113.437 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.37 -30.66 4.32 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.126 -1.614 . . . . 0.0 114.933 0.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.699 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.47 152.51 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 74.8 m -89.34 149.14 23.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.935 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 3' ' ' LEU . 28.0 m -133.79 146.59 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.986 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -139.33 144.83 38.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.759 -0.201 . . . . 0.0 110.764 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.47 0.553 0 O-C-N 124.252 0.97 . . . . 0.0 111.236 178.555 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.459 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 m -89.06 154.99 19.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.986 0.393 . . . . 0.0 111.181 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.22 148.08 49.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.464 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.3 t -144.92 131.4 19.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.434 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.53 -122.04 19.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.274 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.0 -148.32 0.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.061 0.458 . . . . 0.0 110.36 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.454 HG22 HG22 ' A' ' 24' ' ' ILE . 38.7 p -75.36 152.81 38.05 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.129 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 m -84.69 39.6 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.703 0.763 . . . . 0.0 109.269 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HE1' ' HB2' ' A' ' 23' ' ' PRO . 32.1 m-85 -107.25 -45.23 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.718 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.59 -50.65 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tm? -150.15 -47.38 0.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.17 -71.31 2.55 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.894 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 p -167.54 126.53 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.366 0.603 . . . . 0.0 112.0 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -80.76 -30.9 36.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.52 125.54 25.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.9 m -72.26 -9.11 58.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.343 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -87.39 -17.71 31.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.23 0.538 . . . . 0.0 109.896 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.1 m -89.97 134.75 34.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.923 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -106.44 142.6 35.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.9 t -81.73 96.23 7.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.23 0.538 . . . . 0.0 111.319 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.24 82.76 6.5 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 3.4 p90 -27.24 123.12 0.24 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.612 ' HB2' ' HE1' ' A' ' 9' ' ' PHE . 16.4 Cg_endo -104.61 36.31 5.03 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.193 -1.17 . . . . 0.0 114.133 0.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -139.72 153.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.397 0.544 . . . . 0.0 111.178 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 m -87.64 140.47 29.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.292 0.568 . . . . 0.0 111.682 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 m -136.3 155.79 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.569 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -150.23 122.66 8.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 121.728 0.775 . . . . 0.0 110.369 -179.45 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.285 0 N-CA-C 112.944 -0.063 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -136.29 155.53 49.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 110.273 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 26' ' ' VAL . 97.9 mt -75.91 126.6 31.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.9 m -72.07 -22.54 61.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.949 0.404 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.77 19.58 72.88 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -123.99 150.79 44.43 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.3 p -109.64 137.08 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.222 0.534 . . . . 0.0 112.203 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.619 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 53.0 t -101.51 -17.03 16.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.853 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -62.26 -27.56 69.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.658 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.25 -58.56 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.8 tm? -153.15 -54.07 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.95 142.13 4.27 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.923 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -71.88 147.64 46.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 111.356 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.98 -53.09 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.699 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 32.6 t70 -70.94 123.87 23.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.438 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 m -71.44 -16.44 62.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.511 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -89.74 -4.84 57.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.416 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 59.1 m -87.52 124.59 33.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -78.14 139.67 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.884 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -74.05 72.19 1.65 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.135 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.19 73.29 8.97 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -35.46 137.25 0.43 Allowed Pre-proline 0 N--CA 1.466 0.332 0 O-C-N 124.54 1.15 . . . . 0.0 112.732 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.6 -28.12 7.81 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.282 -1.549 . . . . 0.0 114.797 1.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.795 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.36 -162.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 30.4 m -128.52 145.95 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.741 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 3' ' ' LEU . 30.0 m -119.87 143.45 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 79.2 tttt -150.7 136.37 18.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.736 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.681 0.613 . . . . 0.0 111.124 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.726 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 p -150.01 -163.6 1.82 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.515 HD22 HG13 ' A' ' 24' ' ' ILE . 72.8 mt -77.15 160.3 29.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.612 0.244 . . . . 0.0 110.455 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 3.4 t -145.83 132.15 19.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.688 0.28 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.13 -123.37 32.84 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.823 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -131.55 -137.59 0.2 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 20.1 p -87.78 143.24 27.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.281 0.562 . . . . 0.0 111.351 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 42.9 t -87.9 -17.66 30.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.202 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.412 ' HE2' ' HB3' ' A' ' 23' ' ' PRO . 2.7 p90 -69.73 -18.16 63.5 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.805 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.43 -47.27 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.06 0.457 . . . . 0.0 110.562 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.6 tm? -151.68 -62.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.858 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.02 130.87 2.56 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.605 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -83.72 68.95 10.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.19 50.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.944 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.94 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.1 t70 -80.75 157.07 25.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -69.88 -18.81 63.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.707 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 32.3 p -134.87 37.76 3.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.873 0.368 . . . . 0.0 111.187 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . 40.4 t -140.12 151.35 45.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -119.67 140.72 50.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 110.015 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 134.62 38.41 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 49.0 t30 -147.89 158.08 43.86 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -115.56 135.07 22.58 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 120.996 0.427 . . . . 0.0 110.799 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.416 ' HD2' HD13 ' A' ' 24' ' ' ILE . 6.1 Cg_exo -76.61 -43.32 0.66 Allowed 'Cis proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.28 -1.55 . . . . 0.0 113.175 0.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.784 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.67 156.74 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 57.8 m -85.8 174.04 9.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.23 151.78 32.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.993 0.425 . . . . 0.0 111.458 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.707 ' HG3' ' O ' ' A' ' 17' ' ' SER . 48.9 tttm -148.72 133.23 17.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 . . . . . 0 N--CA 1.472 0.666 0 O-C-N 124.463 1.102 . . . . 0.0 111.621 178.663 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.765 -0.134 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 t -150.87 -162.12 1.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.676 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.4 pt? -80.52 133.03 35.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 110.9 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.1 t -75.53 -40.08 57.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.877 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.85 -56.35 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.94 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -89.67 170.47 10.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.167 0.508 . . . . 0.0 110.528 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.472 HG22 HG22 ' A' ' 24' ' ' ILE . 33.5 p -110.04 145.78 36.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.852 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.571 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 35.4 t -88.9 32.79 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -37.65 12.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.707 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.65 -56.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.396 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -152.77 -52.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 109.712 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.571 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -179.84 163.09 30.07 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 43.7 m -62.38 132.65 53.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.82 0.343 . . . . 0.0 110.734 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -50.41 64.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.772 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.6 t0 -77.73 131.24 37.58 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.5 m -64.69 -17.85 64.46 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.514 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.58 -8.07 55.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.019 0.438 . . . . 0.0 110.795 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 85.7 m -89.18 122.61 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.798 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -84.86 143.78 28.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.232 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 m -80.27 66.78 5.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.109 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -88.25 70.16 9.17 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.427 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 7.0 m-85 -30.78 135.28 0.21 Allowed Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 124.647 1.217 . . . . 0.0 113.551 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.17 -27.25 6.03 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.94 -1.692 . . . . 0.0 114.808 0.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.4 153.66 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 85.8 m -88.61 140.4 29.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.925 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.15 139.76 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.645 0.259 . . . . 0.0 110.735 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HE3' ' HB2' ' A' ' 17' ' ' SER . 79.2 tttt -151.55 146.38 25.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.418 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.829 0.706 . . . . 0.0 111.458 179.212 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 N-CA-C 112.911 -0.076 . . . . 0.0 112.911 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -110.14 158.99 17.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.45 126.66 30.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.983 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.796 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 47.7 t -83.11 140.87 32.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.07 47.36 1.93 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.318 -0.468 . . . . 0.0 113.525 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.439 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 39.9 t0 -151.53 165.2 34.97 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.733 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 41.2 p -129.29 139.38 51.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 77.8 m -98.1 -2.9 39.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.36 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.442 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.8 p90 -66.58 -26.31 67.05 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.115 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -70.05 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.109 0.48 . . . . 0.0 110.493 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -153.38 -53.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.486 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.15 153.41 16.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 0.6 OUTLIER -64.99 137.53 57.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.698 0.249 . . . . 0.0 110.763 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -70.36 -41.64 72.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -80.78 122.3 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.049 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.7 t -69.67 -11.18 60.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.201 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -24.6 23.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.981 0.42 . . . . 0.0 110.52 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 68.9 m -87.5 128.64 35.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -85.25 148.8 25.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.225 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.8 m -76.97 127.31 32.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.176 0.513 . . . . 0.0 111.596 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -146.07 73.74 1.35 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.517 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 5.0 m-85 -36.18 134.49 0.57 Allowed Pre-proline 0 N--CA 1.462 0.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.756 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.43 -27.97 7.6 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.169 -1.596 . . . . 0.0 115.216 1.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.761 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.24 -164.77 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.796 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 61.4 m -116.88 159.76 21.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.522 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.45 135.51 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.8 ttpt -152.46 141.7 21.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 . . . . . 0 N--CA 1.464 0.266 0 O-C-N 123.635 0.584 . . . . 0.0 110.707 179.401 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.913 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -149.46 156.05 41.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.499 HD22 HG13 ' A' ' 24' ' ' ILE . 53.5 mt -71.67 133.75 45.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 26.4 m -71.13 -32.22 68.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 109.922 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.25 -39.17 2.9 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.553 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -88.36 143.93 26.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.206 0.527 . . . . 0.0 111.087 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 36.2 p -92.3 139.9 30.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.718 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.9 p -89.47 -18.6 26.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -66.95 -22.78 65.92 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.105 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.473 ' O ' HD22 ' A' ' 11' ' ' LEU . 61.5 t -81.12 -53.26 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.755 0.312 . . . . 0.0 111.089 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -138.48 -54.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 8' ' ' CYS . . . 171.62 -148.51 11.06 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 78.7 m -117.43 134.28 55.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.688 0.244 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.08 -47.15 72.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.545 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.891 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m-20 -80.0 140.56 36.53 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 m -67.09 -24.1 65.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.249 0.547 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -93.92 6.13 49.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.082 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.891 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 51.6 m -89.65 123.26 33.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.664 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -87.59 146.72 25.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.39 71.4 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.238 0.542 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -88.78 74.5 8.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 74.7 m-85 -27.27 130.87 0.18 Allowed Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 124.646 1.216 . . . . 0.0 113.839 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 29.3 Cg_endo -90.45 -23.04 7.85 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.366 -1.514 . . . . 0.0 114.491 0.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.707 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -91.27 160.1 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.31 0.576 . . . . 0.0 112.518 -178.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.3 m -88.66 140.47 29.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.344 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.39 140.3 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.637 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.4 ttpt -131.5 120.95 23.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.882 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 N--CA 1.47 0.566 0 O-C-N 124.38 1.05 . . . . 0.0 110.903 -179.532 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 t -155.2 -141.73 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.603 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.9 mt -80.2 143.88 33.41 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.03 -39.69 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.952 0.406 . . . . 0.0 110.761 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.92 -29.86 10.2 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.807 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 150.21 23.98 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.52 HG22 HG22 ' A' ' 24' ' ' ILE . 69.0 p -95.1 137.21 34.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.264 0.554 . . . . 0.0 112.468 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 53.2 t -109.41 -12.3 14.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.177 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.523 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 9.6 p90 -63.18 -27.25 69.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.465 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.73 -56.22 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.482 . . . . 0.0 110.653 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.8 tm? -153.17 -53.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.359 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 177.84 145.51 5.94 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.751 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 63.0 m -68.57 140.56 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.107 0.48 . . . . 0.0 111.494 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -68.93 -44.47 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.32 116.56 6.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.399 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.8 m -75.29 -12.32 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.7 m -89.15 -15.61 33.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.181 0.515 . . . . 0.0 110.142 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.17 137.41 32.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.604 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.17 128.56 34.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -62.2 130.38 45.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.51 0.672 . . . . 0.0 112.023 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 46.6 t30 -150.83 152.68 34.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.914 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 2.4 m-85 -104.72 134.18 19.79 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 78.0 Cg_endo -81.23 -33.61 3.1 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.329 -1.53 . . . . 0.0 113.209 0.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.73 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.02 152.46 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.946 -179.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p -86.71 173.06 9.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.408 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.82 152.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.337 . . . . 0.0 111.243 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -131.3 142.74 50.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 N--CA 1.465 0.323 0 O-C-N 124.29 0.994 . . . . 0.0 111.853 -178.557 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 m -149.36 154.08 38.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.024 0.44 . . . . 0.0 111.161 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.619 HD23 HG12 ' A' ' 26' ' ' VAL . 72.6 mt -69.28 138.02 53.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.373 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.64 ' SG ' ' HG2' ' A' ' 27' ' ' LYS . 73.4 m -82.82 -39.07 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.774 0.321 . . . . 0.0 111.094 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.92 -31.81 3.8 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -87.95 153.06 21.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.12 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.726 HG22 HG22 ' A' ' 24' ' ' ILE . 17.6 p -122.8 156.04 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.688 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 m -87.81 -13.99 40.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CE1' HG13 ' A' ' 10' ' ' VAL . 4.8 p90 -74.53 -25.19 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -83.13 -58.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 111.209 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.502 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.0 tm? -151.6 -54.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.51 -160.49 34.09 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.746 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 m -87.13 131.66 34.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.555 0.217 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -80.31 -44.46 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.433 0.635 . . . . 0.0 109.37 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.38 129.31 35.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.724 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.6 t -71.17 -23.35 62.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.128 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.434 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 2.9 m -89.69 37.31 0.87 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.814 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 34.9 t -139.88 154.18 47.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -119.34 145.36 46.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -83.39 120.24 25.64 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.242 0.544 . . . . 0.0 111.349 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -122.53 82.54 1.99 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 27.2 m-85 -31.59 123.73 0.36 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.305 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 63.6 Cg_endo -102.33 25.4 14.1 Favored 'Cis proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.062 -1.224 . . . . 0.0 114.713 0.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.726 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -131.14 151.66 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.411 0.551 . . . . 0.0 112.294 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.692 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 74.2 m -89.79 132.92 34.99 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.838 0.351 . . . . 0.0 110.376 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.619 HG12 HD23 ' A' ' 3' ' ' LEU . 27.2 m -137.49 153.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.64 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 5.9 pttm -139.76 137.07 34.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.644 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 N--CA 1.468 0.439 0 O-C-N 124.322 1.014 . . . . 0.0 110.566 -179.132 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.411 0 N-CA-C 113.541 0.177 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.9 m -100.66 -172.92 2.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.005 0.402 . . . . 0.0 111.02 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.15 129.12 38.11 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 54.0 t -76.97 -34.46 57.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.21 18.33 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.02 156.48 19.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.332 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -127.47 144.67 51.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 111.112 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.5 m -87.32 -23.81 24.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.8 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -70.56 -22.88 62.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -82.25 -57.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.289 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.7 tm? -152.78 -55.13 0.12 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.573 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.9 -165.12 38.31 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.471 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.415 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 9.5 m -91.46 126.72 36.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.752 0.31 . . . . 0.0 110.541 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -81.68 -43.47 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.037 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.902 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 9.2 t0 -62.22 137.03 58.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.06 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -70.21 -33.57 71.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.381 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -96.28 40.01 1.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.902 ' HB2' ' HB3' ' A' ' 15' ' ' ASP . 37.9 t -124.07 147.19 48.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.504 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -123.33 146.65 47.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.11 131.47 35.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.12 0.486 . . . . 0.0 111.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -139.11 78.06 1.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.4 m-85 -27.31 125.87 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.85 -1.068 . . . . 0.0 113.651 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 64.1 Cg_endo -99.28 14.69 26.83 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.828 -1.322 . . . . 0.0 114.403 0.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -124.62 155.51 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.2 0.524 . . . . 0.0 112.313 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.768 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 72.1 m -90.03 144.19 26.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.141 0.496 . . . . 0.0 110.95 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.437 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 25.9 m -113.35 151.21 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.133 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 4' ' ' CYS . 31.6 ttpt -150.5 123.12 8.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.872 0.844 . . . . 0.0 110.236 -179.035 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.466 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -140.15 154.95 47.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.268 0.534 . . . . 0.0 110.844 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.588 HD21 HD12 ' A' ' 24' ' ' ILE . 89.0 mt -67.16 128.49 36.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.84 24.96 7.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.06 30.5 75.76 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.647 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.763 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 4.7 t0 -126.31 156.48 40.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.422 ' HB ' ' CD1' ' A' ' 9' ' ' PHE . 6.7 p -145.11 141.38 28.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.196 0.522 . . . . 0.0 112.126 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.1 m -89.23 42.89 1.11 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 23' ' ' PRO . 3.3 m-85 -74.44 -50.12 19.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.564 HG23 ' H ' ' A' ' 11' ' ' LEU . 1.2 m -71.13 -59.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.766 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.564 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.3 tm? -151.77 -50.95 0.12 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 -176.22 36.55 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.404 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.6 m -67.94 141.84 56.2 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.877 0.398 . . . . 0.0 111.751 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -67.94 -47.74 67.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.7 128.47 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.015 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 m -71.44 -9.49 58.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.413 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -88.21 -15.3 36.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 110.639 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 88.1 m -90.01 137.4 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 31.2 t -89.51 147.92 23.71 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.485 0.659 . . . . 0.0 109.778 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 77.46 9.88 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.476 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -88.33 65.27 7.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 7.2 m-85 -26.91 124.78 0.22 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 114.269 -1.332 . . . . 0.0 114.074 -176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 42.6 Cg_endo -99.42 13.58 26.48 Favored 'Cis proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.608 -1.414 . . . . 0.0 113.583 0.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.588 HD12 HD21 ' A' ' 3' ' ' LEU . 10.1 pt -109.23 143.94 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.763 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 72.1 m -91.99 128.97 38.03 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.61 0.719 . . . . 0.0 111.745 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.532 HG12 HD23 ' A' ' 3' ' ' LEU . 28.2 m -115.54 143.13 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.808 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -150.11 132.01 15.15 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 121.985 0.898 . . . . 0.0 109.865 -178.527 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 N-CA-C 112.962 -0.055 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -90.96 152.0 20.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 111.176 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 24' ' ' ILE . 21.4 mt -76.83 130.58 37.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.86 -63.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.262 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.44 -47.68 0.25 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 119.303 -1.427 . . . . 0.0 114.3 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.62 153.21 21.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 69.1 p -84.78 155.57 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.149 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 10.0 t -131.2 29.8 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 0.0 110.506 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -92.07 -22.88 19.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.704 0.288 . . . . 0.0 110.98 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -71.74 -61.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.068 0.461 . . . . 0.0 111.067 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.4 tm? -152.75 -50.86 0.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.468 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -167.24 141.3 6.8 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 p -78.56 144.55 35.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.334 0.588 . . . . 0.0 111.795 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -65.29 -23.9 67.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.553 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 68.6 m-20 -68.04 82.95 0.22 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -60.36 -31.61 70.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.21 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 m -89.92 29.28 1.21 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 76.3 m -142.81 156.99 45.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.17 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -89.98 154.66 19.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.522 0.677 . . . . 0.0 110.583 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.71 73.31 9.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.07 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.78 87.95 7.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -41.7 135.37 2.11 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.029 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -97.72 29.37 14.88 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.402 -1.499 . . . . 0.0 114.288 1.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 20.0 pt -140.36 -169.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.941 -0.474 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -112.05 134.16 53.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.11 155.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.087 0.47 . . . . 0.0 112.055 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -147.36 134.01 19.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.14 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.467 0.376 0 O-C-N 123.558 0.536 . . . . 0.0 110.395 -179.56 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -130.15 152.04 50.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.704 0.288 . . . . 0.0 110.351 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.674 HD22 HG13 ' A' ' 24' ' ' ILE . 50.4 mt -73.06 139.27 46.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.603 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 20.7 p -161.83 154.33 19.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.7 0.286 . . . . 0.0 111.089 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.16 -125.4 7.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.161 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -139.21 -128.97 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.476 HG22 HG22 ' A' ' 24' ' ' ILE . 20.5 p -126.21 142.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.227 0.537 . . . . 0.0 111.222 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 87.7 m -93.29 3.28 55.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.965 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -75.02 -24.13 58.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.878 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.13 -54.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -152.71 -61.99 0.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.331 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.41 150.47 5.52 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.652 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.0 m -70.59 128.63 36.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.942 0.371 . . . . 0.0 110.677 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.01 -33.24 75.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.447 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.74 126.94 31.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.664 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t -81.72 1.38 34.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.092 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -87.94 -39.71 14.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.264 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 82.9 m -88.11 124.24 33.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.176 0.512 . . . . 0.0 109.723 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -79.57 147.38 32.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 m -79.15 63.75 3.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -88.05 78.57 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.439 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 5.9 m-85 -33.4 138.84 0.26 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 124.504 1.127 . . . . 0.0 113.266 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.61 -33.93 2.73 Favored 'Cis proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.003 -1.665 . . . . 0.0 115.012 0.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.69 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.54 166.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 41.3 m -89.68 141.81 28.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.443 HG12 HD23 ' A' ' 3' ' ' LEU . 32.6 m -135.4 147.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.323 0.583 . . . . 0.0 112.263 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 21.7 ttpp -150.08 134.73 17.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.604 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 110.234 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.439 0 CA-C-O 120.457 -0.079 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 p -98.16 170.96 8.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.876 0.338 . . . . 0.0 111.105 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.82 128.81 36.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.2 t -66.66 -47.9 71.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.45 -43.88 1.25 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.712 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.509 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 30.8 m-20 -87.51 148.66 24.82 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.115 0.483 . . . . 0.0 110.484 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.744 HG22 HG22 ' A' ' 24' ' ' ILE . 14.5 p -91.7 140.58 29.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.417 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 7.7 t -105.29 32.89 3.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.014 0.435 . . . . 0.0 111.617 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -95.04 -16.5 22.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 t -85.26 -64.5 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.5 tm? -152.55 -48.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.009 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.07 -150.81 7.44 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.641 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 6' ' ' ASP . 84.9 m -141.59 168.02 20.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.74 0.27 . . . . 0.0 110.541 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -68.15 -55.11 13.56 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.729 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.9 t0 -72.67 130.19 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -76.2 -13.93 60.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.185 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.536 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -88.36 -4.29 58.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.199 0.523 . . . . 0.0 110.331 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 72.9 m -88.43 120.61 29.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.547 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.4 m -76.15 142.3 41.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -80.61 74.8 7.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -88.8 78.22 7.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 63.7 m-85 -33.5 128.55 0.41 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.999 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 65.2 Cg_endo -100.75 25.63 16.42 Favored 'Cis proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.175 -1.177 . . . . 0.0 114.343 0.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.744 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -136.52 152.57 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.814 -0.554 . . . . 0.0 111.636 -179.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 66.1 m -88.32 140.86 29.04 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.999 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -117.56 147.01 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.686 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.616 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 50.9 tttm -148.3 129.69 14.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 C--N 1.329 -0.295 0 O-C-N 123.752 0.658 . . . . 0.0 110.573 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 CA-C-O 120.155 -0.247 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 m -94.02 149.56 21.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.377 0.588 . . . . 0.0 111.067 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.598 HD23 HG12 ' A' ' 26' ' ' VAL . 74.1 mt -59.39 128.91 39.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.704 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 28.2 p -84.48 -36.48 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.62 -30.28 1.55 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.748 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.67 165.2 16.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.0 111.06 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.466 HG22 HG22 ' A' ' 24' ' ' ILE . 7.0 p -138.81 143.32 38.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.936 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.52 -14.4 43.12 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.607 ' HB3' ' HB2' ' A' ' 23' ' ' PRO . 16.0 p90 -77.03 -17.71 58.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.739 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -89.0 -58.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.948 0.404 . . . . 0.0 110.418 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.9 tm? -152.62 -54.48 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.935 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.94 -150.1 12.73 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.436 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 m -116.76 123.75 47.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.939 0.369 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -76.37 -39.15 54.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 10.5 t0 -62.39 117.89 6.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.199 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 m -63.7 -28.14 69.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.1 p -95.63 1.55 53.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 111.705 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.711 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 8.7 t -89.64 140.75 29.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -95.03 140.71 29.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.07 78.01 9.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -87.93 70.45 9.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 6.6 p90 -32.59 131.56 0.32 Allowed Pre-proline 0 N--CA 1.454 -0.238 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.73 -177.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.607 ' HB2' ' HB3' ' A' ' 9' ' ' PHE . 63.9 Cg_endo -96.24 23.58 25.04 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.355 -1.519 . . . . 0.0 114.404 1.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.466 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -130.06 144.97 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.89 -0.506 . . . . 0.0 112.161 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 61.6 m -89.36 132.76 34.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.992 0.425 . . . . 0.0 110.227 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.598 HG12 HD23 ' A' ' 3' ' ' LEU . 27.2 m -131.4 151.51 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 18' ' ' CYS . 13.6 mtmm -128.94 126.23 39.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.332 0.586 . . . . 0.0 110.53 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t -150.69 -161.08 1.26 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 pp -73.3 134.15 44.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.991 0.424 . . . . 0.0 110.6 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.9 t -85.79 -49.94 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.27 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.04 -47.3 0.81 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.361 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.95 172.46 9.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.34 0.59 . . . . 0.0 111.322 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.811 HG22 HG22 ' A' ' 24' ' ' ILE . 2.7 p -120.61 154.28 35.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.245 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.6 m -88.42 37.41 0.82 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.808 0.337 . . . . 0.0 110.557 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' A' ' 23' ' ' PRO . 37.2 m-85 -144.5 38.03 1.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.545 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -146.43 -60.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.662 179.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.545 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.2 tm? -151.54 -55.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.51 -140.64 5.83 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -116.01 139.45 50.25 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -67.92 -55.52 12.5 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 14.4 t0 -66.72 138.03 57.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.081 0.467 . . . . 0.0 111.34 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -66.69 -32.95 74.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.604 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.4 m -93.67 17.1 12.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.126 0.489 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 46.5 t -89.77 150.28 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -120.9 150.61 40.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.645 0.26 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -93.08 130.63 38.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.012 0.434 . . . . 0.0 110.947 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -140.41 85.4 2.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.7 m-85 -32.31 128.88 0.33 Allowed Pre-proline 0 N--CA 1.465 0.275 0 O-C-N 124.197 0.936 . . . . 0.0 113.196 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 44.4 Cg_endo -99.11 22.01 22.74 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.699 -1.376 . . . . 0.0 114.711 1.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.811 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -135.76 164.73 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.352 0.596 . . . . 0.0 112.401 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.725 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 91.7 m -88.86 144.88 25.91 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.42 143.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 110.771 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 17.7 tptm -151.14 141.05 21.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 1.4 m-20 . . . . . 0 N--CA 1.47 0.547 0 O-C-N 123.814 0.696 . . . . 0.0 111.491 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -135.84 147.38 48.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.506 HD23 HG12 ' A' ' 26' ' ' VAL . 92.9 mt -77.44 132.58 38.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.001 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 59.9 m -98.57 148.95 23.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.905 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.33 1.72 55.41 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -87.97 137.93 31.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.01 -0.595 . . . . 0.0 109.96 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.777 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 21.3 p -110.86 137.01 49.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.869 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 43.6 t -102.5 -12.14 18.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.909 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.421 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 8.1 p90 -67.27 -25.89 66.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -73.67 -61.33 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 110.805 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -152.95 -54.76 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.702 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.91 144.35 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.499 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.61 140.85 41.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.727 0.299 . . . . 0.0 111.033 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.62 -48.57 66.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.491 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -65.17 121.6 15.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -74.38 -9.21 58.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.002 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.549 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 1.5 m -87.08 -25.06 24.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.159 0.504 . . . . 0.0 109.951 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 95.4 m -89.45 116.86 27.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.4 t -85.09 155.68 21.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.314 0.578 . . . . 0.0 110.238 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -70.63 123.95 23.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.868 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -147.63 70.99 1.18 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.531 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 3.6 m-85 -33.86 135.63 0.34 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 114.321 -1.308 . . . . 0.0 112.908 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.6 -31.67 5.01 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.312 -1.537 . . . . 0.0 115.126 0.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.786 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.53 -161.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.484 0.659 . . . . 0.0 112.77 -178.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 12.0 m -125.49 153.66 43.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.066 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.506 HG12 HD23 ' A' ' 3' ' ' LEU . 18.2 m -122.52 133.87 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 111.226 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.58 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 20.8 ttpt -112.76 109.02 18.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.997 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 124.524 1.14 . . . . 0.0 110.474 -179.161 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.3 0 N-CA-C 112.802 -0.119 . . . . 0.0 112.802 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -150.91 -157.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.419 HD22 HG13 ' A' ' 24' ' ' ILE . 86.4 mt -80.36 129.43 34.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.681 0.277 . . . . 0.0 110.507 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.05 -54.31 7.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.986 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.37 -39.57 1.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.515 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 58.7 m-20 -86.62 148.37 25.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.054 0.454 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.673 HG22 HG22 ' A' ' 24' ' ' ILE . 17.7 p -97.32 138.76 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.553 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 48.6 t -92.32 -19.77 21.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -68.25 -25.58 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.894 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.96 -56.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.485 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.5 tm? -152.46 -62.8 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.128 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.96 148.48 5.29 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.092 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.73 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -72.33 138.17 47.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.276 0.23 . . . . 0.0 110.984 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -78.78 -30.8 45.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.584 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 13.2 t0 -66.93 126.8 30.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 t -68.64 -15.42 63.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.088 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.524 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.44 -14.11 38.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.498 . . . . 0.0 110.121 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.594 ' SG ' ' HD2' ' A' ' 27' ' ' LYS . 72.2 m -88.98 124.18 34.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.783 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.93 133.28 33.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 124.75 24.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.293 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' CYS . 7.4 t-20 -151.47 153.53 34.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -97.94 133.46 23.24 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.349 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.05 -25.67 6.54 Favored 'Cis proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.198 -1.584 . . . . 0.0 113.887 0.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -107.76 159.34 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.178 0.514 . . . . 0.0 112.365 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.5 m -85.94 152.33 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -109.06 140.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 82.9 tttt -151.51 144.88 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.467 0.383 0 O-C-N 123.848 0.718 . . . . 0.0 111.342 179.18 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.341 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -146.5 -162.04 1.45 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.5 130.18 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.97 0.414 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.0 t -83.31 -45.41 13.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.05 -38.84 2.71 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.701 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.8 t0 -87.86 157.38 19.0 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.612 HG22 HG22 ' A' ' 24' ' ' ILE . 54.1 p -111.48 142.35 43.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.867 0.365 . . . . 0.0 111.603 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.714 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 11.0 t -125.89 30.85 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.077 0.465 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.598 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 23.3 p90 -93.66 7.12 45.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.7 -57.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.118 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.419 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.5 mm? -97.79 -108.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.032 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.555 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 179.74 133.73 2.05 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.535 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 6' ' ' ASP . 80.5 m -69.09 117.81 11.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -79.31 -23.56 43.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.657 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -58.73 124.69 20.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -68.83 -29.35 67.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.0 p -92.01 38.1 0.99 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.752 0.787 . . . . 0.0 109.126 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 45.0 t -150.47 146.36 26.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.775 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.25 136.58 53.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.786 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -65.87 131.27 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.5 0.666 . . . . 0.0 111.766 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -151.25 160.31 43.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.17 132.92 21.84 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-O 120.629 0.252 . . . . 0.0 110.699 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 97.0 Cg_endo -83.27 -32.48 3.26 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.105 -1.623 . . . . 0.0 112.906 -0.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.72 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -97.01 157.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.858 -179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.786 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 65.2 m -86.88 163.86 16.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.12 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -109.11 148.68 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.14 0.495 . . . . 0.0 111.645 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 21.7 ttmm -145.67 125.51 13.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.524 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.718 0.77 . . . . 0.0 111.042 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 t -89.94 174.66 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 110.52 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.95 128.18 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB3' ' C ' ' A' ' 25' ' ' CYS . 47.2 t -90.07 136.15 33.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.65 44.54 2.02 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.242 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 13' ' ' CYS . 41.8 t0 -151.67 164.63 36.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.419 ' HB ' ' CD2' ' A' ' 9' ' ' PHE . 36.6 p -124.55 139.0 54.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.0 110.777 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 5.8 t -97.93 -8.76 27.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.999 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.461 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 7.4 p90 -68.63 -24.68 64.58 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.641 0.258 . . . . 0.0 110.637 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.05 -58.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.995 0.426 . . . . 0.0 110.617 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -152.97 -56.47 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.927 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.409 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 175.67 149.25 7.29 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -64.99 131.62 47.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.723 0.296 . . . . 0.0 110.652 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.1 -38.34 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 18' ' ' CYS . 55.8 t0 -66.88 130.44 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -72.36 -21.29 61.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.17 -14.44 38.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.862 0.839 . . . . 0.0 109.223 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . 47.2 t -89.53 141.77 28.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.408 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 31.0 t -108.53 149.95 28.14 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.409 0.624 . . . . 0.0 110.594 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.643 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 47.6 t -69.25 128.23 35.88 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.716 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 44.1 t30 -152.18 148.21 27.33 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 4.9 m-85 -111.34 134.29 21.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.4 -36.01 1.96 Allowed 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.941 -1.691 . . . . 0.0 112.706 -0.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.1 152.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.491 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.7 m -85.98 172.65 10.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.056 0.455 . . . . 0.0 111.32 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.14 149.84 31.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.29 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.7 tmmt? -146.53 125.02 12.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 124.254 1.022 . . . . 0.0 112.061 -177.603 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.79 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.5 m -151.89 168.32 25.53 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.451 ' HA ' HG12 ' A' ' 26' ' ' VAL . 3.5 pp -66.23 140.04 58.13 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.604 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 t -74.13 -39.75 63.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.835 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 121.97 -38.2 2.67 Favored Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.517 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 45.0 p-10 -90.16 -174.89 4.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.365 0.602 . . . . 0.0 111.089 179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.492 HG22 ' HA ' ' A' ' 24' ' ' ILE . 17.1 p -133.96 142.46 47.7 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.549 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 37.7 t -97.14 -8.78 29.3 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.804 0.335 . . . . 0.0 111.002 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.417 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.6 p90 -69.67 -26.99 64.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.056 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.558 HG23 ' H ' ' A' ' 11' ' ' LEU . 1.1 m -80.26 -61.54 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.634 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.558 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.0 mm? -133.77 -58.5 0.86 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.771 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 168.57 161.51 18.77 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.635 -179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 25.7 m -67.63 137.37 55.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.678 0.275 . . . . 0.0 111.039 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -74.9 -52.12 12.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.806 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.759 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 12.2 t0 -75.21 135.58 41.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.061 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.3 t -66.42 -21.3 66.21 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -89.06 -7.21 56.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 111.005 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 78.7 m -89.38 118.13 28.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.16 0.505 . . . . 0.0 110.734 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 19.6 p -83.92 144.49 29.15 Favored 'General case' 0 C--O 1.243 0.752 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.741 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 55.8 m -74.8 68.43 1.73 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.32 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -88.0 67.21 8.9 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.402 ' H ' ' HD1' ' A' ' 22' ' ' TYR . 5.2 m-85 -29.8 135.52 0.19 Allowed Pre-proline 0 N--CA 1.469 0.499 0 O-C-N 124.673 1.233 . . . . 0.0 113.437 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.37 -30.66 4.32 Favored 'Cis proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.126 -1.614 . . . . 0.0 114.933 0.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.699 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.47 152.51 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -177.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 74.8 m -89.34 149.14 23.16 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.935 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 3' ' ' LEU . 28.0 m -133.79 146.59 31.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 121.107 -0.237 . . . . 0.0 110.986 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 0.0 OUTLIER -139.33 144.83 38.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.759 -0.201 . . . . 0.0 110.764 -179.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.47 0.553 0 O-C-N 124.252 0.97 . . . . 0.0 111.236 178.555 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.459 0 N-CA-C 113.553 0.181 . . . . 0.0 113.553 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 m -89.06 154.99 19.74 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.986 0.393 . . . . 0.0 111.181 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 99.0 mt -70.22 148.08 49.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.464 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.3 t -144.92 131.4 19.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.434 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 66.53 -122.04 19.23 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.274 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.0 -148.32 0.26 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.061 0.458 . . . . 0.0 110.36 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.454 HG22 HG22 ' A' ' 24' ' ' ILE . 38.7 p -75.36 152.81 38.05 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.129 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 m -84.69 39.6 0.75 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.703 0.763 . . . . 0.0 109.269 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.612 ' HE1' ' HB2' ' A' ' 23' ' ' PRO . 32.1 m-85 -107.25 -45.23 4.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.718 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.59 -50.65 11.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.877 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.1 tm? -150.15 -47.38 0.13 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.17 -71.31 2.55 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.894 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 p -167.54 126.53 1.32 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.366 0.603 . . . . 0.0 112.0 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -80.76 -30.9 36.03 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.873 178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -65.52 125.54 25.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.9 m -72.26 -9.11 58.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.343 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.7 m -87.39 -17.71 31.67 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.23 0.538 . . . . 0.0 109.896 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.1 m -89.97 134.75 34.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.923 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -106.44 142.6 35.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 13.9 t -81.73 96.23 7.5 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.23 0.538 . . . . 0.0 111.319 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -89.24 82.76 6.5 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 3.4 p90 -27.24 123.12 0.24 Allowed Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -176.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.612 ' HB2' ' HE1' ' A' ' 9' ' ' PHE . 16.4 Cg_endo -104.61 36.31 5.03 Favored 'Cis proline' 0 N--CA 1.455 -0.759 0 C-N-CA 124.193 -1.17 . . . . 0.0 114.133 0.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.454 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -139.72 153.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 CA-C-N 118.397 0.544 . . . . 0.0 111.178 -179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.9 m -87.64 140.47 29.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.292 0.568 . . . . 0.0 111.682 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 m -136.3 155.79 35.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.569 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -150.23 122.66 8.47 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 . . . . . 0 N--CA 1.465 0.319 0 CA-C-O 121.728 0.775 . . . . 0.0 110.369 -179.45 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.285 0 N-CA-C 112.944 -0.063 . . . . 0.0 112.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m -136.29 155.53 49.96 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.689 0.281 . . . . 0.0 110.273 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.507 HD23 HG12 ' A' ' 26' ' ' VAL . 97.9 mt -75.91 126.6 31.32 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.9 m -72.07 -22.54 61.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.949 0.404 . . . . 0.0 110.917 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.77 19.58 72.88 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -123.99 150.79 44.43 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.779 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 44.3 p -109.64 137.08 47.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.222 0.534 . . . . 0.0 112.203 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.619 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 53.0 t -101.51 -17.03 16.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.853 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -62.26 -27.56 69.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.658 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.25 -58.56 5.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.01 0.433 . . . . 0.0 110.953 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.8 tm? -153.15 -54.07 0.11 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.95 142.13 4.27 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.923 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 88.3 m -71.88 147.64 46.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 111.356 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.98 -53.09 60.42 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.699 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' OD2' ' HD2' ' A' ' 27' ' ' LYS . 32.6 t70 -70.94 123.87 23.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.888 0.375 . . . . 0.0 110.438 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.1 m -71.44 -16.44 62.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.511 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.1 m -89.74 -4.84 57.49 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.724 0.297 . . . . 0.0 111.416 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 59.1 m -87.52 124.59 33.63 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.3 m -78.14 139.67 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.884 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 59.7 m -74.05 72.19 1.65 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.135 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -88.19 73.29 8.97 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -35.46 137.25 0.43 Allowed Pre-proline 0 N--CA 1.466 0.332 0 O-C-N 124.54 1.15 . . . . 0.0 112.732 -177.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -78.6 -28.12 7.81 Favored 'Cis proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.282 -1.549 . . . . 0.0 114.797 1.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.795 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.36 -162.97 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -178.351 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.857 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 30.4 m -128.52 145.95 50.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.741 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.507 HG12 HD23 ' A' ' 3' ' ' LEU . 30.0 m -119.87 143.45 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.024 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 79.2 tttt -150.7 136.37 18.11 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.736 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.681 0.613 . . . . 0.0 111.124 179.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.726 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.2 p -150.01 -163.6 1.82 Allowed 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.515 HD22 HG13 ' A' ' 24' ' ' ILE . 72.8 mt -77.15 160.3 29.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.612 0.244 . . . . 0.0 110.455 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.608 ' HB2' ' HB2' ' A' ' 27' ' ' LYS . 3.4 t -145.83 132.15 19.57 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.688 0.28 . . . . 0.0 111.473 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 58.13 -123.37 32.84 Favored Glycine 0 N--CA 1.448 -0.558 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.823 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -131.55 -137.59 0.2 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 20.1 p -87.78 143.24 27.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.281 0.562 . . . . 0.0 111.351 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 42.9 t -87.9 -17.66 30.89 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.202 -179.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.412 ' HE2' ' HB3' ' A' ' 23' ' ' PRO . 2.7 p90 -69.73 -18.16 63.5 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.805 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 88.2 t -76.43 -47.27 30.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 121.06 0.457 . . . . 0.0 110.562 179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.6 tm? -151.68 -62.76 0.18 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.858 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.02 130.87 2.56 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.605 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.2 m -83.72 68.95 10.08 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -74.19 50.59 0.39 Allowed 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.944 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.94 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 18.1 t70 -80.75 157.07 25.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.3 m -69.88 -18.81 63.43 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.707 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 32.3 p -134.87 37.76 3.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.873 0.368 . . . . 0.0 111.187 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . 40.4 t -140.12 151.35 45.25 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -119.67 140.72 50.2 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-O 121.007 0.432 . . . . 0.0 110.015 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -77.37 134.62 38.41 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.441 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.432 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 49.0 t30 -147.89 158.08 43.86 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -115.56 135.07 22.58 Favored Pre-proline 0 C--N 1.307 -1.261 0 CA-C-O 120.996 0.427 . . . . 0.0 110.799 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.416 ' HD2' HD13 ' A' ' 24' ' ' ILE . 6.1 Cg_exo -76.61 -43.32 0.66 Allowed 'Cis proline' 0 CA--C 1.532 0.383 0 C-N-CA 123.28 -1.55 . . . . 0.0 113.175 0.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.784 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.67 156.74 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -178.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 57.8 m -85.8 174.04 9.61 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.7 m -134.23 151.78 32.85 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.993 0.425 . . . . 0.0 111.458 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.707 ' HG3' ' O ' ' A' ' 17' ' ' SER . 48.9 tttm -148.72 133.23 17.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.706 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 . . . . . 0 N--CA 1.472 0.666 0 O-C-N 124.463 1.102 . . . . 0.0 111.621 178.663 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 N-CA-C 112.765 -0.134 . . . . 0.0 112.765 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 t -150.87 -162.12 1.48 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.676 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.4 pt? -80.52 133.03 35.76 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.979 0.419 . . . . 0.0 110.9 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.1 t -75.53 -40.08 57.48 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.98 -0.555 . . . . 0.0 109.877 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 128.85 -56.35 0.74 Allowed Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.94 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -89.67 170.47 10.43 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.167 0.508 . . . . 0.0 110.528 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.472 HG22 HG22 ' A' ' 24' ' ' ILE . 33.5 p -110.04 145.78 36.47 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.852 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.571 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 35.4 t -88.9 32.79 0.79 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -91.79 -37.65 12.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.707 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.4 t -65.65 -56.95 12.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.396 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -152.77 -52.68 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.268 0.556 . . . . 0.0 109.712 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.571 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -179.84 163.09 30.07 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 43.7 m -62.38 132.65 53.28 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.82 0.343 . . . . 0.0 110.734 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -66.13 -50.41 64.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.792 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.772 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.6 t0 -77.73 131.24 37.58 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.5 m -64.69 -17.85 64.46 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.514 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.58 -8.07 55.35 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.019 0.438 . . . . 0.0 110.795 -179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 85.7 m -89.18 122.61 32.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.798 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 m -84.86 143.78 28.83 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.232 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.2 m -80.27 66.78 5.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.109 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -88.25 70.16 9.17 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.427 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 7.0 m-85 -30.78 135.28 0.21 Allowed Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 124.647 1.217 . . . . 0.0 113.551 -178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -86.17 -27.25 6.03 Favored 'Cis proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.94 -1.692 . . . . 0.0 114.808 0.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -88.4 153.66 3.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 85.8 m -88.61 140.4 29.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.925 179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -112.15 139.76 35.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.645 0.259 . . . . 0.0 110.735 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HE3' ' HB2' ' A' ' 17' ' ' SER . 79.2 tttt -151.55 146.38 25.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.418 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 . . . . . 0 N--CA 1.467 0.387 0 O-C-N 123.829 0.706 . . . . 0.0 111.458 179.212 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 N-CA-C 112.911 -0.076 . . . . 0.0 112.911 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.1 m -110.14 158.99 17.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.896 0.379 . . . . 0.0 110.998 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.45 126.66 30.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.299 -0.41 . . . . 0.0 109.983 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.796 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 47.7 t -83.11 140.87 32.39 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.07 47.36 1.93 Allowed Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.318 -0.468 . . . . 0.0 113.525 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.439 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 39.9 t0 -151.53 165.2 34.97 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.733 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 41.2 p -129.29 139.38 51.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.281 0.562 . . . . 0.0 111.949 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 77.8 m -98.1 -2.9 39.01 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.36 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.442 ' CD2' ' HB ' ' A' ' 7' ' ' THR . 5.8 p90 -66.58 -26.31 67.05 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.115 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.3 t -70.05 -61.17 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 121.109 0.48 . . . . 0.0 110.493 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -153.38 -53.94 0.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.486 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.15 153.41 16.73 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.569 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 0.6 OUTLIER -64.99 137.53 57.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.698 0.249 . . . . 0.0 110.763 -179.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -70.36 -41.64 72.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 -179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -80.78 122.3 26.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.887 0.375 . . . . 0.0 110.049 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.7 t -69.67 -11.18 60.64 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.201 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.1 m -88.02 -24.6 23.45 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.981 0.42 . . . . 0.0 110.52 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.553 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 68.9 m -87.5 128.64 35.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.114 0.483 . . . . 0.0 110.282 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -85.25 148.8 25.89 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.225 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.8 m -76.97 127.31 32.48 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.176 0.513 . . . . 0.0 111.596 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -146.07 73.74 1.35 Allowed 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.517 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 5.0 m-85 -36.18 134.49 0.57 Allowed Pre-proline 0 N--CA 1.462 0.146 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.756 -177.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.43 -27.97 7.6 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.169 -1.596 . . . . 0.0 115.216 1.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.761 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.24 -164.77 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -177.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.796 ' HB2' ' HB3' ' A' ' 4' ' ' CYS . 61.4 m -116.88 159.76 21.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.522 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.6 m -135.45 135.51 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.79 0.329 . . . . 0.0 110.753 179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.553 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 39.8 ttpt -152.46 141.7 21.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 . . . . . 0 N--CA 1.464 0.266 0 O-C-N 123.635 0.584 . . . . 0.0 110.707 179.401 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.913 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -149.46 156.05 41.39 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.499 HD22 HG13 ' A' ' 24' ' ' ILE . 53.5 mt -71.67 133.75 45.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.486 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 26.4 m -71.13 -32.22 68.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.116 0.484 . . . . 0.0 109.922 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.25 -39.17 2.9 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.553 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -88.36 143.93 26.71 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.206 0.527 . . . . 0.0 111.087 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 36.2 p -92.3 139.9 30.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.718 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.9 p -89.47 -18.6 26.41 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -66.95 -22.78 65.92 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.105 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.473 ' O ' HD22 ' A' ' 11' ' ' LEU . 61.5 t -81.12 -53.26 12.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.755 0.312 . . . . 0.0 111.089 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.473 HD22 ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -138.48 -54.9 0.63 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.86 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 8' ' ' CYS . . . 171.62 -148.51 11.06 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.498 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 78.7 m -117.43 134.28 55.02 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.688 0.244 . . . . 0.0 110.405 179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.08 -47.15 72.13 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.545 -179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.891 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 2.8 m-20 -80.0 140.56 36.53 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 178.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 m -67.09 -24.1 65.91 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.249 0.547 . . . . 0.0 110.396 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.0 m -93.92 6.13 49.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.082 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.891 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 51.6 m -89.65 123.26 33.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.975 0.417 . . . . 0.0 110.664 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.7 m -87.59 146.72 25.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 46.8 t -79.39 71.4 5.95 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.238 0.542 . . . . 0.0 111.183 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -88.78 74.5 8.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 74.7 m-85 -27.27 130.87 0.18 Allowed Pre-proline 0 N--CA 1.466 0.34 0 O-C-N 124.646 1.216 . . . . 0.0 113.839 -177.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 29.3 Cg_endo -90.45 -23.04 7.85 Favored 'Cis proline' 0 CA--C 1.539 0.744 0 C-N-CA 123.366 -1.514 . . . . 0.0 114.491 0.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.707 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -91.27 160.1 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.31 0.576 . . . . 0.0 112.518 -178.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 8' ' ' CYS . 73.3 m -88.66 140.47 29.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.344 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 m -113.39 140.3 34.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.882 0.372 . . . . 0.0 110.445 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.637 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 35.4 ttpt -131.5 120.95 23.68 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.882 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.7 t70 . . . . . 0 N--CA 1.47 0.566 0 O-C-N 124.38 1.05 . . . . 0.0 110.903 -179.532 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.873 0 N-CA-C 112.646 -0.182 . . . . 0.0 112.646 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 t -155.2 -141.73 0.1 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.192 0.52 . . . . 0.0 110.603 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.9 mt -80.2 143.88 33.41 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 44.7 t -72.03 -39.69 68.96 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.952 0.406 . . . . 0.0 110.761 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.92 -29.86 10.2 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.807 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -87.36 150.21 23.98 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.52 HG22 HG22 ' A' ' 24' ' ' ILE . 69.0 p -95.1 137.21 34.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.264 0.554 . . . . 0.0 112.468 -178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.543 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 53.2 t -109.41 -12.3 14.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.177 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.523 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 9.6 p90 -63.18 -27.25 69.23 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.465 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.1 t -68.73 -56.22 12.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.111 0.482 . . . . 0.0 110.653 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.8 tm? -153.17 -53.35 0.11 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.359 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.45 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 177.84 145.51 5.94 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.751 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.543 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 63.0 m -68.57 140.56 55.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.107 0.48 . . . . 0.0 111.494 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -68.93 -44.47 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.889 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -65.32 116.56 6.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.399 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.8 m -75.29 -12.32 60.25 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.7 m -89.15 -15.61 33.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.181 0.515 . . . . 0.0 110.142 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.17 137.41 32.34 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.604 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -85.17 128.56 34.71 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 25' ' ' CYS . 0.5 OUTLIER -62.2 130.38 45.13 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.51 0.672 . . . . 0.0 112.023 -178.646 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 25' ' ' CYS . 46.6 t30 -150.83 152.68 34.1 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.503 -1.226 . . . . 0.0 107.914 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.421 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 2.4 m-85 -104.72 134.18 19.79 Favored Pre-proline 0 C--N 1.31 -1.11 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 78.0 Cg_endo -81.23 -33.61 3.1 Favored 'Cis proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.329 -1.53 . . . . 0.0 113.209 0.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.73 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -105.02 152.46 6.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.946 -179.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 20' ' ' CYS . 1.6 p -86.71 173.06 9.73 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.408 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -113.82 152.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.809 0.337 . . . . 0.0 111.243 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -131.3 142.74 50.16 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 N--CA 1.465 0.323 0 O-C-N 124.29 0.994 . . . . 0.0 111.853 -178.557 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.866 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 m -149.36 154.08 38.4 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 121.024 0.44 . . . . 0.0 111.161 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.619 HD23 HG12 ' A' ' 26' ' ' VAL . 72.6 mt -69.28 138.02 53.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.373 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.64 ' SG ' ' HG2' ' A' ' 27' ' ' LYS . 73.4 m -82.82 -39.07 22.2 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.774 0.321 . . . . 0.0 111.094 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 126.92 -31.81 3.8 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.418 ' OD1' ' HB2' ' A' ' 25' ' ' CYS . 0.0 OUTLIER -87.95 153.06 21.6 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.101 -0.55 . . . . 0.0 110.12 179.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.726 HG22 HG22 ' A' ' 24' ' ' ILE . 17.6 p -122.8 156.04 35.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.688 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.1 m -87.81 -13.99 40.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.415 ' CE1' HG13 ' A' ' 10' ' ' VAL . 4.8 p90 -74.53 -25.19 59.17 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.502 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.6 OUTLIER -83.13 -58.03 3.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.048 0.451 . . . . 0.0 111.209 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.502 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.0 tm? -151.6 -54.66 0.14 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.497 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.51 -160.49 34.09 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.746 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 m -87.13 131.66 34.09 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.555 0.217 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -80.31 -44.46 19.52 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.433 0.635 . . . . 0.0 109.37 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -77.38 129.31 35.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.724 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.6 t -71.17 -23.35 62.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.128 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.434 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 2.9 m -89.69 37.31 0.87 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.297 0.57 . . . . 0.0 109.814 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 34.9 t -139.88 154.18 47.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.673 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 m -119.34 145.36 46.24 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 19.7 t -83.39 120.24 25.64 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.242 0.544 . . . . 0.0 111.349 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -122.53 82.54 1.99 Allowed 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 27.2 m-85 -31.59 123.73 0.36 Allowed Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 115.049 -0.978 . . . . 0.0 113.305 -176.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 63.6 Cg_endo -102.33 25.4 14.1 Favored 'Cis proline' 0 CA--C 1.542 0.894 0 C-N-CA 124.062 -1.224 . . . . 0.0 114.713 0.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.726 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -131.14 151.66 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 CA-C-N 118.411 0.551 . . . . 0.0 112.294 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.692 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 74.2 m -89.79 132.92 34.99 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 120.838 0.351 . . . . 0.0 110.376 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.619 HG12 HD23 ' A' ' 3' ' ' LEU . 27.2 m -137.49 153.84 29.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.95 0.405 . . . . 0.0 111.44 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.64 ' HG2' ' SG ' ' A' ' 4' ' ' CYS . 5.9 pttm -139.76 137.07 34.77 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.644 178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.9 t70 . . . . . 0 N--CA 1.468 0.439 0 O-C-N 124.322 1.014 . . . . 0.0 110.566 -179.132 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.411 0 N-CA-C 113.541 0.177 . . . . 0.0 113.541 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.9 m -100.66 -172.92 2.28 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 117.005 0.402 . . . . 0.0 111.02 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 98.7 mt -71.15 129.12 38.11 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 27' ' ' LYS . 54.0 t -76.97 -34.46 57.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.213 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.94 -27.21 18.33 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -87.02 156.48 19.74 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.7 -0.75 . . . . 0.0 109.332 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.2 p -127.47 144.67 51.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.824 0.345 . . . . 0.0 111.112 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 56.5 m -87.32 -23.81 24.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.8 -178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.4 p90 -70.56 -22.88 62.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.506 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 93.9 t -82.25 -57.83 4.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.031 0.443 . . . . 0.0 110.289 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.7 tm? -152.78 -55.13 0.12 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.573 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 166.9 -165.12 38.31 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.471 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.415 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 9.5 m -91.46 126.72 36.64 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.752 0.31 . . . . 0.0 110.541 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 27.0 t30 -81.68 -43.47 18.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.037 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.902 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 9.2 t0 -62.22 137.03 58.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.06 -179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.8 m -70.21 -33.57 71.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.381 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 m -96.28 40.01 1.14 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.681 0.753 . . . . 0.0 109.166 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.902 ' HB2' ' HB3' ' A' ' 15' ' ' ASP . 37.9 t -124.07 147.19 48.06 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.504 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.5 m -123.33 146.65 47.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.3 t -90.11 131.47 35.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.12 0.486 . . . . 0.0 111.526 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -139.11 78.06 1.65 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.4 m-85 -27.31 125.87 0.22 Allowed Pre-proline 0 N--CA 1.467 0.396 0 CA-C-N 114.85 -1.068 . . . . 0.0 113.651 -177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 64.1 Cg_endo -99.28 14.69 26.83 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.828 -1.322 . . . . 0.0 114.403 0.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.612 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -124.62 155.51 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-O 121.2 0.524 . . . . 0.0 112.313 -179.1 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.768 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 72.1 m -90.03 144.19 26.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.141 0.496 . . . . 0.0 110.95 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.437 ' C ' ' HB2' ' A' ' 4' ' ' CYS . 25.9 m -113.35 151.21 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.133 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 4' ' ' CYS . 31.6 ttpt -150.5 123.12 8.55 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.872 0.844 . . . . 0.0 110.236 -179.035 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.466 0 N-CA-C 113.881 0.313 . . . . 0.0 113.881 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.3 m -140.15 154.95 47.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.268 0.534 . . . . 0.0 110.844 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.588 HD21 HD12 ' A' ' 24' ' ' ILE . 89.0 mt -67.16 128.49 36.57 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.4 p -98.84 24.96 7.04 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.06 30.5 75.76 Favored Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.647 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.763 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 4.7 t0 -126.31 156.48 40.34 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.94 -1.134 . . . . 0.0 107.94 179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.422 ' HB ' ' CD1' ' A' ' 9' ' ' PHE . 6.7 p -145.11 141.38 28.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.196 0.522 . . . . 0.0 112.126 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.1 m -89.23 42.89 1.11 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.136 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 23' ' ' PRO . 3.3 m-85 -74.44 -50.12 19.67 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.013 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.564 HG23 ' H ' ' A' ' 11' ' ' LEU . 1.2 m -71.13 -59.1 3.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.766 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.564 ' H ' HG23 ' A' ' 10' ' ' VAL . 2.3 tm? -151.77 -50.95 0.12 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.14 -176.22 36.55 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.404 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 28.6 m -67.94 141.84 56.2 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 123.877 0.398 . . . . 0.0 111.751 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -67.94 -47.74 67.83 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.7 128.47 33.67 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.015 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.9 m -71.44 -9.49 58.26 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.413 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -88.21 -15.3 36.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.013 0.435 . . . . 0.0 110.639 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 88.1 m -90.01 137.4 32.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 31.2 t -89.51 147.92 23.71 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 121.485 0.659 . . . . 0.0 109.778 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.79 77.46 9.88 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.476 -179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -88.33 65.27 7.94 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 177.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 7.2 m-85 -26.91 124.78 0.22 Allowed Pre-proline 0 N--CA 1.466 0.338 0 CA-C-N 114.269 -1.332 . . . . 0.0 114.074 -176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 42.6 Cg_endo -99.42 13.58 26.48 Favored 'Cis proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.608 -1.414 . . . . 0.0 113.583 0.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.588 HD12 HD21 ' A' ' 3' ' ' LEU . 10.1 pt -109.23 143.94 18.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.763 ' HB2' ' HB3' ' A' ' 6' ' ' ASP . 72.1 m -91.99 128.97 38.03 Favored 'General case' 0 C--O 1.244 0.786 0 CA-C-O 121.61 0.719 . . . . 0.0 111.745 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.532 HG12 HD23 ' A' ' 3' ' ' LEU . 28.2 m -115.54 143.13 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.808 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -150.11 132.01 15.15 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.468 0.435 0 CA-C-O 121.985 0.898 . . . . 0.0 109.865 -178.527 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 N-CA-C 112.962 -0.055 . . . . 0.0 112.962 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m -90.96 152.0 20.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.98 0.419 . . . . 0.0 111.176 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.443 HD22 HD11 ' A' ' 24' ' ' ILE . 21.4 mt -76.83 130.58 37.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 78.4 m -79.86 -63.0 1.51 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.851 -0.339 . . . . 0.0 111.262 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.44 -47.68 0.25 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 119.303 -1.427 . . . . 0.0 114.3 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -88.62 153.21 21.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.662 0.744 . . . . 0.0 112.513 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.691 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 69.1 p -84.78 155.57 21.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.149 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' SG ' ' HA2' ' A' ' 12' ' ' GLY . 10.0 t -131.2 29.8 4.6 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.156 0.503 . . . . 0.0 110.506 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -92.07 -22.88 19.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 120.704 0.288 . . . . 0.0 110.98 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -71.74 -61.67 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.068 0.461 . . . . 0.0 111.067 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.4 tm? -152.75 -50.86 0.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.468 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . -167.24 141.3 6.8 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.6 p -78.56 144.55 35.48 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.334 0.588 . . . . 0.0 111.795 -179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 59.0 m-80 -65.29 -23.9 67.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.553 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 68.6 m-20 -68.04 82.95 0.22 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.172 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.6 p -60.36 -31.61 70.49 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.21 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 18.7 m -89.92 29.28 1.21 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.662 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' SG ' ' HB3' ' A' ' 15' ' ' ASP . 76.3 m -142.81 156.99 45.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.17 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 47.4 t -89.98 154.66 19.66 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.522 0.677 . . . . 0.0 110.583 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.7 t -82.71 73.31 9.75 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 114.529 -1.214 . . . . 0.0 111.07 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -88.78 87.95 7.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 178.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -41.7 135.37 2.11 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.32 -0.855 . . . . 0.0 112.029 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -97.72 29.37 14.88 Favored 'Cis proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.402 -1.499 . . . . 0.0 114.288 1.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.691 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 20.0 pt -140.36 -169.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 O-C-N 121.941 -0.474 . . . . 0.0 112.02 -179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -112.05 134.16 53.78 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.1 m -135.11 155.69 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.087 0.47 . . . . 0.0 112.055 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -147.36 134.01 19.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.14 179.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 . . . . . 0 N--CA 1.467 0.376 0 O-C-N 123.558 0.536 . . . . 0.0 110.395 -179.56 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -130.15 152.04 50.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.704 0.288 . . . . 0.0 110.351 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.674 HD22 HG13 ' A' ' 24' ' ' ILE . 50.4 mt -73.06 139.27 46.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.035 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.603 ' O ' ' HB2' ' A' ' 25' ' ' CYS . 20.7 p -161.83 154.33 19.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.7 0.286 . . . . 0.0 111.089 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 78.16 -125.4 7.16 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.161 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -139.21 -128.97 0.12 Allowed 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.476 HG22 HG22 ' A' ' 24' ' ' ILE . 20.5 p -126.21 142.07 51.67 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.227 0.537 . . . . 0.0 111.222 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 87.7 m -93.29 3.28 55.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.965 -179.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -75.02 -24.13 58.3 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.878 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 47.8 t -77.13 -54.34 13.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -152.71 -61.99 0.15 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.331 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.41 150.47 5.52 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.652 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.0 m -70.59 128.63 36.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.942 0.371 . . . . 0.0 110.677 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -64.01 -33.24 75.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.447 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.74 126.94 31.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.664 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.0 t -81.72 1.38 34.64 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.092 -179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -87.94 -39.71 14.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.031 0.444 . . . . 0.0 110.264 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.433 ' HA ' ' HB2' ' A' ' 27' ' ' LYS . 82.9 m -88.11 124.24 33.59 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.176 0.512 . . . . 0.0 109.723 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.0 m -79.57 147.38 32.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.7 -178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.2 m -79.15 63.75 3.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.727 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -88.05 78.57 8.17 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.439 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 5.9 m-85 -33.4 138.84 0.26 Allowed Pre-proline 0 N--CA 1.466 0.374 0 O-C-N 124.504 1.127 . . . . 0.0 113.266 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.61 -33.93 2.73 Favored 'Cis proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.003 -1.665 . . . . 0.0 115.012 0.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.69 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.54 166.72 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -177.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 41.3 m -89.68 141.81 28.26 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.443 HG12 HD23 ' A' ' 3' ' ' LEU . 32.6 m -135.4 147.72 28.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 121.323 0.583 . . . . 0.0 112.263 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.604 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 21.7 ttpp -150.08 134.73 17.53 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.604 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 110.234 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.439 0 CA-C-O 120.457 -0.079 . . . . 0.0 113.234 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.6 p -98.16 170.96 8.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.876 0.338 . . . . 0.0 111.105 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.8 mt -72.82 128.81 36.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.2 t -66.66 -47.9 71.08 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.45 -43.88 1.25 Allowed Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.712 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.509 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 30.8 m-20 -87.51 148.66 24.82 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.115 0.483 . . . . 0.0 110.484 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.744 HG22 HG22 ' A' ' 24' ' ' ILE . 14.5 p -91.7 140.58 29.57 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.417 178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 7.7 t -105.29 32.89 3.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.014 0.435 . . . . 0.0 111.617 -178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -95.04 -16.5 22.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.7 t -85.26 -64.5 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.5 tm? -152.55 -48.61 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.009 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.07 -150.81 7.44 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.641 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 6' ' ' ASP . 84.9 m -141.59 168.02 20.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.74 0.27 . . . . 0.0 110.541 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -68.15 -55.11 13.56 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.729 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 11.9 t0 -72.67 130.19 39.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 110.252 -179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.1 m -76.2 -13.93 60.16 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.185 -179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.536 ' HB2' ' HE2' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -88.36 -4.29 58.69 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.199 0.523 . . . . 0.0 110.331 -179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 72.9 m -88.43 120.61 29.97 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.547 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 25' ' ' CYS . 1.4 m -76.15 142.3 41.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.389 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 49.5 t -80.61 74.8 7.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -88.8 78.22 7.66 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 63.7 m-85 -33.5 128.55 0.41 Allowed Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.999 -177.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 65.2 Cg_endo -100.75 25.63 16.42 Favored 'Cis proline' 0 CA--C 1.54 0.779 0 C-N-CA 124.175 -1.177 . . . . 0.0 114.343 0.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.744 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -136.52 152.57 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 O-C-N 121.814 -0.554 . . . . 0.0 111.636 -179.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 66.1 m -88.32 140.86 29.04 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.999 179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 m -117.56 147.01 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.686 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.616 ' HG2' ' OD1' ' A' ' 28' ' ' ASP . 50.9 tttm -148.3 129.69 14.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.616 ' OD1' ' HG2' ' A' ' 27' ' ' LYS . 1.1 m-20 . . . . . 0 C--N 1.329 -0.295 0 O-C-N 123.752 0.658 . . . . 0.0 110.573 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.526 0 CA-C-O 120.155 -0.247 . . . . 0.0 113.666 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 m -94.02 149.56 21.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 117.377 0.588 . . . . 0.0 111.067 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.598 HD23 HG12 ' A' ' 26' ' ' VAL . 74.1 mt -59.39 128.91 39.43 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.704 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 28.2 p -84.48 -36.48 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.022 -0.671 . . . . 0.0 110.881 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 146.62 -30.28 1.55 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.748 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.67 165.2 16.31 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.232 0.539 . . . . 0.0 111.06 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.466 HG22 HG22 ' A' ' 24' ' ' ILE . 7.0 p -138.81 143.32 38.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.936 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 70.2 m -86.52 -14.4 43.12 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.607 ' HB3' ' HB2' ' A' ' 23' ' ' PRO . 16.0 p90 -77.03 -17.71 58.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.739 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 97.0 t -89.0 -58.96 3.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.948 0.404 . . . . 0.0 110.418 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.9 tm? -152.62 -54.48 0.12 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.935 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 171.94 -150.1 12.73 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.436 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.4 m -116.76 123.75 47.92 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.939 0.369 . . . . 0.0 111.006 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -76.37 -39.15 54.57 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.598 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 10.5 t0 -62.39 117.89 6.75 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.199 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.1 m -63.7 -28.14 69.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.1 p -95.63 1.55 53.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.719 0.295 . . . . 0.0 111.705 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.711 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 8.7 t -89.64 140.75 29.25 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.954 0.407 . . . . 0.0 110.748 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -95.03 140.71 29.6 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 53.6 t -84.07 78.01 9.83 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.62 179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 47.1 t30 -87.93 70.45 9.47 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 6.6 p90 -32.59 131.56 0.32 Allowed Pre-proline 0 N--CA 1.454 -0.238 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.73 -177.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.607 ' HB2' ' HB3' ' A' ' 9' ' ' PHE . 63.9 Cg_endo -96.24 23.58 25.04 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.355 -1.519 . . . . 0.0 114.404 1.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.466 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -130.06 144.97 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 O-C-N 121.89 -0.506 . . . . 0.0 112.161 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 61.6 m -89.36 132.76 34.81 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.992 0.425 . . . . 0.0 110.227 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.598 HG12 HD23 ' A' ' 3' ' ' LEU . 27.2 m -131.4 151.51 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 18' ' ' CYS . 13.6 mtmm -128.94 126.23 39.2 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.332 0.586 . . . . 0.0 110.53 -179.436 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.238 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.3 t -150.69 -161.08 1.26 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.2 pp -73.3 134.15 44.1 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.991 0.424 . . . . 0.0 110.6 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.9 t -85.79 -49.94 7.53 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.27 -179.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.04 -47.3 0.81 Allowed Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.361 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.95 172.46 9.56 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.34 0.59 . . . . 0.0 111.322 -178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.811 HG22 HG22 ' A' ' 24' ' ' ILE . 2.7 p -120.61 154.28 35.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.245 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.6 m -88.42 37.41 0.82 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.808 0.337 . . . . 0.0 110.557 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' A' ' 23' ' ' PRO . 37.2 m-85 -144.5 38.03 1.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.71 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.545 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -146.43 -60.16 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.662 179.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.545 ' H ' HG23 ' A' ' 10' ' ' VAL . 1.2 tm? -151.54 -55.17 0.14 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 172.51 -140.64 5.83 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.512 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 30.2 m -116.01 139.45 50.25 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -67.92 -55.52 12.5 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.715 ' HB3' ' HB2' ' A' ' 18' ' ' CYS . 14.4 t0 -66.72 138.03 57.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.081 0.467 . . . . 0.0 111.34 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.6 m -66.69 -32.95 74.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.604 -179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.4 m -93.67 17.1 12.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.126 0.489 . . . . 0.0 110.894 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 46.5 t -89.77 150.28 22.35 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.25 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -120.9 150.61 40.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.645 0.26 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 10.2 t -93.08 130.63 38.64 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.012 0.434 . . . . 0.0 110.947 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -140.41 85.4 2.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 23' ' ' PRO . 17.7 m-85 -32.31 128.88 0.33 Allowed Pre-proline 0 N--CA 1.465 0.275 0 O-C-N 124.197 0.936 . . . . 0.0 113.196 -177.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.509 ' HA ' ' HA ' ' A' ' 22' ' ' TYR . 44.4 Cg_endo -99.11 22.01 22.74 Favored 'Cis proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.699 -1.376 . . . . 0.0 114.711 1.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.811 HG22 HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -135.76 164.73 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-O 121.352 0.596 . . . . 0.0 112.401 -179.08 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.725 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 91.7 m -88.86 144.88 25.91 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.42 143.46 32.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.948 0.404 . . . . 0.0 110.771 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 17.7 tptm -151.14 141.05 21.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.346 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' HG3' ' A' ' 27' ' ' LYS . 1.4 m-20 . . . . . 0 N--CA 1.47 0.547 0 O-C-N 123.814 0.696 . . . . 0.0 111.491 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.835 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.6 m -135.84 147.38 48.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.883 0.373 . . . . 0.0 110.309 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.506 HD23 HG12 ' A' ' 26' ' ' VAL . 92.9 mt -77.44 132.58 38.54 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.001 -179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.541 ' SG ' ' HB2' ' A' ' 27' ' ' LYS . 59.9 m -98.57 148.95 23.26 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.905 179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.33 1.72 55.41 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -87.97 137.93 31.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.01 -0.595 . . . . 0.0 109.96 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.777 ' HA ' ' HA ' ' A' ' 24' ' ' ILE . 21.3 p -110.86 137.01 49.03 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.869 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 43.6 t -102.5 -12.14 18.03 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.909 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.421 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 8.1 p90 -67.27 -25.89 66.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.996 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.3 t -73.67 -61.33 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.016 0.436 . . . . 0.0 110.805 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -152.95 -54.76 0.12 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.702 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.91 144.35 5.23 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.499 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 81.1 m -76.61 140.85 41.17 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.727 0.299 . . . . 0.0 111.033 -179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -67.62 -48.57 66.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.491 -178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -65.17 121.6 15.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.977 0.418 . . . . 0.0 110.639 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -74.38 -9.21 58.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.002 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.549 ' HB2' ' HD3' ' A' ' 27' ' ' LYS . 1.5 m -87.08 -25.06 24.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.159 0.504 . . . . 0.0 109.951 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 95.4 m -89.45 116.86 27.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.4 t -85.09 155.68 21.4 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-O 121.314 0.578 . . . . 0.0 110.238 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.3 m -70.63 123.95 23.08 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.868 -179.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -147.63 70.99 1.18 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.531 ' HD1' ' H ' ' A' ' 22' ' ' TYR . 3.6 m-85 -33.86 135.63 0.34 Allowed Pre-proline 0 N--CA 1.465 0.302 0 CA-C-N 114.321 -1.308 . . . . 0.0 112.908 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -77.6 -31.67 5.01 Favored 'Cis proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.312 -1.537 . . . . 0.0 115.126 0.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.786 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.53 -161.28 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.484 0.659 . . . . 0.0 112.77 -178.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 12.0 m -125.49 153.66 43.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.066 179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.506 HG12 HD23 ' A' ' 3' ' ' LEU . 18.2 m -122.52 133.87 67.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.163 0.506 . . . . 0.0 111.226 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.58 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 20.8 ttpt -112.76 109.02 18.25 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.997 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 124.524 1.14 . . . . 0.0 110.474 -179.161 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.3 0 N-CA-C 112.802 -0.119 . . . . 0.0 112.802 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.8 t -150.91 -157.56 0.83 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.419 HD22 HG13 ' A' ' 24' ' ' ILE . 86.4 mt -80.36 129.43 34.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.681 0.277 . . . . 0.0 110.507 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 7.2 t -75.05 -54.31 7.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.986 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.37 -39.57 1.66 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.718 -0.753 . . . . 0.0 111.515 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.73 ' HB2' ' HB3' ' A' ' 13' ' ' CYS . 58.7 m-20 -86.62 148.37 25.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.054 0.454 . . . . 0.0 110.478 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.673 HG22 HG22 ' A' ' 24' ' ' ILE . 17.7 p -97.32 138.76 34.29 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.553 179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 21' ' ' ASN . 48.6 t -92.32 -19.77 21.79 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -68.25 -25.58 65.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.894 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 94.9 t -79.96 -56.53 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.941 0.401 . . . . 0.0 110.485 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 11' ' ' LEU . 1.5 tm? -152.46 -62.8 0.16 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.128 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 160.96 148.48 5.29 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.092 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.73 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 0.5 OUTLIER -72.33 138.17 47.13 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 122.276 0.23 . . . . 0.0 110.984 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -78.78 -30.8 45.74 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.584 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 13.2 t0 -66.93 126.8 30.24 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 t -68.64 -15.42 63.52 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.088 -179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.524 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -88.44 -14.11 38.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.145 0.498 . . . . 0.0 110.121 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.594 ' SG ' ' HD2' ' A' ' 27' ' ' LYS . 72.2 m -88.98 124.18 34.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.783 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.93 133.28 33.61 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 124.75 24.96 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.293 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' CYS . 7.4 t-20 -151.47 153.53 34.81 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -97.94 133.46 23.24 Favored Pre-proline 0 C--N 1.306 -1.308 0 CA-C-O 120.909 0.385 . . . . 0.0 110.349 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.05 -25.67 6.54 Favored 'Cis proline' 0 CA--C 1.536 0.61 0 C-N-CA 123.198 -1.584 . . . . 0.0 113.887 0.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.716 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -107.76 159.34 7.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.178 0.514 . . . . 0.0 112.365 -178.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.5 m -85.94 152.33 23.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.474 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 m -109.06 140.5 27.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.81 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.594 ' HD2' ' SG ' ' A' ' 18' ' ' CYS . 82.9 tttt -151.51 144.88 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 N--CA 1.467 0.383 0 O-C-N 123.848 0.718 . . . . 0.0 111.342 179.18 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.341 0 N-CA-C 112.947 -0.061 . . . . 0.0 112.947 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -146.5 -162.04 1.45 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.7 mt -73.5 130.18 39.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.97 0.414 . . . . 0.0 111.065 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 36.0 t -83.31 -45.41 13.8 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.233 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.05 -38.84 2.71 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.701 -179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 43.8 t0 -87.86 157.38 19.0 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.612 HG22 HG22 ' A' ' 24' ' ' ILE . 54.1 p -111.48 142.35 43.87 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.867 0.365 . . . . 0.0 111.603 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.714 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 11.0 t -125.89 30.85 5.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.077 0.465 . . . . 0.0 110.399 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.598 ' HB3' ' HA ' ' A' ' 23' ' ' PRO . 23.3 p90 -93.66 7.12 45.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.097 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 11' ' ' LEU . 0.1 OUTLIER -148.7 -57.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.118 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.419 ' H ' HG23 ' A' ' 10' ' ' VAL . 3.5 mm? -97.79 -108.09 0.17 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.032 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.555 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 179.74 133.73 2.05 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.984 -0.627 . . . . 0.0 111.535 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 6' ' ' ASP . 80.5 m -69.09 117.81 11.21 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.172 0.511 . . . . 0.0 110.279 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 p30 -79.31 -23.56 43.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.657 -177.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -58.73 124.69 20.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.1 0.476 . . . . 0.0 110.998 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.5 m -68.83 -29.35 67.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.15 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.0 p -92.01 38.1 0.99 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.752 0.787 . . . . 0.0 109.126 178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 25' ' ' CYS . 45.0 t -150.47 146.36 26.59 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.775 -178.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.25 136.58 53.59 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.786 ' HA ' ' SG ' ' A' ' 25' ' ' CYS . 1.2 m -65.87 131.27 45.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.5 0.666 . . . . 0.0 111.766 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 1.0 OUTLIER -151.25 160.31 43.89 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 179.478 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -112.17 132.92 21.84 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-O 120.629 0.252 . . . . 0.0 110.699 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.598 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 97.0 Cg_endo -83.27 -32.48 3.26 Favored 'Cis proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.105 -1.623 . . . . 0.0 112.906 -0.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.72 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -97.01 157.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.858 -179.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.786 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 65.2 m -86.88 163.86 16.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.12 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.8 m -109.11 148.68 12.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 121.14 0.495 . . . . 0.0 111.645 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 4' ' ' CYS . 21.7 ttmm -145.67 125.51 13.5 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.524 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.1 t70 . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.718 0.77 . . . . 0.0 111.042 179.964 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.9 t -89.94 174.66 7.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.18 0.514 . . . . 0.0 110.52 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.7 mt -72.95 128.18 34.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.353 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' HB3' ' C ' ' A' ' 25' ' ' CYS . 47.2 t -90.07 136.15 33.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.518 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -76.65 44.54 2.02 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 121.106 -0.568 . . . . 0.0 113.242 -179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 13' ' ' CYS . 41.8 t0 -151.67 164.63 36.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.419 ' HB ' ' CD2' ' A' ' 9' ' ' PHE . 36.6 p -124.55 139.0 54.28 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.933 0.397 . . . . 0.0 110.777 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . 5.8 t -97.93 -8.76 27.44 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.999 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.461 ' HA ' ' CE2' ' A' ' 22' ' ' TYR . 7.4 p90 -68.63 -24.68 64.58 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.641 0.258 . . . . 0.0 110.637 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.8 t -75.05 -58.47 4.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.995 0.426 . . . . 0.0 110.617 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -152.97 -56.47 0.13 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.927 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' HA2' ' SG ' ' A' ' 8' ' ' CYS . . . 175.67 149.25 7.29 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 -179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.643 ' SG ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -64.99 131.62 47.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.723 0.296 . . . . 0.0 110.652 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -73.1 -38.34 66.4 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.457 0.54 . . . . 0.0 112.457 -178.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.535 ' HB3' ' CB ' ' A' ' 18' ' ' CYS . 55.8 t0 -66.88 130.44 43.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.755 0.312 . . . . 0.0 110.755 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -72.36 -21.29 61.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.921 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.17 -14.44 38.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.862 0.839 . . . . 0.0 109.223 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.535 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . 47.2 t -89.53 141.77 28.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.408 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 31.0 t -108.53 149.95 28.14 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 121.409 0.624 . . . . 0.0 110.594 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.643 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 47.6 t -69.25 128.23 35.88 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.109 -1.405 . . . . 0.0 111.716 -179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 24' ' ' ILE . 44.1 t30 -152.18 148.21 27.33 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TYR . . . . . 0.461 ' CE2' ' HA ' ' A' ' 9' ' ' PHE . 4.9 m-85 -111.34 134.29 21.18 Favored Pre-proline 0 C--N 1.312 -1.064 0 CA-C-O 120.955 0.407 . . . . 0.0 111.102 -179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -82.4 -36.01 1.96 Allowed 'Cis proline' 0 CA--C 1.534 0.504 0 C-N-CA 122.941 -1.691 . . . . 0.0 112.706 -0.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.704 HD13 ' H ' ' A' ' 24' ' ' ILE . 0.2 OUTLIER -89.1 152.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.491 -179.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 8' ' ' CYS . 69.7 m -85.98 172.65 10.51 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.056 0.455 . . . . 0.0 111.32 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.6 m -126.14 149.84 31.28 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.29 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HE3' ' HB3' ' A' ' 27' ' ' LYS . 1.7 tmmt? -146.53 125.02 12.39 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 124.254 1.022 . . . . 0.0 112.061 -177.603 . . . . . . . . 0 0 . 1 stop_ save_